omeprazole and pantoprazole

omeprazole has been researched along with pantoprazole in 676 studies

Research

Studies (676)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	169 (25.00)	18.2507
2000's	386 (57.10)	29.6817
2010's	96 (14.20)	24.3611
2020's	25 (3.70)	2.80

Authors

Authors	Studies
Figala, V; Klemm, K; Kohl, B; Krüger, U; Rainer, G; Schaefer, H; Senn-Bilfinger, J; Simon, WA; Sturm, E	1
Nakamura, K; Nishikawa, Y; Seto, Y; Tada, K; Tanitame, A; Terauchi, H	1
Fromm, MF; Klotz, U; Pauli-Magnus, C; Rekersbrink, S	1
Beijnen, JH; Borst, P; Breedveld, P; Pluim, D; Schellens, JH; Schinkel, AH; Sönmezer, O; Tibben, MM; van Tellingen, O; Zelcer, N	1
Bariwal, J; Bhosale, AV; Jagtap, JR; Jain, KS; Kale, AP; Shah, AK; Shelke, SM	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Pérez-Villanueva, J; Romo-Mancillas, A; Yépez-Mulia, L	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Dalvie, D; Loi, CM; Smith, DA	1
Fako, VE; Liu, JY; Pflug, B; Wu, X; Zhang, JT	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bala, V; Chhonker, YS	1
Beghyn, T; Bosc, D; Charton, J; Deprez, B; Deprez-Poulain, R; Guillaume, V; Herledan, A; Hermant, P; Landry, V; Leroux, F; Liang, W; Pottiez, V; Sheng, L; Tang, WJ; Urata, S; Warenghem, S	1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF	1
Beil, W; Sewing, KF; Staar, U	1
Doyle, E; Huber, R; Picot, VS	1
Bliesath, H; Hartmann, M; Lühmann, R; Müller, P; Schneider, A; Simon, B; Wurst, W	1
Ockert, D; Reznik, GK; Rohr, I	1
Christ, B; Hauschke, D; Ockert, D; Tuch, K	1
Khalil, H; Leucht, U; Lühmann, R; Müller, P; Schneider, A; Simon, B	1
Dorrian, CA; Fullarton, GM; Harwood, J; Macdonald, AM; McColl, KE; Nujumi, AM	1
Broom, C; Hannan, A; Walt, RP; Weil, J	1
Büdingen, C; Fahr, S; Kinder, B; Koske, M; Simon, WA	1
Bräuer, U; Kromer, W; Postius, S	1
Bliesath, H; Hartmann, M; Huber, R; Lührmann, B; Schulz, HU; Steinijans, VW; Wurst, W	2
Hartmann, M; Huber, R; Radtke, HW; Steinijans, VW	2
Klemm, K; Leying, H; Opferkuch, W; Suerbaum, S	1
Bliesath, H; Hartmann, M; Huber, R; Lühmann, R; Müller, P; Simon, B; Wurst, W	1
Gönne, S; Kromer, W; Postius, S; Riedel, R	1
Hartmann, R; Huber, R; Lühmann, R; Marinis, E; Müller, P; Simon, B; Wurst, W	1
Fallowfield, C; Keeling, DJ; Laing, SM; Simon, WA; Taylor, AG	1
Doyle, E; McDowall, RD; Murkitt, GS; Picot, VS; Rogers, SJ	1
Brand, U; Gönne, S; Hanauer, G; Kromer, W; Parsons, ME; Postius, S; Riedel, R; Simon, WA	1
Banks, MC; Doyle, E; Huber, R; Müller, W; Norwood, PC; Rogers, SJ	1
Bliesath, H; Bohnenkamp, W; Hartmann, M; Huber, R; Lühmann, R; Müller, P; Simon, B; Wurst, W	1
Dítĕ, P; Prásek, J	1
Besancon, M; Prinz, C; Sachs, G; Shin, JM; Simon, A	1
Classen, M; Schepp, W	1
Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B	1
Beker, JA; Bianchi Porro, G; Bigard, MA; Delle Fave, G; Devis, G; Gouerou, H; Maier, C	1
Bliesath, H; Duursema, L; Groenewoud, G; Hundt, HK; Middle, MV; Müller, FO; Schall, R; Steinijans, VW	1
Herz, R; Hölscher, AH; Mössner, J; Schneider, A	1
Bliesath, H; Groenewoud, G; Huber, R; Hundt, HK; Middle, MV; Müller, FO; Schall, R; Steinijans, VW	2
Hotz, J; Plein, K; Rose, K; Schönekäs, H	1
Gütz, H; Hüttemann, W; Schepp, W; Witzel, L	1
Cremer, M; Delle Fave, G; Lambert, R; Lamers, CB; Maier, C	1
Classen, M; Dammann, HG; Koop, H; Lühmann, R; Schepp, W; Schneider, A	1
Bethke, T; Burkhardt, F; Dammann, HG; Khalil, H; Luehmann, R; Wolf, N	1
Creutzfeldt, W	2
Adamek, RJ; Opferkuch, W; Pfaffenbach, B; Ricken, D; Szymanski, C; Wegener, M	1
Bliesath, H; Hartmann, M; Huber, R; Radtke, HW; Steinijans, VW; Wurst, W; Zech, K	3
Bliesath, H; De Mey, C; Hartmann, M; Huber, R; Meineke, I; Steinijans, VW; Wurst, W	2
Benet, LZ; Zech, K	1
Tucker, GT	1
Londong, W	1
Bader, JP; Delchier, JC	1
Rehner, M; Schepp, W; Witzel, L	1
Brunner, G; Harke, U	1
Arnold, R	1
Judmaier, G; Koelz, HR	1
Bliesath, H; Hartmann, M; Huber, R; Lühmann, R; Wurst, W	2
Besancon, M; Sachs, G; Shin, JM; Simon, A	2
de Mey, C; Laroche, J; Meineke, I; Pue, MA	1
Bliesath, H; Hartmann, M; Lühmann, R; Wurst, W	1
Bliesath, H; Hartmann, M; Huber, R; Koch, HJ; Kunz, K; Steinijans, VW; Wurst, W	2
Huber, R; Kohl, B; Sachs, G; Senn-Bilfinger, J; Simon, WA; Sturm, E	1
Rehner, M; Rohner, HG; Schepp, W	1
Kromer, W	2
Kaplan, B; Mears, JM	1
Knudsen, T; Wilson, BV	1
Bliesath, H; Hartmann, M; Huber, R; Lühmann, R; Steinijans, VW; Zech, K	2
Bliesath, H; Hartmann, M; Huber, R; Lücker, PW; Lühmann, R; Theiss, U; Wurst, W	1
Bethke, TD; Botha, JF; Cariem, AK; Eloff, FP; Grundling, HD; Honiball, PJ; Marks, IN; Segal, I; Simjee, AE; Spies, SK; Theron, I; van Rensburg, CJ; van Zyl, JH	1
Huber, R; Kolassa, N; Radtke, HW; Steinijans, VW; Zech, K	1
Bliesath, H; Huber, R; Koch, HJ; Mascher, H; Steinijans, VW; Wurst, W	2
Bliesath, H; Huber, R; Koch, HJ; Kunz, K; Steinijans, VW; Wurst, W	2
Tanaka, M; Yamazaki, H	1
Belaïche, J; Colin, R; Corinaldesi, R; Geldof, H; Maier, C; Valentini, M	1
Andersson, T	1
Bliesath, H; Brod, I; Gugler, R; Hartmann, M; Huber, R; Klotz, U; Rudi, J; Steinijans, VW; Wurst, W	1
Fitton, A; Wiseman, L	1
Arnold, R; Eissele, R; Fischer, R; Flüg, M; Koop, H; Kuly, S; Lühmann, R; Mönnikes, H; Rose, K; Schneider, A	1
Hakusui, H; Nakamichi, N; Ryokawa, Y; Sekino, H; Tanaka, M; Yamazaki, H	1
Bliesath, H; Hartmann, M; Huber, R; Koch, HJ; Mascher, H; Steinijans, VW; Wurst, W	1
Lamers, CB	1
Parsons, ME	1
Meyer, UA	1
Bardhan, KD	1
Leonhardt, U; Ramadori, G; Ritzel, U	1
Dítĕ, P; Drazná, E; Dufek, V; Dvorák, M; Fric, P; Huslarová, A; Jirásek, V; Kunovská, M; Münzová, H; Pelech, T; Petrtýl, J; Roth, Z; Svoboda, J; Zádorová, Z; Zavoral, M	1
Birkel, M; Bliesath, H; Ehrlich, A; Fuder, H; Hartmann, M; Huber, R; Lücker, PW; Steinijans, VW; Timmer, W; Wieckhorst, G; Wurst, W	1
Hildebrandt, AG; Kleeberg, U; Krusekopf, S; Ruckpaul, K	1
Labenz, J; Lütke, A; Stolte, M; Tillenburg, B; Weismüller, J	1
Eberle, D; Hummel, RP; Kuhn, R	1
Florent, C; Forestier, S	1
Hakusui, H; Nakamichi, N; Sekino, H; Tanaka, M; Yamazaki, H	1
Andersson, T; Unge, P	1
Berstad, A; Hatlebakk, JG	1
Hakusui, H; Masubuchi, N; Okazaki, O	2
Bateman, DN	1
Lühmann, R; Müssig, S; Schneider, A; Witzel, L	1
Abucar, A; Armbrecht, U; Hameeteman, W; Schneider, A; Stockbrügger, RW	1
Adamek, RJ; Pfaffenbach, B; Szymanski, C	3
Masubuchi, N; Okazaki, O	1
Andersson, K; Bayati, A; Lee, H; Lorentzon, P	1
Chiocca, JC; Salis, GB	1
Döbrönte, Z; Juhász, L; Lonovics, J; Papp, J	1
Hakusui, H; Ishizaki, T; Kaneko, S; Ohkubo, T; Otani, K; Ryokawa, Y; Sugawara, K; Suzuki, A; Tanaka, M; Yamamori, S	1
Dohmen, W; Seelis, RE	1
Hartmann, M; Huber, R; Kromer, W; Krüger, U; Steinijans, VW	1
Daikeler, R; Glaser, J; Hein, J; Schmidt, M; Stolte, M; Vieth, M; Weithofer, G	1
Malfertheiner, P; Nakao, M	1
Andersson, T; Holmberg, J; Röhss, K; Walan, A	1
Bahlmann, J; Hartmann, M; Huber, R; Kliem, V; Lühmann, R; Wurst, W	1
Müller, P; Simon, B	1
Hetzel, D	1
Andriulli, A; Festa, V; Perri, F	1
Koop, H; Maier, C; Mössner, J; Porst, H; Schneider, A; Wübbolding, H	1
Lambert, JR; Treiber, G	1
Girdwood, AH; Grundlings, HD; Hanslo, D; Louw, JA; Marks, IN; van Rensburg, CJ	1
Bardhan, KD; Brookes, A; Cherian, P; Jones, RB; McCaldin, B; Morris, P; Morton, D; Perry, MJ; Slater, DN; Thompson, M	1
Diehl, KL; Geyer, P; Jaspersen, D; Martens, E; Schoeppner, H	1
Adler, G; Ellenrieder, V; Fensterer, H; Glasbrenner, B; Waurick, M	1
Améndola, R; Corti, R; Ferro, FE; Kogan, Z; Lineado, A; Morgade, L; Musi, AO; Roldán, CD; Schenone, L; Solagna, A; Valero, J; Zerbo, O	1
Gamberini, S; Gullini, S; Matarese, V; Pazzi, P; Rizzo, C; Scagliarini, R	1
Li, AP; Masubuchi, N; Okazaki, O	1
Gleiter, CH	1
Dettmer, A; Fischer, R; Lühmann, R; Schneider, A; Sielaff, F; Vogt, R	1
Adamek, RJ; Bethke, TD	1
Meier, E; Meining, A; Stolte, M	1
Zaigler, M	1
Ehrlich, A; Emeklibas, S; Fuder, H; Hartmann, M; Lücker, PW; Lühmann, R; Timmer, W; Wurst, W	1
Bliesath, H; Hartmann, M; Huber, R; Koch, H; Mascher, H; Steinijans, VW; Wurst, W	1
Masubuchi, N; Tanaka, M; Yamazaki, H	1
Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C	1
Dattilo, M; Figura, N	1
Bisso, G; Celle, G; Fiorucci, S; Malesci, A; Mela, GS; Pivari, M; Savarino, V; Termini, R; Usai, P; Vigneri, S; Zentilin, P	1
Kato, S; Konaka, A; Nishijima, M; Takeuchi, K; Yasuhiro, T	1
Gadenstaetter, M; Glaser, K; Hinder, RA; Profanter, C; Wetscher, GJ	1
Bozzola, L; Di Mario, F; Franceschi, M; Furlan, F; Leandro, G; Pilotto, A; Rassu, M; Valerio, G	1
Bliesath, H; Hartmann, M; Koch, H; Mascher, H; Steinijans, VW; Wurst, W; Zech, K	1
Addolorato, G; Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, GB; Papa, A	1
Abdul Aal, GM; Abdul Rasheed, Z; Awad, S; Dajani, AI; Gautam, S; Nayal, S; Nounou, M; Ukabam, S	1
Abdul Aal, G; Abdul Rasheed, Z; Awad, S; Dajani, AI; Gautam, S; Nayal, S; Nounou, MA; Ukabam, S	1
Cain, C; Holtmann, G; Malfertheiner, P	1
Faure, C; Languepin, J; Pelatan, C	1
Horbach, S; Kromer, W; Lühmann, R	1
Eloff, FP; Fischer, R; Grundling, HD; Honiball, PJ; Louw, JA; Simjee, AE; Spies, SK; Theron, I; Van Rensburg, CJ; Van Zyl, JH	1
Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Nuciforo, G	2
Ferron, GM; Fruncillo, RJ; Martin, PT; Mayer, PR; Paul, JC; Yacoub, L	1
Nagao, T; Nishioka, K; Urushidani, T	1
Caballero Plasencia, A; Carmona Soria, I; Herrerías Gutiérrez, J; López-Andrade, A; Martín Ruiz, J; Rodríguez Téllez, M; Valenzuela Barranco, M	1
Adler, G; Boeck, W; Ellenrieder, V; Glasbrenner, B; Marre, R; Richter, C	1
Dilger, K; Klotz, U; Zheng, Z	1
Ekpe, A; Jacobsen, T	1
Martin, P; McKeand, W; Ohning, G; Paul, J; Pisegna, JR; Walsh, JH	1
Burkhardt, F; Dammann, HG	1
Deprez, P; Escourrou, J; Fischer, R; Geldof, H; Maier, C; Saggioro, A	1
De Mascarel, A; Lamouliatte, H; Megraud, F; Samoyeau, R	1
Modlin, I; Playford, RJ; Podas, T	1
Axon, AT; Bardhan, KD; Braun, W; Cooper, BT; Dillon, J; Gatz, G; Tildesley, G; Wyatt, JI	1
Ivandić, A; Pezerović, D; Stimac, D; Takac, B; Vcev, A; Vceva, A	1
Bustamante, M; Stollman, N	1
de Paula Castro, L; Lyra, LG; Malafaia, O; Meneghelli, UG; Zaterka, S	1
Bong, JL; Douglas, WS; Lucke, TW	1
Lorf, T; Ramadori, G; Ringe, B; Schwörer, H	2
Dammann, HG; Fölsch, UR; Hahn, EG; Kirchner, T; Kist, M; Klör, HU; Strobel, S; von Kleist, DH	1
Morgan, CA; Nairn, P; Yusoff, IF	1
Fitscha, P; Schweeger, I; Sinzinger, H	1
Horvat, D; Ivandić, A; Jurisić-Orzen, D; Kotromanović, Z; Maksimović, Z; Males, J; Mandić, B; Nedić, P; Pezerović, D; Stimac, D; Stimac, T; Takac, B; Vcev, A; Vceva, A; Vladika, I; Vranjes, Z	1
Lew, E; Martin, P; Maton, PN; Metz, DC; Paul, J; Pisegna, JR; Pratha, V	1
Moustafa, AA	1
Beg, M; Bochenek, W; Forsmark, C; Lew, EA; Metz, DC; Modlin, IM; Pisegna, JR; Soffer, EF; Starr, JA; Walsh, JH	1
Goldwater, DR; Hunt, RH; Pan, WJ; Pilmer, BL; Zhang, Y	1
Bethke, T; de K Grundling, H; Fischer, R; O'Keefe, SJ; Retief, FJ; Theron, I; van Rensburg, CJ; van Zyl, JH	1
Eherer, A; Friedrich, G; Habermann, W; Lindbichler, F; Raith, J	1
Bakke, I; Brenna, E; Qvigstad, G; Sandvik, AK; Waldum, HL	1
Armuzzi, A; Gasbarrini, A; Gasbarrini, G; Ghirlanda, G; Ojetti, V; Pitocco, D; Pola, P; Silveri, NG	1
Fumagalli, I; Hotz, J; Lühmann, R; Plein, K; Schneider, A; Wurzer, H	1
Carpio, D; García Grávalos, R; Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM	1
Grau Amorós, J	1
Bratović, I; Gogov, B; Gribajcević, M; Lacević, N; Radović, S; Vukobrat-Bijedić, Z	1
Geus, WP; Lamers, CB; Mathôt, RA; Mulder, PG	1
Battaglia, G; Di Mario, F; Franceschi, M; Germanà, B; Leandro, G; Marin, R; Pilotto, A; Valerio, G	1
Horn, J	1
Daake, H; Frevel, M; Janisch, HD; Kellner, HU; Krezdorn, HG; Tanneberger, D; Wack, R	1
Bianchi Porro, G; Imbesi, V; Lazzaroni, M; Montrone, F; Santagada, T	1
Malki, SA; Yeomans, ND	1
Howden, CW	1
Dunn, NR; Freemantle, S; Martin, RM; Shakir, S	1
Cheah, P; Chin, S; Goh, K; Parasakthi, N; Ranjeev, C; Rosmawati, M; Tan, Y	1
Metz, DC	1
Botta, F; Chiarbonello, B; Fasoli, A; Giannini, E; Lantieri, PB; Malfatti, F; Risso, D; Romagnoli, P; Savarino, V; Testa, R	1
Thomson, AB	1
Bochenek, W; Richter, JE	1
Avner, DL	1
Trépanier, EF	1
Jungnickel, PW	1
Areni, A; Biasco, G; Calabrese, C; Di Febo, G; Miglioli, M; Scialpi, C	1
Bedogni, G; Bertoni, G; Ghirarduzzi, A; Iori, I; Silingardi, M; Tincani, E	1
Pisegna, JR	3
Fiebiger, W; Raderer, M; Stummvoll, G; Weinländer, G	1
Rosandić, M	1
Armuzzi, A; Bartolozzi, F; Cammarota, G; Candelli, M; Canducci, F; Cremonini, F; De Lorenzo, A; Gasbarrini, A; Gasbarrini, G; Ojetti, V; Pola, P; Santarelli, L	1
Humphries, TJ	1
Andriulli, A; Bergoli, ML; Caruso, N; Clemente, R; Festa, V; Perri, F; Quitadamo, M; Villani, MR	1
Dehesa, C; Kassel, G	1
Bohle, W; Zoller, WG	1
Ferron, GM; Mayer, PR; McKeand, W	1
Menges, M; Müller, M; Zeitz, M	1
Ishizaki, T; Kaneko, S; Ohkubo, T; Otani, K; Ryokawa, Y; Sugawara, K; Suzuki, A; Tanaka, M	1
Broutet, N; de Mascarel, A; Lamouliatte, H; Marais, A; Mégraud, F; Salamon, R; Samoyeau, R	1
Lorf, T; Ramadori, G; Ringe, B; Schwrer, H	1
Anic, T; Aralica, G; Bilic, I; Buljat, G; Ivankovic, D; Mikus, D; Mise, S; Perovic, D; Petek, M; Prkacin, I; Rotkvic, I; Rucman, R; Seiwerth, S; Separovic, J; Sikiric, P; Stancic-Rokotov, D; Zoricic, I	1
Bakke, I; Chen, D; Håkanson, R; Tostrup-Skogaker, N; Waldum, HL; Zhao, CM	1
Athmann, C; Boldt, JH; Brunner, G	1
Biedermann, A; Kaspari, S; Mey, J	1
Bradley, CP; Greenfield, SM; Jones, MI; Jowett, S; Seal, R	1
Drewe, J; Geiser, HR; Meier, R; Wettstein, A	1
Bardou, M	1
Dupas, JL; Houcke, P; Samoyeau, R	1
Gerson, LB; Triadafilopoulos, G	1
Poole, P	1
Bardhan, KD; Bishop, AE; Cherian, P; Fischer, R; Lühmann, R; McCaldin, B; Morris, P; Ng, W; Perry, MJ; Polak, JM; Romanska, H; Rowland, A; Schneider, A; Thompson, M	1
Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR	1
Andriulli, A; Festa, V; Perri, F; Quitadamo, M; Villani, MR	1
Bozzola, L; Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Rassu, M; Soffiati, G; Valerio, G	1
Tytgat, GN	1
Chiu, YL; Freston, J; Lukasik, N; Pan, WJ; Täubel, J	1
Adamek, RJ; Behrendt, J; Wenzel, C	1
Azevedo, R; Correia, O; Delgado, L; Lomba Viana, H; Polónia, J	1
Bardhan, KD; van Rensburg, CJ	1
Caro, JJ; Salas, M; Ward, A	1
Brundler, R; Gaia, C; Gut, A; Halter, F; Inauen, W; Netzer, P	1
Abell, M; Ferron, GM; Getsy, J; Mayer, P; Noveck, RJ; Paul, J; Pockros, P; Preston, RA; Turner, M	1
Bardhan, KD; Van Rensburg, C	1
Hamlin, M; Kennedy, M; Shepherd, K	1
Herszényi, L; Tulassay, Z	1
Chiu, YL; Lukasik, NL; Pan, WJ; Pilmer, BL; Sharma, VK; Täubel, JJ	1
Gadenstaetter, M; Klaus, A; Klingler, PJ; Obrist, P; Profanter, C; Weiss, H; Wetscher, GJ; Wykypiel, H	1
Kaddu, S; Kränke, B; Mayr-Kanhäuser, S; Müllegger, RR	1
Armstrong, D; Paré, P; Pericak, D; Pyzyk, M	2
Fuleihan, N; Hamdan, AL; Sharara, AI; Younes, A	1
Samsom, M; Schwartz, MP; Smout, AJ; Van Berge Henegouwen, GP	1
Jensen, DM; Nieto, JM; Ohning, GV; Pisegna, JR; Tang, SJ	1
Désir, B; Poitras, P	1
Bochenek, W; Forsmark, C; Lew, EA; Metz, DC; Pisegna, JR; Soffer, EF; Starr, JA	1
Sachs, G; Welage, LS; Wolfe, MM	1
Barbir, A; Hovat, D; Ivandić, A; Kurbel, S; Mihaljević, S; Ostojić, R; Stimac, D; Takac, B; Vcev, A; Vceva, A	1
Cass, QB; Cassiano, NM; Degani, AL; Pedrazolli, J	1
Barth, J; Hahne, W	1
Appelman, SA; Chiu, YL; Goldwater, DR; Huang, JQ; Hunt, RH; James, CF; Keith, RG; Pilmer, BL; Sridhar, S; Thomson, AB	1
Anderloni, A; Bianchi Porro, G; Imbesi, V; Maconi, G; Parente, F; Sainaghi, M; Sangaletti, O	1
Vigl, M; Wessely, P; Zebenholzer, K	1
Bruni, AT; Ferreira, MM; Leite, VB	1
Bochenek, W; Castell, DO; Katz, PO; Tutuian, R	1
Bauer, A; Elsner, P; Hipler, C; Kaatz, M	1
Bhathal, PS; Macrae, FA; Royce, SG; Tagkalidis, PP	1
Hase, S; Takeuchi, K	1
Bochenek, WJ; Ferron, GM; Metz, DC; Paul, J; Pisegna, JR; Soffer, E; Turner, MB	1
Calvet, X; Gisbert, JP; Vallve, M; Vergara, M	1
Anaizi, NH; Dentinger, PJ; Swenson, CF	1
Gościmski, A; Matras, J; Wallner, G	1
Almeida, JR; Boaventura, S; Castro, LP; Ferrari, AP; Fischer, R; Haddad, MT; Jorge, JL; Leitão, O; Magalhães, AF; Maguilnik, I; Meneghelli, UG; Moraes-Filho, JP; Silva, E; Tolentino, M	1
Mignon, M; Ramdani, A; Samoyeau, R	1
de Groot, GH; Mulder, CJ; Otten, MH; Oudkerk Pool, M; Smit, JM; Tan, TG; van Milligen de Wit, AW; Westerveld, BD	1
Steinberg, KP	1
Morgan, D	1
Gollnick, H; Martens-Lobenhoffer, J; Meyer, FP; Stötzel, B; Tröger, U	1
Cabane, J; Ciroldi, M; Fardet, L; Izzedine, H; Tiev, KP	2
Tahboub, RM; Vanderhoff, BT	1
Armstrong, D; Gervais, M; Kazim, F; Pyzyk, M	1
Bermejo, F; Boixeda, D; Defarges, V; García-Plaza, A; Hernández-Ranz, F; López-Sanromán, A; Martín-De-Argila, C; Milicua, JM	1
He, JR; Ling, QH; Wang, CL; Wu, XP	1
Alvares Cabral, MM; Corrêa, PR; Dani, R; Esteves, AM; Moreira, LS; Nogueira, AM; Queiroz, DM; Reis, LF; Rocha, GA; Santos, A; Silva, LD; Tanure, J	1
Morozov, IA	1
Katelaris, P; Moore, MG; Sprogis, A; Talley, NJ	1
Eherer, A; Friedrich, G; Habermann, W; Kiesler, K	1
Abdel-Razak, O; Gazy, AA; Mahgoub, H; Moneeb, MS; Wahbi, AA	1
Cui, M; Hu, F; Jiang, H; Zheng, X	1
Thomson, AB; Yacyshyn, BR	1
Frissora, C; Katz, PO	1
Bochenek, W; DeVault, K; Kovacs, TO; Miska, D; Wilcox, CM	1
Cheer, SM; Faulds, D; Lamb, HM; Prakash, A	1
Cai, Q; Dabney-Smith, K; Ghazale, A; Nam, J	1
Bochenek, WJ; Metz, DC	1
Leitner, A; Zöllner, P	1
Avni, Y; Bruck, R; Frenkel, D; Levine, A; Moss, SF; Niv, Y; Shevah, O; Shirin, H	1
Key, C; Shakir, SA; Wilton, LV	1
De Micheli, E; Frazzoni, M; Grisendi, A; Savarino, V	1
Delgado, J; Dibildox, M; Gonzalez, J; Madrazo-de la Garza, A; Vargas, A; Yañez, P	1
Bochenek, W; Chey, W; Cryer, B; Forsmark, CE; Metz, DC; Pisegna, JR; Soffer, E	1
Huggins, RM; Latour, JK; Scates, AC	1
Biagini, R; Bilardi, C; Dulbecco, P; Gambaro, C; Iiritano, E; Mansi, C; Mele, MR; Savarino, V; Tessieri, L; Usai, P; Vigneri, S; Zentilin, P	1
Cordes, A; Maier, KP; Vogt, W	1
Bendheim, MØ; Martinsen, TC; Skogaker, NE; Waldum, HL	1
Beckerling, A; Gatz, G; Ulmer, HJ	1
Karlstadt, RG; Walker, K	1
Kleeberg, U; Krusekopf, S; Roots, I	1
Hiramoto, JS; Norton, JA; Terdiman, JP	1
Koelz, HR; Labenz, J; Petersen, KU; Rösch, W	2
Hogan, D; Pratha, V; Sachs, G; Shin, JM	1
Bohuschke, M; Costa Neves, B; Fumagalli, I; Gatz, G; Körner, T; Schütze, K; van Leendert, RJ	1
Brouwers, JR; Klok, RM; Postma, MJ; van Hout, BA	1
Bohuschke, M; Gatz, G; Kirchner, T; Kist, M; Leodolter, A; Malfertheiner, P; Peitz, U; Strobel, S	1
Bermejo, F; Boixeda, D; García Plaza, A; Hernández Ranz, F; López Sanromán, A; Martín De Argila, C	1
Armstrong, D; Goeree, R; Meyer, F; Paré, P; Pericak, D; Pyzyk, M	1
Franceschi, M; Leandro, G; Pilotto, A	1
Eherer, AJ; Friedrich, G; Habermann, W; Hammer, HF; Kiesler, K; Krejs, GJ	1
Radi, A	2
Blum, AL; Dorta, G; Jornod, P; Pantoflickova, D; Ravic, M	1
Wellhöfer, B	1
Hellström, PM; Vitols, S	1
Fedele, R; Isola, S; Mancuso, V; Mazzeo, L; Ricciardi, L; Saitta, S	1
Agbaba, D; Karljikovic-Rajic, K; Marinkovic, V; Novovic, D	1
Abell, M; Ferron, GM; Getsy, J; Ku, S; Mayer, PR; Paul, J; Unruh, M	1
de Boer, SY; de Boer, WA; Siem, H; v d Meeberg, PC	1
Urban, E	1
Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A	1
Abdel Razeq, SA; El-Abasawy, N; Fouad, MM; Ismail, MM; Salama, F	1
Karamanlioglu, B; Memiş, D; Pamukçu, Z; Saral, P; Turan, A; Türe, M	1
Lin, YA; Pauly, MV; Wang, YR	1
Balashova, NN; Busarova, GA; Maev, IV	1
Pais, SA; Yang, R	1
Gong, J; Luo, JY; Niu, CY; Wang, XQ; Zhu, YL	1
Gandhi, MS; Goswami, SS; Santani, D; Shah, MB; Shah, PJ	1
Hidalgo Balsera, A; Manso Rodríguez, G; Piedra Cerezal, A; Sánchez Alvarez, L	1
Erk, N	1
Bochenek, WJ; Davis, KD; El-Zimaity, HM; Fraga, PD; Graham, DY; Mack, ME; Osato, MS; Peters, S; Wang, W	1
Barbato, A; Landi, L; Panizzolo, C; Rugge, M; Semenzato, R	1
Chen, Y; Katz, PO; Miner, P; Sostek, M	1
Hartmann, M; Lühmann, R; Theron, I; Thorpe, A; van Rensburg, CJ; Venter, L; Wurst, W	1
Maltz, C	1
Dietrich, K; Fischer, R; González-Carro, P; Lühmann, R; Straszak, A; Stupnicki, T; Terjung, A; Thomas, KB	1
Améndola, R; Caruso, N; Corti, R; Diwecj, J; Menéndez, G; Schenone, L; Soutric, J	1
Ra, A; Tobe, SW	1
Castell, DO; Katz, PO; Tutuian, R; Xue, S	1
Agibalov, AN; Chubenko, SS; Gaĭdukov, VO; Onishenko, AV	1
Calabresi, L; Di Paolo, A; Ferrara, S; Pazzucconi, F; Sirtori, C; Tacca, MD	1
Bustamante Baléna, M; Ponce García, J	1
Boccali, I; Hennig, M; Pehl, C; Schepp, W	1
Aselmann, H; Bellin, T; Ceylan, D; Dahlke, MH; Flemming, P; Klempnauer, J; Meier, PN; Oldhafer, K; Piso, P; Schlitt, HJ	1
Bampton, PA; Craig, A; Hagan, S; Hebbard, GG; Yap, LM; Young, GP	1
Knoth, H	1
Weber, R	1
Calvet, X; Gisbert, JP; Khorrami, S; Pajares, JM	1
Gillessen, A	2
Kidd, M; Modlin, I	1
Sachs, G; Shin, JM	2
Singh, G	1
Becker, TL; de Mendonça, S; Gambero, A; Maróstica, M; Pedrazzoli, J; Ribeiro, ML	1
Aeed, H; Avni, Y; Boaz, M; Levine, A; Moss, SF; Niv, Y; Shabat-Sehayek, V; Shevah, O; Shirin, H	1
Loonen, AJ; Mookhoek, EJ	1
Guda, NM; Kreiner, MJ; Noonan, M; Partington, S; Vakil, N	1
Chen, A; Chen, JL; Hsu, PI; Jou, HS; Lai, KH; Lin, CK; Lo, CC; Lo, GH; Peng, NJ; Shie, CB; Tsai, PM; Tseng, HH; Wu, CJ	1
Karaoglu, AO; Yasa, MH; Yukselen, V	1
Ahlström, M; Andersson, TB; Li, XQ; Weidolf, L	1
Barrientos-Astigarraga, RE; de Nucci, G; Mendes, GD; Oliveira, CH; Peres, O; Rezende, VM	1
Fischer, R; van Rensburg, C; van Zyl, J; Vieweg, W	1
Ghazzawi, IM; Obeidat, WA; Zuriekat, FA	1
Akarsu, M; Bozbas, A; Hulagu, S; Kadayifci, A; Koruk, M; Savas, MC; Simsek, I; Sivri, B; Tozun, N; Uraz, S	1
Xie, ZY; Yang, BH; Zhang, YF; Zhong, DF	1
Bochenek, W; Fraga, P; Mack, M; Richter, JE; Sabesin, SM	1
Chen, SQ; Lu, YP; Wang, CH; Wang, LX; Yang, Z; Zhu, H	1
Connemann, B; Härtter, S; Hiemke, C; Sachse, J; Schönfeldt-Lecuona, C	1
Lind, T; Röhss, K; Wilder-Smith, C	1
Alonso, C; Bernal, JL; del Nozal, MJ; Jiménez, JJ; Toribio, L	1
Martin, RA	1
Andrews, CN; Atkinson, K; Enns, R; Fishman, M; Hahn, M; Kwan, P; Levy, A	2
Steward, DL	1
Hill, RK; Larson, N; Simpson, CB; Velazquez, R	1
Christiansen, SC; Eddleston, J; Kollmeier, AP; Zuraw, BL	1
D'Ambrosio, LP; Franceschi, M; Leandro, G; Longoa, MG; Orsitto, G; Perri, FC; Pilotto, A; Scarcelli, C	1
Hellström, PM	1
Chan, HH; Hsu, PI; Lai, KH; Lin, CK; Lo, CC; Lo, GH; Shie, CB; Tsai, PM; Wang, WM; Wu, CJ; Wu, DC	1
Arancia, G; Belardelli, F; De Milito, A; Fais, S; Federici, C; Iessi, E; Logozzi, M; Lozupone, F; Luciani, F; Lugini, L; Marra, M; Molinari, A; Montinaro, A; Parmiani, G; Rivoltini, L; Spada, M	1
Accornero, L; Bilardi, C; Dulbecco, P; Iiritano, E; Mamone, M; Mansi, C; Parodi, A; Reglioni, S; Savarino, E; Savarino, V; Vigneri, S; Zentilin, P	1
Iinuma, K; Kato, S; Konno, M; Maisawa, S; Nakayama, Y; Shimizu, T; Tajiri, H; Toyoda, S; Yoshimura, N	1
Buzás, GM	1
Ferron, GM; Mayer, PR; Plante, L; Unruh, M	1
Bochenek, WJ; Fraga, PD; Mack, ME; Metz, DC	1
Ahuja, V; Kashyap, PC; Madan, K; Sharma, MP	1
Katz, PO	2
Enns, R	1
Cho, SW; Hahm, KB; Kim, DK; Kim, HC; Kim, YB; Lee, JE; Oh, TY; Yeo, M	1
Joneja, JS; Raina, VK; Sharma, D; Sharma, DB	1
Orr, WC	1
Arnon, J; Clementi, M; De Santis, M; Diav-Citrin, O; Malm, H; Ornoy, A; Robert-Gnansia, E; Schaefer, C; Shechtman, S; Valti, E; van Tonningen, MR	1
Pauly, MV; Wang, YR	1
Michetti, P; Mottet, C	1
Bardhan, KD; Bishop, AE; Luehmann, R; McCaldin, B; Morris, P; Polak, JM; Romanska, HM; Rowland, A; Schaefer-Preuss, S; Thompson, M	1
Goossens, D; Jonkers, D; Russel, M; Stobberingh, E; Stockbrügger, R; Thijs, A; van den Bogaard, A	1
Kotar-Jordan, B; Ograjsek, N; Vrecer, F; Zupancic, V	1
Beglinger, C; Lehmann, FS	1
Fried, MW; Galanko, J; Mitchell, KL; Russo, MW; Schmitz, SM; Shaheen, NJ; Shrestha, R; Stuart, E; Zacks, S	1
Cortina, G; Dulai, GS; Fontana, L; Ippoliti, A; Jensen, DM	1
Kashif, M; Rahman, N	1
Breedveld, P; Cipriani, G; Pluim, D; Schellens, JH; Schinkel, AH; van Tellingen, O; Wielinga, P	1
Chen, X; Xie, Z; Zhong, D	1
Calleja, JL; De Tejada, AH; Navarro, A; Suarez, M	1
Babic, Z; Lucijanic-Mlinac, M; Marusic, M; Nesanovic, M; Stajcar, V	1
Allen, DG; Bersenas, AM; Conlon, PD; Mathews, KA	1
Ahnfelt, L; Dahl, OE; Eriksson, BI; Nehmiz, G; Rathgen, K; Stähle, H; Stangier, J; Svärd, R	1
Barry, M; Bennett, K; McGowan, B; Tilson, L	1
Bagin, R; Castell, D; Goldlust, B; Hepburn, B; Major, J	1
Cao, H; Hu, ZQ; Ikejima, T; Sun, LX; Wang, MW; Zhao, WH	1
Codina, C; Gratacós, L; Lluís, M; López, B; Nicolás, JM; Nogué, S; Ribas, J; Soy, D	1
Droździk, M; Ferenc, K; Gawrońska-Szklarz, B; Pawlik, A; Safranow, K; Starzyńska, T; Wrześniewska, J	1
Choi, EK; Hong, WS; Jung, HY; Kim, JH; Kim, JS; Lee, GH; Min, YI	1
Koteshwara, M; Ramakrishna, NV; Vishwottam, KN; Wishu, S	1
Huang, HH; Xie, ZY; Zhong, DF	1
Giguère, S; Ryan, CA; Sanchez, LC; Vickroy, T	1
Avgerinos, A; Bergele, C; Papaxoinis, K; Raptis, SA; Sgouros, S; Sklavos, P; Viazis, N; Vlachogiannakos, J	1
Abramo, A; Antonioli, L; Baldi, S; Blandizzi, C; Carazzina, G; Colucci, R; Del Tacca, M; Fornai, M; Lubrano, V; Natale, G; Tuccori, M	1
Berghöfer, P; Heinze, H; Kaspari, S; Kupcinskas, L	1
Bohuschke, M; Dekkers, CP; Gatz, G; Körner, T; Scholten, T; Schütze, K	1
Darabi, K	1
Singh, G; Triadafilopoulos, G	1
Xie, Z; Xu, H; Zhang, Y; Zhong, D	1
Holtmann, G	1
Halstead, LA	1
Brown, RE; Remák, E; Robinson, A; Yuen, C	1
Ateş, Y; Bağci, S; Ciğerim, M; Dağalp, K; Kadayifçi, A; Karslioğlu, Y; Savaş, MC; Uygun, A; Yeşilova, Z	1
Foucar, MK; Pai, RK; Snider, WK; Starkey, CR; Viswanatha, D; Wilson, CS	1
Bartsch, R; Drach, J; Hejna, M; Raderer, M; Wöhrer, S	1
Johnson, CE	1
Vakil, N	1
Calvet, X; Gomollón, F	1
Ademà, JM; Enrique, A; Esteller, E; Estivill, E; Matiño, E; Modolell, I; Segarra, F	1
Bates, D; Kaplan, GG; McDonald, D; Panaccione, R; Romagnuolo, J	1
Mori, S; Okazaki, K; Tahashi, K	1
Armstrong, D	1
Akdur, S; Genc, H; Karakan, S; Karakan, T; Kayatas, M; Ozisler, C; Sennaroglu, E; Ucler, R; Urun, Y	1
Burton, MS; Hogan, DL; Karlstadt, RG; Lane, JR; Lynn, RB; Pratha, VS; Williams, PJ	1
Chey, W; Comer, GM; Cryer, B; Forsmark, CE; Metz, DC; Pisegna, JR; Soffer, E	1
Areni, A; Calabrese, C; Di Febo, G; Fabbri, A; Scialpi, C; Zahlane, D	1
Borody, TJ; Clancy, R; Herdman, K; Llorente, R; Ng, C; Pang, G; Surace, R; Wettstein, AR	1
Derk, CT; Jacobs-Kosmin, D; Sandorfi, N	1
Hartmann, HJ; Simon, WA; Sturm, E; Weser, U	1
Franceschi, M; Leandro, G; Perri, F; Pilotto, A	1
Colomé, LM; Guterres, SS; Pohlmann, AR; Raffin, RP	1
Aladağ, M; Alan, H; Ateş, F; Cikim, K; Demirel, U; Harputluoğlu, MM; Hilmioğlu, F; Kantarçeken, B; Karincaoğlu, M; Sertkaya, A; Yildirim, B	1
Domanovits, H; Kavouras, S; Matalas, A; Skenderi, K; Sodeck, GH; Thalmann, M; Yannikouris, N	1
Stark, JE; Vesta, KS; Watson, TD	1
Amer, F; Hunt, B; Kukulka, MJ; Metz, DC; Samra, N; Vakily, M	1
Avorn, J; Canning, C; Dormuth, CR; Glynn, RJ; Maclure, M; Schneeweiss, S	1
Coleman, PL; Geevasinga, N; Roger, SD; Webster, AC	1
Bishop, PR; Comer, GM; Gremse, D; Soffer, EF; Tolia, V; Tsou, VM	1
Gunaratnam, NT; Inadomi, J; Jessup, TP; Lascewski, DP	1
Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Mujeeb, SA; Shafi, HM; Shah, AH; Shah, NA; Sodhi, JS; Yattoo, GN; Zargar, SA	1
Gillessen, A; Naumburger, A; Schöffel, L	1
El-Bardicy, MG; El-Sherif, ZA; El-Tarras, MF; Mohamed, AO	1
Clark, DW; Strandell, J	1
Bozkurt, B; Demirkan, K; Kalyoncu, AF; Karakaya, G	1
Akyol, H; Barisik, NO; Bingul, S; Colak, E; Kaptanoglu, L; Kucuk, HF; Kurt, N; Torlak, OA	1
Butruk, E; de Boer, SY; Dekkers, CP; Fischer, R; Lühmann, R; Raps, D; Regula, J; Simon, L; Terjung, A; Thomas, KB	1
El-Eswed, B; Qaisi, AM; Tutunji, LF; Tutunji, MF	1
Koçyiğit-Kaymakçoğlu, B; Rollas, S; Unsalan, S	1
Garcia, I; Krishna, P; Rosen, CA	1
Edwards, SJ; Lind, T; Lundell, L	1
Field, B; Hogan, DL; Lynn, RB; Metz, DC; Pratha, V	1
Celikel, T; Dogan, M; Eryuksel, E; Golabi, P; Sehitoglu, MA	1
Harrell, SP; Koopman, J; Lentsch, E; Parker, K; Winstead, W; Wo, JM	1
Comer, GM; Jensen, DM; Pace, SC; Soffer, E	1
Boehm, BO; Dietrich, JW	1
Mönnikes, H	1
Brørs, O	1
Manley, P; Marshall, MR; Pilmore, H; Simpson, IJ; Thein, H; Voss, D; Williams, L	1
Keyvani, L; Leeson, S; Murthy, S; Targownik, LE	1
Cheng, YC; Lin, HJ; Lo, WC; Perng, CL	1
Bayan, K; Canoruç, F; Daniş, R; Dursun, M; Ertem, M; Kilinç, N; Tüzün, Y; Yilmaz, S	1
Esplugues, JV; Martí-Cabrera, M; Ponce, J	1
Lin, HJ	1
Andersson, S; Nelander, H; Ohlén, K	1
Forrester, MB	1
Antunes, E; Gambero, A; Martins de Oliveira, R; Pedrazzoli, J	1
Molnar, B; Mullner, K; Tulassay, Z	1
Boyer, K; Tolia, V	1
Andriulli, A; Annese, V; D'Ambrosio, LP; Di Mario, F; Franceschi, M; Leandro, G; Paris, F; Pilotto, A; Scarcelli, C; Seripa, D	1
Cho, YK; Choi, HS; Hwang, SJ; Jeon, WK; Kim, BI; Kim, HJ; Park, DI; Park, JS; Sohn, CI	1
Bodner, J; Bonatti, H; Gadenstaetter, M; Hugl, B; Wetscher, GJ; Wykypiel, H	1
Bygum, A; Dam, C	1
Galmiche, JP	1
Labenz, J	1
Cheong, JY; Cho, SW; Kim, DK; Lee, KJ; Park, HJ; Yeo, M	1
Pai, N; Pai, V	1
Franck, PF; Geus, WP; Hunfeld, NG; Kuipers, EJ; Mathot, RA; Mulder, PG; Touw, DJ; van Schaik, RH	1
Pérez-Manauta, J	1
Andersson, T; Weidolf, L	1
Brugnera, R; Calabrese, C; Di Febo, G; Gabusi, V; Gionchetti, P; Liguori, G; Rizzello, F; Straforini, G	1
Charlemagne, A; Fagnani, F; Le Jeunne, P; Mouly, S	1
Calvet, X; Garcia, P; Gisbert, JP; Vergara, M; Villoria, A	1
Naseri, E; Yenişehirli, A	1
Koutsostathis, N; Stefanaki, E; Vovolis, V	1
Bagin, RG; Ballard, ED; Gautille, TC; Howden, CW; Koch, FK	1
Gursoy, O; Memiş, D; Sut, N	1
Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Shon, CI; Song, MJ	1
Christ, G; Jilma, B; Kreiner, G; Lang, IM; Siller-Matula, JM; Spiel, AO	1
Brunet, C; Dine, T; Dupin-Spriet, T; Gressier, B; Kambia, NK; Luyckx, M	1
Zheng, RN	1
Pellicano, R	1
Goto, S; Serebruany, V	1
Braun, S; Hadamitzky, M; Kastrati, A; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; Vogt, W; von Beckerath, N	1
Bharathi, DV; Chatki, PK; Hotha, KK; Jagadeesh, B; Mullangi, R; Naidu, A; Thriveni, K	1
Davies, JE; Lickorish, D; Sarraf, F; Sheraly, AR	1
Bredenoord, AJ; ten Berg, JM; van Werkum, JW	1
Mathews, KD; Norgard, NB; Wall, GC	1
Mihoubi, A; Tho, A	1
Cortes, JR; Gonzalez-Nuñez, MA; Masa, JF; Molina-Infante, J; Perez-G, M; Rivas, MD; Sanchez, JF; Zamorano, J	1
Tan, VP; Wong, BC	1
Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Shah, AH; Sodhi, JS; U-Saif, R; Yatoo, GN; Zargar, SA	1
Alessi, MC; Bali, L; Bonnet, JL; Brissy, O; Cuisset, T; Frere, C; Gaborit, B; Morange, PE; Poyet, R; Quilici, J	1
Lekkerkerker, JF; Mulder, CJ; Otten, MH	1
Bretagne, JF	1
Hunt, RH; Padol, S; Yaghoobi, M; Yuan, Y	1
Chan, FK	1
Chang, CH; Hsu, PI; Huang, YB; Lin, PC; Tseng, PL	1
de Sousa, M; Garrido, A; Iborra, MI; Saperas, E	1
Gaedigk, A; Kearns, GL; Leeder, JS	1
Börgel, J; Endres, HG; Engelhardt, A; Krüger, JC; Lask, S; Mügge, A; Neubauer, H	1
Keyhanfar, F; Mahmoudian, M; Motevalian, M; Noubarani, M	1
Descotes, J; Gouraud, A; Vial, T; Vochelle, V	1
Howden, CW; Kahrilas, PJ	1
Angiolillo, DJ; Bergougnan, L; Cheng, S; Dubar, M; Gibson, CM; Hurbin, F; LaCreta, FP; Nicolas, O; Ollier, C; Perrin, L	1
El-Tantawy, AS; Khalil, SM; Mohamed, GG; Nour El-Dien, FA	1
Hunt, R; Sachs, G; Shin, JM	1
Cai, J; Fan, L; Liu, CF; Sun, J; Wang, ZG; Wu, Q	1
Caínzos-Romero, T; Fernández-Fernández, FJ; Ferreira-González, L; Sesma, P	1
Bjornsson, E	1
Juurlink, DN	1
Benninga, MA; Omari, TI; Smits, MJ; Tabbers, MM; van der Pol, RJ; van Wijk, MP	1
Albuquerque, A; Araújo, C; Fontes-Carvalho, R; Pimentel-Nunes, P; Ribeiro, VG	1
Castel, A; van 't Wout, J; Vlasveld, LT	1
Hasenfuss, G; Maier, L; Schillinger, W; Schmitto, J; Schotola, H; Schwörer, H; Sohns, C; Sossalla, S; Toischer, K	1
Buckley, DB; Kazmi, F; Ogilvie, BW; Paris, BL; Parkinson, A; Rostami-Hodjegan, A; Toren, P; Yerino, P	1
Chen, X; Liu, Y; Peng, M; Shi, S; Zhang, Y	1
Hwang, JH; Jeong, SH; Jo, HJ; Jung, HC; Kim, JM; Kim, JW; Kim, JY; Kim, N; Lee, DH; Lee, JH; Lee, SH; Nam, RH; Park, HK; Park, YS; Shin, CM; Song, IS	1
Buyukafsar, K; Erenmemisoglu, A; Ozkur, M; Pektas, M; Un, I; Yurtsever, AS	1
Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B	1
de Rooij, FW; Huisman, EJ; Renooij, W; Siersema, PD; van Erpecum, KJ; van Hoek, B; van Vlerken, LG	1
Bernasconi, GC; Cass, QB; Cassiano, NM; Oliveira, RV	1
Chang, SY; Chen, C; Chimalakonda, A; Hurley, J; Rodrigues, AD; Thorndike, D; Vuppugalla, R; Wagner, A; Yang, Z; Zvyaga, T	1
Abdul Razzak, E; Herrero, T; Tomás, M; Tornero, P	1
Bravi, MC; Colucci, P; Famularo, G; Gasbarrone, L; Minisola, G	1
Cegieła, U; Folwarczna, J; Nowińska, B; Pytlik, M	1
Bytzer, P; Mattsson, H; van Zanten, SV; Wernersson, B	1
Chularojanamontri, L; Dhana, N; Jiamton, S; Jongjarearnprasert, K; Kulthanan, K; Manapajon, A; Suvanasuthi, S	1
Chang, CY; Lin, HC; Lo, GH; Perng, DS; Tai, CM; Wang, HM	1
Banahan, BF; Bentley, JP; Datar, MV; Mahabaleshwarkar, RK; Null, KD; Strum, MW; Yang, Y	1
Baker, RD; Baker, SS; Burlingame, AL; Egilmez, NK; Forte, JG; Liu, W; Trinidad, J; Virtuoso, LP; Zhu, L	1
Almebayadh, M; Avril, MF; Carlotti, A; Dupin, N; Goulvestre, C; Le Guern, V; Mouthon, L; Regnier-Rosencher, E	1
Bhushan, R; Dixit, S; Dubey, R	1
Abramowitz, Y; Arbel, Y; Banai, S; Berliner, S; Birati, EY; Deutsch, V; Finkelstein, A; Halkin, A; Herz, I; Keren, G; Kletzel, H	1
Hatlebakk, JG; Jonasson, C; Tvete, IF	1
Forte, JG; Guan, S; Machen, TE; Watson, C; Zhu, L	1
Afonso, C; Rajab, A; Rudler, H; Seuleiman, M; Touma, M	1
Angioli, R; Damiani, P; Improta, G; Petrella, C; Plotti, F; Scarpignato, C; Severini, C; Signore, F; Terranova, C	1
Cao, Z; Kang, T; Tian, C; Yu, D; Zhu, L; Zhu, R	1
Burburan, PJ; Matubia, VN; Parkin, DW; Ramcharan, SS; Rosario, I; Shea, TA; Stockman, BJ	1
Adams, AL; Black, MH; Jacobsen, SJ; Shi, JM; Zhang, JL	1
Juurlink, D	1
Bhatt, DL	1
Kim, EH; Kim, HY; Lee, SK; Park, CH; Roh, YH	1
Buder, R; Firlinger, F; Lenz, K; Lohr, G; Voglmayr, M	1
Abad-Santos, F; Cabaleiro, T; Ochoa, D; Prieto-Pérez, R; Rivas, Â; Román, M; Sánchez-Rojas, SD; Talegón, M	1
Popadynets', IR	1
Bilker, WB; Brensinger, CM; Flockhart, DA; Freeman, CP; Hennessy, S; Kasner, SE; Kimmel, SE; Leonard, CE	1
Hauser, G; JajacKnez, A; Salkic, N; Stimac, D; Vukelic, K	1
Cayla, G; Collet, JP; Finzi, J; Hulot, JS; Montalescot, G; Simon, N	1
Akers, KS; Boyd, NK; Niece, KL	1
Bruijnzeel-Koomen, CA; de Bruin-Weller, MS; van den Broek, MP; van der Schaft, J; van Schaik, RH	1
Benjak, A; Busso, P; Cole, ST; Pojer, F; Rybniker, J; Sala, C; Vocat, A	1
Alber, H; Amann, A; Beer, B; Hofstaetter, S; Klieber, M; Modak, A; Neururer, M; Oberacher, H	1
Saniee, P; Shahreza, S; Siavoshi, F	1
Accassat, S; Basset, T; Bertoletti, L; Delavenne, X; Hodin, S; Mismetti, P; Ollier, E	1
Becker, ML; Franken, WP; Karapinar, F; Schalekamp, T; van der Hoeven, RT; Verzijl-Zeegers, R	1
Abbas, MG; Akter, N; Akter, S; Bhuiyan, MA; Hassan, MR; Shahriar, M	1
Andabak, M; Babic, Z; Banic, M; Bilić, B; Bogdanovic, Z; Dorosulic, Z; Heinzl, R; Kujundzic, M; Marusic, M; Petrovic, Z	1
Barbeau, G; Bertrand, OF; De Larochellière, R; Déry, JP; Déry, U; Gleeton, O; Harvey, A; Larose, É; Modak, A; Nguyen, CM; Noël, B; Paradis, JM; Proulx, G; Rinfret, S; Rodés-Cabau, J; Roy, L; Roy, M	1
Torlot, FJ; Whitehead, DJ	1
Akyuz, F; Baran, B; Besisik, F; Demir, K; Emrence, Z; Evirgen, S; Gokturk, S; Karaca, C; Kaymakoglu, S; Ormeci, A; Soyer, OM; Ustek, D	1
Bednarek, J; Chyrchel, B; Kruszelnicka, O; Nessler, J; Surdacki, A; Świerszcz, J	1
Christensen, RD; Haastrup, PF; Hansen, JM; Jarbøl, DE; Paulsen, MS; Søndergaard, J	1
Agoston, AT; Castell, DO; Cipher, DJ; Dunbar, KB; Genta, RM; Huo, X; Odze, RD; Pham, TH; Souza, RF; Spechler, SJ	1
Chen, MH; Chu, CJ; Hou, MC; Huang, YH; Lee, FY; Lin, HC; Lu, CL; Su, TP; Tsai, CF; Wang, YP	1
Badowski, M; Hung, YT; Law, EH; Lee, TA; Sanchez, A; Weems, K	1
Klyarytska, I; Kriviy, V; Modak, AS; Rabotyagova, Y; Tsapyak, T	1
Carracedo-Martínez, E; Vázquez-Mourelle, R	1
Dabrowski, A; Garley, M; Jabłońska, E; Jamiołkowski, J; Kostrzewska, M; Ratajczak-Wrona, W	1
Dabiri, Y; Fahimi, F; Foroutan, A; Foroutan, N; Habibi, M; Salamzadeh, J	1
Gründer, G; Haen, E; Hiemke, C; Kuzin, M; Paulzen, M; Schoretsanitis, G; Stegmann, B	1
Li, MJ; Li, Q; Liu, LQ; Sun, M	1
Brown, A; Dohr, J; Hunzelmann, N	1
Bhaskaran, K; Douglas, IJ; Langan, S; Smeeth, L; Thomas, S; Tomlinson, LA; Yates, TA	1
Chen, D; Fei, G; Lu, B; Wang, B; Wang, J; Wang, X; Wu, B; Zhang, L; Zou, D; Zou, X	1
Calissendorff, J; Falhammar, H; Lindh, JD; Mannheimer, B; Nathanson, D; Skov, J	1
Bánovčin, P; Bolek, T; Galajda, P; Kubisz, P; Lipták, P; Mokán, M; Samoš, M; Schnierer, M; Škorňová, I; Staško, J; Urban, L	1
Türkeş, C	1
Karimova, MM; Makarenko, OV; Masheiko, AM; Onul, NM	1
Bánovčin, P; Bolek, T; Galajda, P; Hyrdel, R; Kubisz, P; Mokáň, M; Nosáková, L; Samoš, M; Schnierer, M; Škorňová, I; Stasko, J	1
Barbeito Castiñeiras, G; Bardán García, B; Belles Medall, D; Blanco Dorado, S; Blanco Hortas, A; Campos-Toimil, M; Carracedo, Á; Fernández-Ferreiro, A; Gómez Márquez, A; Lamas, MJ; Latorre-Pellicer, A; López-Vizcaíno, A; Maroñas Amigo, O; Otero Espinar, F; Pérez Del Molino Bernal, ML; Rodríguez Jato, MT; Zarra Ferro, I	1
Ding, H; Hu, L; Huang, Q; Jiang, Y; Liu, Q; Liu, S; Yin, T	1
Abed, MN; Alassaf, FA; Alfahad, M; Jasim, MHM; Qazzaz, ME	1
Huang, X; Liu, Y; Shen, Y; Su, YW; Sun, LN; Wang, YQ; Yang, YQ; Ying, YW; Zhang, XH; Zhang, Y	1
Logtenberg, SJJ; Tobé, TJM; van der Zalm, IJB	1
Arnaud, B; Arnoult, C; Escoffier, J; Hograindleur, JP; Kaba, M; Le Blévec, E; Martinez, G; Nef, S; Ray, PF; Stévant, I	1
Abad-Santos, F; Cabaleiro, T; Mejía, G; Ochoa, D; Román, M; Saiz-Rodríguez, M	1
Abramenko, N; Antonyová, V; Brogyányi, T; Dytrych, P; Ikeda-Saito, M; Jakubek, M; Kaplánek, R; Kejík, Z; Martásek, P; Pajková, M; Sýkora, D; Tatar, A; Veselá, K	1
Adarkwah, CC; Galle, PR; Kostev, K; Labenz, C; Labenz, J; Tanislav, C; Wörns, MA	1
Chen, F; Fang, B; He, X; Wang, S	1
Cheng, T; Gu, ZH; Han, TY; Liu, BF; Pan, P; Yu, H	1
Hancu, G; Kelemen, H; Papp, LA; Tóth, G	1
Begum, A; Fayaz, SH; James, J; Rani, J; Sathyanarayanan, V	1
Chan, AT; Choi, HK; Lei, G; Lu, N; Misra, D; Neogi, T; Wei, J; Zeng, C; Zhang, Y	1
Anitescu, M; Apfelbaum, JL; Choksi, A; Danahey, K; George, D; Hartman, S; House, L; Karrison, T; Knoebel, RW; Ludwig, J; Meltzer, DO; O'Donnell, PH; Ratain, MJ; Schierer, E; Shahul, S; Truong, TM; van Wijk, XMR; Yeo, KJ	1
Chawla, BK; Cohen, RE; Stellrecht, EM; Yerke, LM	1
D'Andrea, E; Desai, RJ; Feldman, WB; Lin, KJ; Liu, J; Pramod Umarje, S; Tesfaye, H; Wang, SV; Zabotka, LE	1
Atkinson, C; Brunton, S; Howden, CW; Jacob, R; Mark Fendrick, A; Pelletier, C; Spechler, SJ; Vaezi, MF	1
Chen, Y; Hou, Y; Li, H; Li, S; Lin, J; Liu, T; Ma, Y; Wang, Y; Yang, H; Zhang, X; Zhang, Y; Zhou, L; Zhou, X	1
Lespessailles, E; Toumi, H	1
Chen, X; Jiang, H; Lu, S; Ma, Z; Xu, S; Yang, X; Zhang, Y; Zhao, J; Zhou, H	1
Ahn, N; Baumeister, SE; Gerlach, R; Günter, A; Güntner, F; Linseisen, J; Meisinger, C; Nolde, M; Rückert-Eheberg, IM; Tauscher, M; Wawro, N	1
Afzal, NA; Andrews, E; Beattie, RM; Hayen, A; Liddicoat, I; Tighe, MP	1

Reviews

111 review(s) available for omeprazole and pantoprazole

Article	Year
Recent advances in proton pump inhibitors and management of acid-peptic disorders. Bioorganic & medicinal chemistry, 2007, Feb-01, Volume: 15, Issue:3 Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Humans; Peptic Ulcer; Proton Pump Inhibitors	2007
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Recent developments in anti-Trichomonas research: An update review. European journal of medicinal chemistry, 2018, Jan-01, Volume: 143 Topics: Antiparasitic Agents; Biological Products; Dose-Response Relationship, Drug; Humans; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trichomonas; Trichomonas Infections	2018
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells	2022
[Proton pump blockers and their significance in gastroenterology]. Vnitrni lekarstvi, 1995, Volume: 41, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Gastrointestinal Diseases; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides; Zollinger-Ellison Syndrome	1995
Continuing development of acid pump inhibitors: site of action of pantoprazole. Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cells, Cultured; Enterochromaffin Cells; Gastric Acid; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Histamine Release; Humans; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Proton Pump Inhibitors; Sulfoxides	1994
[Are proton pump inhibitors safe?]. Der Internist, 1994, Volume: 35, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Carcinogenicity Tests; Gastric Acid; Humans; Lansoprazole; Mutagenicity Tests; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Peptic Ulcer; Prodrugs; Proton Pump Inhibitors; Structure-Activity Relationship; Sulfoxides	1994
Lack of pantoprazole drug interactions in man. International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin	1994
Pharmacokinetics--a relevant factor for the choice of a drug? Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aging; Benzimidazoles; Biological Availability; Half-Life; Humans; Injections, Intravenous; Kidney Diseases; Liver Diseases; Omeprazole; Pantoprazole; Protein Binding; Proton Pump Inhibitors; Sulfoxides	1994
The interaction of proton pump inhibitors with cytochromes P450. Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cytochrome P-450 Enzyme System; Half-Life; Humans; Lansoprazole; Microsomes, Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1994
Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans. Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Enterochromaffin Cells; Female; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Sulfoxides	1994
Clinical efficacy of pantoprazole compared with ranitidine. Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Duodenal Ulcer; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Stomach Ulcer; Sulfoxides	1994
A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole. Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Ulcer; Sulfoxides	1994
Safety of proton pump inhibitors--an overview. Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Interactions; Enterochromaffin Cells; Gastrins; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides	1994
Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Duodenal Ulcer; Enzyme Inhibitors; Humans; Models, Molecular; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pumps; Sulfoxides	1995
Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds. Digestion, 1995, Volume: 56, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Gastric Acid; Humans; Lansoprazole; Omeprazole; Pantoprazole; Sulfoxides	1995
Proton pump inhibitors: new drugs and indications. American family physician, 1996, Volume: 53, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Sulfoxides	1996
Pharmacokinetics and drug interactions--relevant factors for the choice of a drug. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Drug Interactions; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Pharmacokinetics of pantoprazole in man. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Benzimidazoles; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Lack of pantoprazole drug interactions in man: an updated review. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Interactions; Enzyme Inhibitors; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Lack of pantoprazole drug interactions in man: an updated review. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Interactions; Enzyme Inhibitors; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole. Clinical pharmacokinetics, 1996, Volume: 31, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs, 1996, Volume: 51, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Stomach Ulcer; Sulfoxides	1996
The changing role of H2-receptor antagonists in acid-related diseases. European journal of gastroenterology & hepatology, 1996, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Dyspepsia; Enzyme Inhibitors; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Sulfoxides	1996
Pantoprazole, a new proton-pump inhibitor, has a precise and predictable profile of activity. European journal of gastroenterology & hepatology, 1996, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Drug Stability; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides	1996
Triple therapy as a cure for Helicobacter pylori infection. European journal of gastroenterology & hepatology, 1996, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides	1996
Drug interactions with proton pump inhibitors. Drug safety, 1997, Volume: 16, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Sulfoxides	1997
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Clinical pharmacokinetics, 1996, Volume: 31, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides	1996
[Gastroesophageal reflux disease refractory to medical treatment. Which approach: the pill or the scalpel?]. Acta gastroenterologica Latinoamericana, 1997, Volume: 27, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Fundoplication; Gastroesophageal Reflux; Humans; Lansoprazole; Laparoscopy; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Sulfoxides	1997
Pantoprazole--a third proton pump inhibitor. Drug and therapeutics bulletin, 1997, Volume: 35, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Enzyme Inhibitors; Esophagitis, Peptic; Humans; Omeprazole; Pantoprazole; Stomach Ulcer; Sulfoxides	1997
Acid pump inhibitors. The treatment of gastroesophageal reflux. Australian family physician, 1998, Volume: 27, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Pantoprazole; Piperidines; Ranitidine; Sulfoxides	1998
The impact of Helicobacter pylori eradication on peptic ulcer healing. The American journal of gastroenterology, 1998, Volume: 93, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Odds Ratio; Omeprazole; Pantoprazole; Peptic Ulcer; Ranitidine; Stomach Ulcer; Sulfoxides; Treatment Outcome; Wound Healing	1998
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori]. Revista clinica espanola, 1998, Volume: 198, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides	1998
Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors. Journal of clinical gastroenterology, 1998, Volume: 27 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1998
[Proton pump inhibitors in pediatrics]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1999, Volume: 6, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Child; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Proton-Translocating ATPases; Sulfoxides	1999
Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis. Pharmacology, 1999, Volume: 59, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides	1999
Pantoprazole, Prout and the proton pump. Hospital medicine (London, England : 1998), 1999, Volume: 60, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Female; Gastric Acid; Gastric Juice; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Pregnancy; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome	1999
The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review. Journal of clinical gastroenterology, 2000, Volume: 30, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stomach Ulcer; Sulfoxides; Treatment Outcome	2000
The proton-pump inhibitors: similarities and differences. Clinical therapeutics, 2000, Volume: 22, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Gastric Acid; Gastrointestinal Diseases; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2000
Is it time to adopt proton pump inhibitors in the prevention of non-steroidal anti-inflammatory drug gastropathy? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2000, Volume: 32, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stomach Diseases; Sulfoxides	2000
Potential uses of intravenous proton pump inhibitors to control gastric acid secretion. Digestion, 2000, Volume: 62, Issue:2-3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastric Acid; Gastric Acidity Determination; Gastric Outlet Obstruction; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides; Zollinger-Ellison Syndrome	2000
Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole. Current gastroenterology reports, 2000, Volume: 2, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Duodenal Ulcer; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2000
Clinical experience with pantoprazole in gastroesophageal reflux disease. Clinical therapeutics, 2000, Volume: 22, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Biological Availability; Clinical Trials as Topic; Cytochrome P-450 Enzyme System; Drug Interactions; Gastroesophageal Reflux; Humans; Injections, Intravenous; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2000
Intravenous pantoprazole: a new tool for acutely ill patients who require acid suppression. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2000, Volume: 14 Suppl D Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Esophagitis, Peptic; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Omeprazole; Pantoprazole; Sulfoxides; Zollinger-Ellison Syndrome	2000
Pantoprazole: a new proton pump inhibitor. Clinical therapeutics, 2000, Volume: 22, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Duodenal Ulcer; Enzyme Inhibitors; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides	2000
Switching between intravenous and oral pantoprazole. Journal of clinical gastroenterology, 2001, Volume: 32, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Gastrointestinal Diseases; Guidelines as Topic; Hospitalization; Humans; Injections, Intravenous; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2001
[Proton pump inhibitors in acute ulcer bleeding--what is evident?]. Deutsche medizinische Wochenschrift (1946), 2000, Dec-22, Volume: 125, Issue:51-52 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Humans; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton-Translocating ATPases; Sulfoxides	2000
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use]. La Revue du praticien, 2001, Apr-15, Volume: 51, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Duodenal Ulcer; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Stomach Ulcer; Sulfoxides	2001
Proton pump inhibitors and their drug interactions: an evidence-based approach. European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Gastrointestinal Agents; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2001
Pantoprazole. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Jun-01, Volume: 58, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Esophagitis; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2001
Shortcomings of the first-generation proton pump inhibitors. European journal of gastroenterology & hepatology, 2001, Volume: 13 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Biological Availability; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2001
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Clinical therapeutics, 2001, Volume: 23, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Randomized Controlled Trials as Topic; Ranitidine; Sulfoxides; Treatment Outcome	2001
[Comparative study of proton pump inhibitors]. Orvosi hetilap, 2001, Sep-09, Volume: 142, Issue:36 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Duodenal Ulcer; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Stomach Ulcer; Sulfoxides	2001
Review article: rabeprazole-based therapy in Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2002, Volume: 16 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2002
[Proton pump inhibitors: Pantoprazole]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Gastric Acid; Gastrins; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2002
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome	2002
Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibition. Critical care medicine, 2002, Volume: 30, Issue:6 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Clinical Trials as Topic; Gastric Acid; Hospitalization; Humans; Intensive Care Units; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome	2002
Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Critical care medicine, 2002, Volume: 30, Issue:6 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Critical Illness; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Intensive Care Units; Omeprazole; Pantoprazole; Risk Factors; Stress, Psychological; Sulfoxides	2002
Intravenous proton pump inhibitors in the critical care setting. Critical care medicine, 2002, Volume: 30, Issue:6 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Canada; Critical Care; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Randomized Controlled Trials as Topic; Sulfoxides; United States	2002
The clinical importance of proton pump inhibitor pharmacokinetics. Digestion, 2002, Volume: 66, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cost Savings; Duodenal Ulcer; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2002
The pharmacology and clinical relevance of proton pump inhibitors. Current gastroenterology reports, 2002, Volume: 4, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome	2002
Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. Drugs, 2003, Volume: 63, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Dose-Response Relationship, Drug; Esomeprazole; Gastroesophageal Reflux; Helicobacter Infections; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides; Zollinger-Ellison Syndrome	2003
Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cimetidine; Drug Administration Schedule; Enzyme Inhibitors; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Injections, Intravenous; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Sulfoxides	2003
Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review. Helicobacter, 2003, Volume: 8, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2003
Evidence-based analysis: postoperative gastric bleeding: etiology and prevention. Surgical oncology, 2003, Volume: 12, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Evidence-Based Medicine; Humans; Intensive Care Units; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Postoperative Complications; Ranitidine; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Sucralfate; Sulfoxides; Treatment Outcome	2003
Synthesis or rupture: duration of acid inhibition by proton pump inhibitors. Drugs of today (Barcelona, Spain : 1998), 2003, Volume: 39 Suppl A Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Esomeprazole; Gastric Acid; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Time Factors	2003
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands. Clinical therapeutics, 2003, Volume: 25, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cost-Benefit Analysis; Economics, Pharmaceutical; Gastroesophageal Reflux; Humans; Netherlands; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides; Treatment Outcome	2003
[All proton pump inhibitors are equally efficacious in standard dosages]. Lakartidningen, 2003, Jun-19, Volume: 100, Issue:25 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Esomeprazole; Gastric Acid; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2003
Treating patients with acute gastrointestinal bleeding or rebleeding. Pharmacotherapy, 2003, Volume: 23, Issue:10 Pt 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Endoscopy, Gastrointestinal; Gastric Acid; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Jehovah's Witnesses; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Risk Factors; Sulfoxides; Zollinger-Ellison Syndrome	2003
[Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease]. Klinicheskaia meditsina, 2003, Volume: 81, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome	2003
Diagnostic and therapeutic options in the management of nonvariceal upper gastrointestinal bleeding. Current gastroenterology reports, 2003, Volume: 5, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Diathermy; Endoscopy, Gastrointestinal; Fibrin Tissue Adhesive; Gastrointestinal Hemorrhage; Hemostasis; Humans; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Prognosis; Risk Assessment; Sulfoxides	2003
[Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence]. Revista clinica espanola, 2004, Volume: 204, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Gastroscopy; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prognosis; Proton Pump Inhibitors; Sulfoxides	2004
[Treatment of reflux disease. An international consensus conference put things in its place]. Revue medicale de la Suisse romande, 2003, Volume: 123, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastroesophageal Reflux; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2003
Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Infective Agents; Benzimidazoles; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Sulfoxides	2004
The basis of differentiation of PPIs. Drugs of today (Barcelona, Spain : 1998), 2004, Volume: 40 Suppl A Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Cysteine; Dose-Response Relationship, Drug; Gastric Acid; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Rats; Sulfoxides	2004
Understanding NSAID-PPI-COX-2 interrelationships. Drugs of today (Barcelona, Spain : 1998), 2004, Volume: 40 Suppl A Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzimidazoles; Cyclooxygenase Inhibitors; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Sulfoxides	2004
Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis. Alimentary pharmacology & therapeutics, 2004, Nov-15, Volume: 20, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis; Female; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Randomized Controlled Trials as Topic; Sulfoxides; Treatment Outcome	2004
Effectiveness of proton pump inhibitors: beyond cost. Reviews in gastroenterological disorders, 2004, Volume: 4 Suppl 4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Esophagitis; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome	2004
Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management. European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Circadian Rhythm; Esomeprazole; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Prevalence; Proton Pump Inhibitors; Sulfoxides	2005
Role of pantoprazole in the treatment of gastro-oesophageal reflux disease. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Gastric Acid; Gastroesophageal Reflux; H(+)-K(+)-Exchanging ATPase; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Sulfoxides	2005
[Eradication of Helicobacter pylori]. Krankenpflege Journal, 2005, Volume: 43, Issue:4-6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Stomach Neoplasms; Sulfoxides	2005
Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage. International journal of clinical practice, 2005, Volume: 59, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides	2005
Understanding GERD symptoms in the clinical setting. Drugs of today (Barcelona, Spain : 1998), 2005, Volume: 41 Suppl B Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Gastroesophageal Reflux; Humans; Intestinal Mucosa; Omeprazole; Pantoprazole; Sulfoxides; Surveys and Questionnaires	2005
Extraesophageal manifestations of GERD: diagnosis and therapy. Drugs of today (Barcelona, Spain : 1998), 2005, Volume: 41 Suppl B Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; Female; Gastroesophageal Reflux; Humans; Laryngitis; Omeprazole; Pantoprazole; Sulfoxides	2005
What is potent acid inhibition, and how can it be achieved? Drugs, 2005, Volume: 65 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Esomeprazole; Gastric Acid; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2005
[Recent topics on important drugs for H. pylori eradication: Pantoprazole sodium]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Benzimidazoles; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2005
Intravenous proton pump inhibitor therapy: a rationale for use. Reviews in gastroenterological disorders, 2005, Volume: 5 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastroesophageal Reflux; Humans; Injections, Intravenous; Omeprazole; Pantoprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Sulfoxides	2005
Gastroesophageal reflux disease and extraesophageal disease. Reviews in gastroenterological disorders, 2005, Volume: 5 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Asthma; Benzimidazoles; Esophageal pH Monitoring; Gastric Acidity Determination; Gastroesophageal Reflux; Heart Diseases; Humans; Lansoprazole; Lung Diseases; Omeprazole; Otorhinolaryngologic Diseases; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome	2005
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? European journal of clinical pharmacology, 2006, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adverse Drug Reaction Reporting Systems; Enzyme Inhibitors; Esomeprazole; Humans; Lansoprazole; Muscular Diseases; Myositis; Omeprazole; Pantoprazole; Polymyositis; Proton Pump Inhibitors; Rabeprazole; Rhabdomyolysis	2006
Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature. Journal of investigational allergology & clinical immunology, 2006, Volume: 16, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anaphylaxis; Anti-Ulcer Agents; Benzimidazoles; Famotidine; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Skin Tests	2006
Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. Alimentary pharmacology & therapeutics, 2006, Sep-01, Volume: 24, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clinical Trials as Topic; Enzyme Inhibitors; Esomeprazole; Esophagitis, Peptic; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome	2006
The complete remission concept. Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42 Suppl B Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Esophagoscopy; Gastroesophageal Reflux; Gastroscopy; Humans; Omeprazole; Pantoprazole; Severity of Illness Index; Statistics as Topic; Surveys and Questionnaires	2006
[Dosaging of proton pumps inhibitors]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006, Sep-21, Volume: 126, Issue:18 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Gastroesophageal Reflux; Genotype; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Pharmacogenetics; Polymorphism, Genetic; Proton Pump Inhibitors; Sulfoxides	2006
[Safety of proton pump inhibitors]. Medicina clinica, 2006, Nov-25, Volume: 127, Issue:20 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors	2006
[Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice]. Orvosi hetilap, 2007, Mar-25, Volume: 148, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole	2007
Recent advances in chirally pure proton pump inhibitors. Journal of the Indian Medical Association, 2007, Volume: 105, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Esomeprazole; Gastroesophageal Reflux; Humans; Isomerism; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole	2007
Stereoselective disposition of proton pump inhibitors. Clinical drug investigation, 2008, Volume: 28, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Esomeprazole; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Stereoisomerism	2008
Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2008, Oct-01, Volume: 28, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Drug Administration Schedule; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2008
[Proton pump inhibitors, a family of drugs in continuous expansion]. Minerva gastroenterologica e dietologica, 2000, Volume: 46, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Barrett Esophagus; Duodenal Ulcer; Dyspepsia; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Rats; Stomach Ulcer	2000
Drug-drug interaction between clopidogrel and the proton pump inhibitors. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Clinical Trials as Topic; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Humans; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2009
[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!]. Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Lansoprazole; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine	2009
Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Databases, Factual; Endoscopy, Gastrointestinal; Esomeprazole; Esophagitis; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Randomized Controlled Trials as Topic; Registries; Wound Healing	2010
The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Critical care medicine, 2010, Volume: 38, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cimetidine; Critical Care; Histamine H2 Antagonists; Humans; Odds Ratio; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Ranitidine; Risk; Stress, Psychological	2010
Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics, 2011, Volume: 127, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Age Factors; Child; Child, Preschool; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastroesophageal Reflux; Humans; Incidence; Infant; Lansoprazole; Male; Netherlands; Omeprazole; Pantoprazole; Prognosis; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome	2011
The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PloS one, 2014, Volume: 9, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dexlansoprazole; Esomeprazole; Humans; Lansoprazole; Magnesium; Odds Ratio; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Risk Factors; Treatment Outcome	2014
Association Between Proton Pump Inhibitors and Microscopic Colitis. The Annals of pharmacotherapy, 2017, Volume: 51, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Colitis, Microscopic; Dose-Response Relationship, Drug; Esomeprazole; Humans; Omeprazole; Pantoprazole; Practice Guidelines as Topic; Proton Pump Inhibitors	2017
Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis. Medicine, 2017, Volume: 96, Issue:39 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Comparative Effectiveness Research; Dexlansoprazole; Esomeprazole; Esophagitis, Peptic; Female; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Network Meta-Analysis; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome; United States; United States Food and Drug Administration	2017
Chiral separation in the class of proton pump inhibitors by chromatographic and electromigration techniques: An overview. Electrophoresis, 2021, Volume: 42, Issue:17-18 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Electrophoresis; Esomeprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole	2021
The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: A scoping review. Clinical and experimental dental research, 2022, Volume: 8, Issue:5 Topics: Dental Implants; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Retrospective Studies	2022
Proton Pump Inhibitors and Bone Health: An Update Narrative Review. International journal of molecular sciences, 2022, 09-14, Volume: 23, Issue:18 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Antacids; Bone Density; Dexlansoprazole; Esomeprazole; Humans; Lansoprazole; Omeprazole; Osteoporotic Fractures; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; United States	2022
Pharmacological treatment of gastro-oesophageal reflux in children. The Cochrane database of systematic reviews, 2023, 08-22, Volume: 8 Topics: Adolescent; Child; Esomeprazole; Gastroesophageal Reflux; Humans; Infant; Infant, Newborn; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine	2023

Trials

222 trial(s) available for omeprazole and pantoprazole

Article	Year
Reduction of pentagastrin stimulated acid output: a suitable method to predict efficacy of an irreversible proton pump inhibitor in peptic ulcer disease? International journal of clinical pharmacology, therapy, and toxicology, 1992, Volume: 30, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Gastric Acid; Humans; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Pentagastrin; Proton Pump Inhibitors; Proton Pumps; Single-Blind Method; Sulfoxides	1992
Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients. Zeitschrift fur Gastroenterologie, 1992, Volume: 30, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adolescent; Adult; Aged; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Gastric Acidity Determination; Humans; Male; Middle Aged; Omeprazole; Pain Measurement; Pantoprazole; Prospective Studies; Sulfoxides; Wound Healing	1992
Effects of oral pantoprazole on 24-hour intragastric acidity and plasma gastrin profiles. Alimentary pharmacology & therapeutics, 1992, Volume: 6, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Benzimidazoles; Circadian Rhythm; Double-Blind Method; Gastric Acidity Determination; Gastrins; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides	1992
Lack of influence of pantoprazole on the disposition kinetics of theophylline in man. International journal of clinical pharmacology, therapy, and toxicology, 1991, Volume: 29, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Benzimidazoles; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Omeprazole; Pantoprazole; Sulfoxides; Theophylline; Time Factors	1991
Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man. Alimentary pharmacology & therapeutics, 1990, Volume: 4, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Benzimidazoles; Blood Pressure; Gastric Acid; Gastrins; Half-Life; Heart Rate; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Pentagastrin; Sulfoxides	1990
Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study. Scandinavian journal of gastroenterology, 1995, Volume: 30, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Enzyme Inhibitors; Female; Histamine H2 Antagonists; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides; Treatment Outcome	1995
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori]. Leber, Magen, Darm, 1995, Volume: 25, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome	1995
Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. European journal of gastroenterology & hepatology, 1995, Volume: 7, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Diarrhea; Double-Blind Method; Drug Tolerance; Duodenal Ulcer; Duodenoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Wound Healing	1995
Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin. British journal of clinical pharmacology, 1995, Volume: 39, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Blood Coagulation; Cross-Over Studies; Double-Blind Method; Drug Interactions; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Warfarin	1995
A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1995
No influence of pantoprazole on the pharmacokinetics of phenytoin. International journal of clinical pharmacology and therapeutics, 1995, Volume: 33, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Administration, Oral; Adolescent; Adult; Benzimidazoles; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Drug Interactions; Humans; Male; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Reference Standards; Sulfoxides; White People	1995
Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. Scandinavian journal of gastroenterology, 1995, Volume: 30, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Sulfoxides; Time Factors	1995
Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Benzimidazoles; Double-Blind Method; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole; Pain; Pantoprazole; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides	1995
A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group. Digestive diseases and sciences, 1995, Volume: 40, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides; Time Factors	1995
Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study. Journal of clinical gastroenterology, 1995, Volume: 20, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides	1995
Effects of pantoprazole on endocrine function in healthy male volunteers. Alimentary pharmacology & therapeutics, 1994, Volume: 8, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Endocrine Glands; Gastric Juice; Gastric Mucosa; Humans; Hydrocortisone; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Secretory Rate; Sulfoxides; Testosterone	1994
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection]. Deutsche medizinische Wochenschrift (1946), 1995, Mar-17, Volume: 120, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Endoscopy, Digestive System; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Stomach; Stomach Ulcer; Stomatitis; Sulfoxides	1995
Lack of pantoprazole drug interactions in man. International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin	1994
Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction. International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Antipyrine; Benzimidazoles; Chromatography, High Pressure Liquid; Drug Interactions; Half-Life; Humans; Infusions, Intravenous; Longitudinal Studies; Male; Metabolic Clearance Rate; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Research Design; Sulfoxides	1994
Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Duodenal Ulcer; Enterochromaffin Cells; Esophagitis; Female; Gastrins; Humans; Longitudinal Studies; Male; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Sulfoxides	1994
Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group. Alimentary pharmacology & therapeutics, 1994, Volume: 8, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides	1994
Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration. International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Regression Analysis; Single-Blind Method; Sulfoxides	1994
Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects. European journal of clinical pharmacology, 1993, Volume: 44, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Administration, Oral; Adult; Benzimidazoles; Biological Availability; Drug Administration Schedule; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Omeprazole; Pantoprazole; Sulfoxides; Tablets, Enteric-Coated	1993
Pantoprazole and 24-hour intragastric acidity. Alimentary pharmacology & therapeutics, 1993, Volume: 7, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Benzimidazoles; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Gastric Acid; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Sulfoxides	1993
Lack of interaction between pantoprazole and digoxin at therapeutic doses in man. International journal of clinical pharmacology and therapeutics, 1995, Volume: 33, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Blood Pressure; Cross-Over Studies; Digoxin; Drug Interactions; Electrocardiography; Enzyme Inhibitors; Female; Heart Rate; Humans; Male; Omeprazole; Pantoprazole; Single-Blind Method; Sodium-Potassium-Exchanging ATPase; Sulfoxides	1995
Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration--a multicentre study. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Benzimidazoles; Duodenal Ulcer; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pumps; Sulfoxides; Time Factors; Treatment Outcome	1995
Pharmacokinetics of pantoprazole in man. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Biological Availability; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Injections, Intravenous; Kidney Diseases; Liver Cirrhosis; Male; Middle Aged; Omeprazole; Pantoprazole; Phenotype; Protein Binding; Reference Values; Sulfoxides	1996
Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Area Under Curve; Benzimidazoles; Circadian Rhythm; Cross-Over Studies; Diet; Enzyme Inhibitors; Gastric Acid; Gastric Acidity Determination; Half-Life; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Area Under Curve; Benzimidazoles; Enzyme Inhibitors; Half-Life; Humans; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Regression Analysis; Single-Blind Method; Sulfoxides	1996
Lack of influence of pantoprazole on the disposition kinetics of theophylline in man. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Area Under Curve; Benzimidazoles; Bronchodilator Agents; Cross-Over Studies; Drug Interactions; Enzyme Inhibitors; Half-Life; Humans; Infusions, Intravenous; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Theophylline	1996
Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Analgesics, Non-Narcotic; Antipyrine; Area Under Curve; Benzimidazoles; Biotransformation; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Interactions; Enzyme Inhibitors; Half-Life; Humans; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Spectrophotometry, Ultraviolet; Sulfoxides; Therapeutic Equivalency	1996
Lack of interaction between pantoprazole and digoxin at therapeutic doses in man. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Area Under Curve; Benzimidazoles; Cardiotonic Agents; Cross-Over Studies; Digoxin; Drug Interactions; Electrocardiography; Enzyme Inhibitors; Female; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method; Sulfoxides	1996
No influence of pantoprazole on the pharmacokinetics of phenytoin. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anticonvulsants; Area Under Curve; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Half-Life; Humans; Male; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides	1996
Lack of pharmacokinetic interaction between pantoprazole and diclofenac. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticonvulsants; Area Under Curve; Benzimidazoles; Cross-Over Studies; Diclofenac; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Pantoprazole does not interact with nifedipine in man under steady-state conditions. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Anticonvulsants; Area Under Curve; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Drug Interactions; Electrocardiography; Enzyme Inhibitors; Female; Half-Life; Heart Rate; Humans; Male; Nifedipine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1995
Lack of pharmacokinetic interaction between pantoprazole and diclofenac. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Benzimidazoles; Biological Availability; Blood Pressure; Diclofenac; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Omeprazole; Pantoprazole; Random Allocation; Sulfoxides	1996
Lack of pharmacokinetic interaction of pantoprazole with diazepam in man. British journal of clinical pharmacology, 1996, Volume: 42, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Anxiety Agents; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Blood Pressure; Cross-Over Studies; Diazepam; Drug Interactions; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Omeprazole; Pantoprazole; Sulfoxides	1996
Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects. European journal of gastroenterology & hepatology, 1996, Volume: 8, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1996
Pharmacokinetics and tolerance of pantoprazole, a proton pump inhibitor after single and multiple oral doses in healthy Japanese volunteers. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Blood Chemical Analysis; Body Temperature; Dose-Response Relationship, Drug; Electrocardiography; Humans; Japan; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Tablets, Enteric-Coated	1996
Pantoprazole has no influence on steady state pharmacokinetics and pharmacodynamics of metoprolol in healthy volunteers. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adrenergic beta-Antagonists; Adult; Anti-Ulcer Agents; Benzimidazoles; Blood Chemical Analysis; Cross-Over Studies; Double-Blind Method; Drug Interactions; Exercise Test; Female; Heart Rate; Humans; Male; Metoprolol; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stereoisomerism; Sulfoxides	1996
Pantoprazole does not interact with nifedipine in man under steady-state conditions. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Calcium Channel Blockers; Cross-Over Studies; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Female; Hemodynamics; Humans; Liver; Male; Nifedipine; Omeprazole; Pantoprazole; Sulfoxides	1996
[Treatment of duodenal ulcer with pantoprazole. A multicenter study]. Casopis lekaru ceskych, 1996, Dec-04, Volume: 135, Issue:23 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides	1996
Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Diarrhea; Drug Hypersensitivity; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides	1997
Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg. European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Monitoring, Physiologic; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1997
Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH. European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Benzimidazoles; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Reference Values; Sulfoxides	1997
Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides	1997
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection. The American journal of gastroenterology, 1997, Volume: 92, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Sulfoxides	1997
[Evaluation of the effectiveness of pantoprazole and ranitidine in the treatment of duodenal ulcer. Result of an international multicenter study]. Orvosi hetilap, 1997, Nov-09, Volume: 138, Issue:45 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Humans; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides	1997
Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole. British journal of clinical pharmacology, 1998, Volume: 45, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Breath Tests; Caffeine; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1998
[The action of the proton pump inhibitor pantoprazol against acetylsalicylic acid-induced gastroduodenopathy in comparison to ranitidine. An endoscopic controlled, double blind comparison]. Arzneimittel-Forschung, 1998, Volume: 48, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Humans; Male; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Sulfoxides	1998
One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome; Wound Healing	1997
Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Single-Blind Method; Sulfoxides; Treatment Outcome	1998
A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Deglutition Disorders; Double-Blind Method; Endoscopy; Esophageal Stenosis; Gastroesophageal Reflux; Heartburn; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Secondary Prevention; Sulfoxides; Treatment Outcome	1998
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Sulfoxides	1998
Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides; Tinidazole; Treatment Outcome	1998
Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics. Helicobacter, 1998, Volume: 3, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Peptic Ulcer; Sulfoxides; Treatment Outcome	1998
Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Treatment Outcome	1998
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group. The American journal of gastroenterology, 1998, Volume: 93, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Time Factors	1998
Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Gastric Acid; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Sulfoxides	1998
Pantoprazole does not interact with the pharmacokinetics of carbamazepine. International journal of clinical pharmacology and therapeutics, 1998, Volume: 36, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anticonvulsants; Area Under Curve; Benzimidazoles; Biotransformation; Carbamazepine; Cross-Over Studies; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1998
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Endoscopy; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Time Factors	1998
Pantoprazole lacks induction of CYP1A2 activity in man. International journal of clinical pharmacology and therapeutics, 1999, Volume: 37, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Area Under Curve; Benzimidazoles; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Cytochrome P-450 CYP1A2; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Xanthine Oxidase	1999
Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study. European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Benzimidazoles; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides; Tinidazole	1999
Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week. Digestion, 1999, Volume: 60, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Severity of Illness Index; Sulfoxides; Treatment Outcome	1999
One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases. Digestion, 1999, Volume: 60, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome	1999
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology, 1999, Volume: 117, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stomach; Sulfoxides; Treatment Outcome	1999
Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Esophagitis, Peptic; Female; Follow-Up Studies; Humans; Life Tables; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Sulfoxides; Time Factors	1999
Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy. Helicobacter, 1999, Volume: 4, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Sulfoxides; Treatment Outcome	1999
Lack of pharmacokinetic interaction between oral pantoprazole and cisapride in healthy adults. Journal of clinical pharmacology, 1999, Volume: 39, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Biological Availability; Blood Pressure; Chromatography, High Pressure Liquid; Cisapride; Cross-Over Studies; Drug Interactions; Electrocardiography; Enzyme Inhibitors; Gastrointestinal Agents; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1999
Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection. Revista espanola de enfermedades digestivas, 1999, Volume: 91, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Penicillins; Sulfoxides	1999
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Peptic Ulcer; Prospective Studies; Statistics, Nonparametric; Sulfoxides; Treatment Failure	1999
Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline. British journal of clinical pharmacology, 1999, Volume: 48, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Bronchodilator Agents; Cross-Over Studies; Cytochrome P-450 CYP1A2; Double-Blind Method; Drug Interactions; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Theophylline	1999
Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study. The American journal of gastroenterology, 1999, Volume: 94, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Pentagastrin; Proton Pump Inhibitors; Sulfoxides; Zollinger-Ellison Syndrome	1999
Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion. European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Male; Omeprazole; Pantoprazole; Postprandial Period; Proton Pump Inhibitors; Random Allocation; Sulfoxides; Time Factors	1999
Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Esophagoscopy; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Prospective Studies; Proton Pump Inhibitors; Secondary Prevention; Sulfoxides	1999
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Sulfoxides	1999
Pantoprazole suppresses Helicobacter pylori without affecting cure. Helicobacter, 1999, Volume: 4, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Sulfoxides; Urea; Urease	1999
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Double-Blind Method; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Patient Compliance; Proton Pump Inhibitors; Quality Control; Sulfoxides; Treatment Outcome; Urea	2000
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides	2000
Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil. The American journal of gastroenterology, 2000, Volume: 95, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides	2000
Pantoprazole does not affect cyclosporin A blood concentration in kidney-transplant patients. European journal of clinical pharmacology, 2000, Volume: 55, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Cyclosporine; Enzyme Inhibitors; Female; Humans; Immunoassay; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Omeprazole; Pantoprazole; Prednisolone; Sulfoxides; Time Factors	2000
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration. Helicobacter, 2000, Volume: 5, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bronchitis; Clarithromycin; Diarrhea; Digestive System; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Pantoprazole; Patient Compliance; Sulfoxides; Time Factors; Treatment Outcome	2000
Pantoprazole versus omeprazole in the treatment of reflux esophagitis. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 1999, Volume: 53, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Single-Blind Method; Sulfoxides	1999
Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease. The American journal of gastroenterology, 2000, Volume: 95, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome	2000
Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology, 2000, Volume: 118, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome; Zollinger-Ellison Syndrome	2000
Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Biological Availability; Bronchodilator Agents; Delayed-Action Preparations; Drug Interactions; Humans; Lansoprazole; Linear Models; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method; Sulfoxides; Theophylline	2000
Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study. European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Severity of Illness Index; South Africa; Sulfoxides; Treatment Outcome	2000
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. Scandinavian journal of gastroenterology, 2000, Volume: 35, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Tinidazole	2000
Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease. European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides	2000
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Ranitidine; Sulfoxides; Treatment Outcome	2000
[Effect of pantoprazole, amoxicillin and metronidazole treatment on the level of H. pylori eradication and the histological image of antral gastritis in patients with duodenal ulcer]. Medicinski arhiv, 2000, Volume: 54, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Pyloric Antrum; Sulfoxides	2000
Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Drug Administration Schedule; Female; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Sulfoxides; Tablets, Enteric-Coated	2000
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Aging; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Diseases; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Stomach Diseases; Sulfoxides	2000
Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides	2000
Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2000, Volume: 32, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Endoscopy, Digestive System; Female; Humans; Incidence; Male; Middle Aged; Omeprazole; Osteoarthritis; Pantoprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Safety; Stomach Ulcer; Sulfoxides	2000
Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up. Journal of clinical gastroenterology, 2000, Volume: 31, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Stomach; Sulfoxides; Time Factors	2000
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. The American journal of gastroenterology, 2000, Volume: 95, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Radioisotopes; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides	2000
Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group. The American journal of gastroenterology, 2000, Volume: 95, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Time Factors; United States; Wound Healing	2000
Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Azithromycin; Benzimidazoles; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides; Time Factors; Tinidazole	2000
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion, 2001, Volume: 63, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Diarrhea; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Male; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Sulfoxides; Taste Disorders; Tinidazole; Treatment Outcome	2001
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. The American journal of gastroenterology, 2001, Volume: 96, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Biopsy, Needle; Confidence Intervals; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pantoprazole; Probability; Prospective Studies; Rifabutin; Sulfoxides; Tetracycline; Treatment Failure	2001
Pharmacodynamic modeling of pantoprazole's irreversible effect on gastric acid secretion in humans and rats. Journal of clinical pharmacology, 2001, Volume: 41, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Animals; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Humans; Infusions, Intravenous; Male; Models, Animal; Models, Biological; Omeprazole; Pantoprazole; Rats; Rats, Sprague-Dawley; Sulfoxides	2001
Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin. Clinical pharmacology and therapeutics, 2001, Volume: 69, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Anticonvulsants; Area Under Curve; Benzimidazoles; Chromatography, High Pressure Liquid; Half-Life; Humans; Male; Mephenytoin; Metabolic Clearance Rate; Omeprazole; Pantoprazole; Stereoisomerism; Sulfoxides	2001
cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. Journal of clinical microbiology, 2001, Volume: 39, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; Double-Blind Method; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Polymerase Chain Reaction; Sulfoxides; Treatment Outcome	2001
Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease. Digestion, 2001, Volume: 63, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Female; Follow-Up Studies; Gastroesophageal Reflux; Germany; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Quality of Life; Ranitidine; Sulfoxides; Treatment Outcome	2001
Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Fish Oils; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome	2001
Pantoprazole versus lansoprazole in French patients with reflux esophagitis. Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Female; France; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pain; Pantoprazole; Prospective Studies; Sulfoxides	2001
Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies. The American journal of gastroenterology, 2001, Volume: 96, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cell Count; Drug Resistance; Enteroendocrine Cells; Enzyme Inhibitors; Female; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Sulfoxides	2001
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy? Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea	2001
Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy; Helicobacter Infections; Humans; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Smoking; Sulfoxides; Urea	2001
Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Aged, 80 and over; Aging; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome	2001
Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously. The American journal of gastroenterology, 2001, Volume: 96, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Enzyme Inhibitors; Female; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Intubation, Gastrointestinal; Kinetics; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Random Allocation; Rosales; Stomach; Sulfoxides	2001
Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine. European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Secondary Prevention; Sulfoxides	2001
No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease. European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cisapride; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Esophagoscopy; Female; Gastroesophageal Reflux; Gastrointestinal Agents; H(+)-K(+)-Exchanging ATPase; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome	2001
Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Bile Reflux; Esophagitis; Female; Gastroesophageal Reflux; Gastrointestinal Motility; Helicobacter pylori; Humans; Male; Manometry; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2001
Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome	2001
A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Cross-Over Studies; Enzyme Inhibitors; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Intubation, Gastrointestinal; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Suspensions	2001
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. The American journal of gastroenterology, 2001, Volume: 96, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Esophagoscopy; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2001
Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chemoreceptor Cells; Double-Blind Method; Duodenum; Dyspepsia; Female; Gastric Acid; Gastrointestinal Motility; Humans; Hydrochloric Acid; Intestinal Secretions; Male; Manometry; Middle Aged; Omeprazole; Pantoprazole; Proton-Translocating ATPases; Pyloric Antrum; Sodium Chloride; Sulfoxides	2001
Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial). Wiener klinische Wochenschrift, 2001, Dec-17, Volume: 113, Issue:23-24 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Sucralfate; Sulfoxides	2001
Acid suppression in healthy subjects following lansoprazole or pantoprazole. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Monitoring, Physiologic; Omeprazole; Pantoprazole; Single-Blind Method; Sulfoxides	2002
Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Drug Interactions; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Sensitivity and Specificity; Sulfoxides; Time Factors; Urea	2002
Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2002
Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study. Journal of clinical pharmacology, 2002, Volume: 42, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Female; Gastric Acid; Humans; Male; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Pentagastrin; Proton Pumps; Sulfoxides; Time Factors	2002
[Microflora of gastric juice in patients after eradication of Helicobacter pylori and treatment with a proton pump inhibitor]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2002, Volume: 55, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Candida albicans; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Escherichia coli; Esophagitis, Peptic; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Staphylococcus aureus; Sulfoxides	2002
Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2002, Volume: 15, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Probability; Ranitidine; Risk Assessment; Sulfoxides; Treatment Outcome; Wound Healing	2002
Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome. Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Time Factors; Zollinger-Ellison Syndrome	2002
A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre t European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Satisfaction; Proton Pump Inhibitors; Sulfoxides	2002
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pantoprazole; Peptic Ulcer; Prospective Studies; Sulfoxides; Tetracycline; Treatment Failure; Treatment Outcome	2002
Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. The Medical journal of Australia, 2002, Oct-21, Volume: 177, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Treatment Outcome	2002
Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux. Journal of voice : official journal of the Voice Foundation, 2002, Volume: 16, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Surveys and Questionnaires; Time Factors	2002
[Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection]. Zhonghua yi xue za zhi, 2002, Sep-25, Volume: 82, Issue:18 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Time Factors; Treatment Outcome	2002
Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Severity of Illness Index; Sulfoxides; Treatment Outcome	2002
Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis. Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aluminum Hydroxide; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Drug Combinations; Esophagitis; Female; Humans; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Recurrence; Silicic Acid; Sulfoxides; Treatment Outcome	2003
Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test. The American journal of gastroenterology, 2003, Volume: 98, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Benzimidazoles; Breath Tests; Carbon Isotopes; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Reproducibility of Results; Sulfoxides; Time Factors; Urea	2003
Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole. Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Esophagitis, Peptic; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Manometry; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides	2003
Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children. Journal of pediatric gastroenterology and nutrition, 2003, Volume: 36, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Anti-Ulcer Agents; Benzimidazoles; Child; Esophagitis, Peptic; Esophagus; Female; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Safety; Sulfoxides; Time Factors; Treatment Outcome	2003
Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test. Digestive diseases and sciences, 2003, Volume: 48, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzimidazoles; Breath Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Reference Values; Risk Assessment; Sensitivity and Specificity; Sulfoxides	2003
Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study. Digestion, 2003, Volume: 67, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Confidence Intervals; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Safety; Sulfoxides; Therapeutic Equivalency; Treatment Outcome	2003
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. Alimentary pharmacology & therapeutics, 2003, May-01, Volume: 17, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Stomach Ulcer; Sulfoxides	2003
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2003, Volume: 17, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Canada; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Quality of Life; Reproducibility of Results; Self-Assessment; Severity of Illness Index; Sulfoxides; Surveys and Questionnaires; Treatment Outcome	2003
Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole. Alimentary pharmacology & therapeutics, 2003, Jun-01, Volume: 17, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Follow-Up Studies; Humans; Omeprazole; Pantoprazole; Prospective Studies; Recurrence; Sulfoxides; Treatment Outcome	2003
Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scandinavian journal of gastroenterology, 2003, Volume: 38, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Laryngitis; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Severity of Illness Index; Sulfoxides	2003
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Alimentary pharmacology & therapeutics, 2003, Jun-15, Volume: 17, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Antacids; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Time Factors	2003
Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine. Journal of clinical gastroenterology, 2003, Volume: 37, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Gastroesophageal Reflux; Health Status Indicators; Heartburn; Humans; Nizatidine; Omeprazole; Pantoprazole; Quality of Life; Sulfoxides; Treatment Outcome	2003
Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Jul-01, Volume: 60, Issue:13 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Biological Availability; Cross-Over Studies; Drug Stability; Enzyme Inhibitors; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sodium Bicarbonate; Sulfoxides; Suspensions; Tablets	2003
Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection. The Netherlands journal of medicine, 2003, Volume: 61, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Tetracycline	2003
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'. Alimentary pharmacology & therapeutics, 2003, Oct-15, Volume: 18, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea	2003
The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery. Anesthesia and analgesia, 2003, Volume: 97, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Pneumonia, Aspiration; Postoperative Period; Ranitidine; Risk Assessment; Stomach; Sulfoxides	2003
Effect of a single oral dose of rabeprazole on nocturnal acid breakthrough and nocturnal alkaline amplitude. World journal of gastroenterology, 2003, Volume: 9, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Alkalies; Anti-Ulcer Agents; Benzimidazoles; Circadian Rhythm; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Rabeprazole; Sulfoxides	2003
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter, 2003, Volume: 8, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides; Treatment Outcome	2003
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. The American journal of gastroenterology, 2003, Volume: 98, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Chi-Square Distribution; Cross-Over Studies; Esomeprazole; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Least-Squares Analysis; Male; Middle Aged; Omeprazole; Pantoprazole; Rabeprazole; Sulfoxides; Treatment Outcome	2003
Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients. Digestion, 2003, Volume: 68, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Pantoprazole; Rheumatic Diseases; Risk Factors; Sulfoxides	2003
[Acid-supressing capacity of omeprazole 20 mg tablets vs pantoprazole 20 and 40 mg tablets. A pilot study in volunteers]. Acta gastroenterologica Latinoamericana, 2003, Volume: 33, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Analysis of Variance; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Time Factors	2003
Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers. Pharmacological research, 2004, Volume: 49, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP2C19; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Genotype; Half-Life; Humans; Male; Metabolic Clearance Rate; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Sulfoxides	2004
Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole. Alimentary pharmacology & therapeutics, 2004, Jul-01, Volume: 20, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Esomeprazole; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Urea	2004
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection. Journal of the Chinese Medical Association : JCMA, 2004, Volume: 67, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dizziness; Drug Therapy, Combination; Endoscopes, Gastrointestinal; Exanthema; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Sulfoxides; Tranexamic Acid; Treatment Outcome	2004
In treatment of active duodenal ulcer and Helicobacter pylori eradication. Hepato-gastroenterology, 2003, Volume: 50 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome	2003
Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease. Digestion, 2004, Volume: 70, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Odds Ratio; Omeprazole; Pantoprazole; Placebos; Ranitidine; Severity of Illness Index; Sulfoxides; Treatment Outcome	2004
The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing. Current medical research and opinion, 2004, Volume: 20, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome; Wound Healing	2004
Prevention of erosive oesophagitis relapse with pantoprazole. Alimentary pharmacology & therapeutics, 2004, Sep-01, Volume: 20, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Secondary Prevention; Sulfoxides; Survival Analysis	2004
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. European journal of clinical pharmacology, 2004, Volume: 60, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Esomeprazole; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Rabeprazole; Sulfoxides; Treatment Outcome	2004
Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzimidazoles; Dose-Response Relationship, Drug; Endoscopes, Gastrointestinal; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Sulfoxides	2004
Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World journal of gastroenterology, 2004, Dec-15, Volume: 10, Issue:24 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Combined Modality Therapy; Female; Hemostasis, Endoscopic; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Pilot Projects; Prospective Studies; Ranitidine; Secondary Prevention; Sulfoxides	2004
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome	2004
Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2004, Volume: 17, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzamides; Benzimidazoles; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Heartburn; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Morpholines; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome	2004
The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Alimentary pharmacology & therapeutics, 2005, Feb-01, Volume: 21, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abnormalities, Drug-Induced; Adult; Anti-Ulcer Agents; Benzimidazoles; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Proton Pump Inhibitors; Sulfoxides	2005
Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology (Baltimore, Md.), 2005, Volume: 41, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Ulcer	2005
Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointestinal endoscopy, 2005, Volume: 61, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Argon; Barrett Esophagus; Benzimidazoles; Combined Modality Therapy; Electrocoagulation; Female; Humans; Laser Coagulation; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method; Sulfoxides	2005
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients. World journal of gastroenterology, 2005, Apr-21, Volume: 11, Issue:15 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Chronic Disease; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Lansoprazole; Male; Metaplasia; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2005
Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. Journal of clinical pharmacology, 2005, Volume: 45, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Administration, Oral; Adult; Aged; Aged, 80 and over; Area Under Curve; Arthroplasty, Replacement, Hip; Benzimidazoles; Cross-Over Studies; Dabigatran; Drug Interactions; Female; Food-Drug Interactions; Humans; Male; Metabolic Clearance Rate; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Pyridines; Sulfoxides; Thrombin	2005
Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics, 2005, Jun-15, Volume: 21, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Powders; Sulfoxides; Treatment Outcome	2005
Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals. Equine veterinary journal, 2005, Volume: 37, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Animals, Newborn; Anti-Ulcer Agents; Benzimidazoles; Biological Availability; Chromatography, High Pressure Liquid; Female; Gastric Acidity Determination; Gastric Mucosa; Horses; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Random Allocation; Stomach; Sulfoxides	2005
Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective, randomized, placebo-controlled trial. Scandinavian journal of gastroenterology, 2005, Volume: 40, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastric Acid; Gastric Acidity Determination; Hormones; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Somatostatin; Sulfoxides	2005
Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease. European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anthropometry; Anti-Ulcer Agents; Benzimidazoles; Drug Administration Schedule; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Long-Term Care; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Dropouts; Proton Pump Inhibitors; Recurrence; Sulfoxides; Treatment Outcome	2005
On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial. Digestion, 2005, Volume: 72, Issue:2-3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Benzimidazoles; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Statistics, Nonparametric; Sulfoxides; Treatment Outcome	2005
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2004, Volume: 15, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method; Sulfoxides; Treatment Outcome	2004
Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults. Digestive diseases and sciences, 2006, Volume: 51, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Follow-Up Studies; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Pentagastrin; Prospective Studies; Proton Pump Inhibitors; Reference Values; Stomach; Sulfoxides	2006
Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. Alimentary pharmacology & therapeutics, 2006, Feb-01, Volume: 23, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Female; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome; Zollinger-Ellison Syndrome	2006
Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study. Gerontology, 2006, Volume: 52, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Esophagitis, Peptic; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome	2006
Proton pump inhibition prevents gastrointestinal bleeding in ultramarathon runners: a randomised, double blinded, placebo controlled study. British journal of sports medicine, 2006, Volume: 40, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Double-Blind Method; Feces; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Running; Sulfoxides; Treatment Outcome	2006
Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages. Alimentary pharmacology & therapeutics, 2006, Apr-01, Volume: 23, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Gastric Acidity Determination; Genotype; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Lansoprazole; Male; Metabolic Clearance Rate; Middle Aged; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Sulfoxides; Tablets	2006
Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease. Journal of pediatric gastroenterology and nutrition, 2006, Volume: 42, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Omeprazole; Pantoprazole; Severity of Illness Index; Sulfoxides; Surveys and Questionnaires; Time Factors; Treatment Outcome	2006
Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial. Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Chemotherapy, Adjuvant; Double-Blind Method; Endoscopy; Female; Humans; Incidence; India; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Risk Assessment; Risk Factors; Secondary Prevention; Sulfoxides; Treatment Outcome	2006
[Financial restrictions in health care systems could affect treatment quality of GERD-patients]. Zeitschrift fur Gastroenterologie, 2006, Volume: 44, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cost Control; Dose-Response Relationship, Drug; Drug Costs; Esophagitis, Peptic; Female; Germany; Humans; Male; Medical Records; Middle Aged; National Health Programs; Omeprazole; Pain Measurement; Pantoprazole; Quality of Health Care; Quality of Life; Sick Role; Sulfoxides; Treatment Outcome	2006
Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole. The American journal of gastroenterology, 2006, Volume: 101, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Rheumatic Diseases; Risk Factors; Statistics, Nonparametric; Sulfoxides; Treatment Outcome	2006
Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. Digestive diseases and sciences, 2006, Volume: 51, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aluminum Hydroxide; Analysis of Variance; Anti-Ulcer Agents; Benzimidazoles; Body Weights and Measures; Double-Blind Method; Drug Combinations; Esophagitis, Peptic; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Infusions, Intravenous; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pantoprazole; Placebo Effect; Severity of Illness Index; Silicic Acid; Sulfoxides; Treatment Outcome	2006
Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. The American journal of gastroenterology, 2006, Volume: 101, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Esophageal pH Monitoring; Esophagus; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Manometry; Middle Aged; Omeprazole; Pantoprazole; Pressure; Proton Pump Inhibitors; Sulfoxides; Time Factors; Treatment Outcome	2006
Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study. The American journal of gastroenterology, 2006, Volume: 101, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Ranitidine; Secondary Prevention; Sulfoxides; Treatment Outcome; United States	2006
Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial. Clinical therapeutics, 2006, Volume: 28, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Asian People; Circadian Rhythm; Drug Administration Schedule; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Acid; Gastric Acidity Determination; Humans; Infusions, Intravenous; Italy; Male; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Time Factors; Treatment Outcome	2006
Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study. Digestive diseases and sciences, 2007, Volume: 52, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Comorbidity; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Recurrence	2007
Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients. World journal of gastroenterology, 2007, Sep-07, Volume: 13, Issue:33 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Endoscopy, Gastrointestinal; Esophagitis; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome	2007
Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate. Helicobacter, 2007, Volume: 12, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole	2007
Effect of CYP2C192 and 17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians. British journal of clinical pharmacology, 2008, Volume: 65, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Female; Gastric Acidity Determination; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Mutation; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2008
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. Alimentary pharmacology & therapeutics, 2008, Volume: 28, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Esophageal pH Monitoring; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome	2008
Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD. Journal of clinical gastroenterology, 2009, Volume: 43, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Cross-Over Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome; Young Adult	2009
Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients : a randomized, double-blind, placebo-controlled study. Clinical drug investigation, 2008, Volume: 28, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Critical Illness; Double-Blind Method; Esomeprazole; Female; Gastric Acidity Determination; Gastric Juice; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole	2008
Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. World journal of gastroenterology, 2009, Feb-28, Volume: 15, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Esomeprazole; Female; Gastroesophageal Reflux; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Selection	2009
Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Drug Administration Schedule; Duodenal Ulcer; Duodenoscopy; Female; Gastric Acidity Determination; Gastroscopy; Hemostatic Techniques; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Rabeprazole; Recurrence; Stomach Ulcer; Time Factors; Treatment Outcome; Young Adult	2009
Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study. Journal of the American College of Cardiology, 2009, Sep-22, Volume: 54, Issue:13 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Anti-Ulcer Agents; Clopidogrel; Drug Interactions; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Stents; Ticlopidine	2009
Impact of the CYP2C1917 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:6* Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Alleles; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Disulfides; Female; Gene Frequency; Genetic Variation; Genotype; Humans; Male; Metabolic Clearance Rate; Mutation; Omeprazole; Pantoprazole	2010
Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting. Journal of cardiovascular pharmacology, 2010, Volume: 56, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Interactions; Esomeprazole; Female; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Regression Analysis; Stents; Ticlopidine	2010
Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2010, Volume: 13, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Reproducibility of Results; Young Adult	2010
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clinical pharmacology and therapeutics, 2011, Volume: 89, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Proton Pump Inhibitors; Ticlopidine; Young Adult	2011
[Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2010, Volume: 26, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Angioplasty, Balloon; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation; Postoperative Period; Proton Pump Inhibitors; Stents; Ticlopidine	2010
Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction. European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Blood Platelets; Clopidogrel; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2011
Enantioselective disposition of omeprazole, pantoprazole, and lansoprazole in a same Brazilian subjects group. Chirality, 2012, Volume: 24, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Brazil; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stereoisomerism; Substrate Specificity; Young Adult	2012
Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Combined Modality Therapy; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemostasis; Humans; Ligation; Lypressin; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Somatostatin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents	2013
Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study. Clinical cardiology, 2013, Volume: 36, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Aspirin; Chi-Square Distribution; Clopidogrel; Cross-Over Studies; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Famotidine; Female; Histamine H2 Antagonists; Humans; Israel; Linear Models; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method; Ticlopidine; Time Factors; Treatment Outcome	2013
Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial. Medicine, 2015, Volume: 94, Issue:17 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bifidobacterium; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Placebos; Probiotics; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome	2015
Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients. European journal of clinical pharmacology, 2015, Volume: 71, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alleles; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Drug Interactions; Female; Genotype; Humans; Male; Middle Aged; Models, Biological; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2015
In vitro and in vivo evaluation of drug-drug interaction between dabigatran and proton pump inhibitors. Fundamental & clinical pharmacology, 2015, Volume: 29, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line, Tumor; Cyclosporine; Dabigatran; Drug Interactions; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Thrombin; Young Adult	2015
Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software. Alzheimer's research & therapy, 2015, Dec-27, Volume: 7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Cognition; Esomeprazole; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Software; Young Adult	2015
One year treatment of Barrett's oesophagus with proton pump inhibitors (a multi-center study). Acta clinica Belgica, 2015, Volume: 70, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Epithelial Cells; Esophagoscopy; Esophagus; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2015
Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity. Journal of breath research, 2016, Jan-27, Volume: 10, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Blood Platelets; Breath Tests; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Humans; Omeprazole; Pantoprazole; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Ranitidine; Ticlopidine	2016
The effect of proton pump inhibitors on the CYP2C19 enzyme activity evaluated by the pantoprazole- Journal of breath research, 2016, 12-17, Volume: 10, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Biomarkers; Breath Tests; Carbon Radioisotopes; Cytochrome P-450 CYP2C19; Esomeprazole; Female; Gastroesophageal Reflux; Genetic Association Studies; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Pharmacogenetics; Precision Medicine; Proton Pump Inhibitors; Young Adult	2016
The effect of short-term oral treatment with omeprazole or pantoprazole on the function of polymorphonuclear neutrophils. Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Cyclic GMP; Female; Gene Expression Regulation, Enzymologic; Humans; Male; Neutrophils; Nitric Oxide; Nitric Oxide Synthase Type II; Omeprazole; p38 Mitogen-Activated Protein Kinases; Pantoprazole; Phosphoproteins; Time Factors	2017
Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort. PLoS medicine, 2017, Volume: 14, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cohort Studies; Female; Humans; Incidence; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Tuberculosis; United Kingdom	2017
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole. BMC pharmacology & toxicology, 2020, 07-25, Volume: 21, Issue:1 Topics: Adult; Anti-Ulcer Agents; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dietary Fats; Fasting; Female; Food-Drug Interactions; Genotype; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Young Adult	2020
Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial. Anesthesia and analgesia, 2022, 11-01, Volume: 135, Issue:5 Topics: Female; Humans; Hydralazine; Male; Omeprazole; Oxycodone; Pain; Pantoprazole; Perioperative Care; Pharmacogenetics; Prospective Studies; Succinylcholine; Tramadol	2022

Other Studies

344 other study(ies) available for omeprazole and pantoprazole

Article	Year
(H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate. Journal of medicinal chemistry, 1992, Mar-20, Volume: 35, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Benzimidazoles; Dogs; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Omeprazole; Pantoprazole; Pyridines; Rabbits; Structure-Activity Relationship; Sulfoxides	1992
Nicotinamide derivatives as a new class of gastric H+/K(+)-ATPase inhibitors. 1. Synthesis and structure-activity relationships of N-substituted 2-(benzhydryl- and benzylsulfinyl)nicotinamides. Journal of medicinal chemistry, 1997, Jan-31, Volume: 40, Issue:3 Topics: Aminopyrine; Animals; Bucladesine; Enzyme Inhibitors; Gastric Acid; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Molecular Structure; Niacinamide; Parietal Cells, Gastric; Proton Pump Inhibitors; Pyridines; Rabbits; Rats; Rats, Wistar; Structure-Activity Relationship	1997
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein. Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 364, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Biological Transport; Caco-2 Cells; Digoxin; Drug Interactions; Enzyme Inhibitors; Epithelial Cells; Humans; Lansoprazole; LLC-PK1 Cells; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Sulfoxides; Swine	2001
Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. Cancer research, 2004, Aug-15, Volume: 64, Issue:16 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Baculoviridae; Benzimidazoles; Biological Transport; Camptothecin; Cell Line; DNA, Complementary; Dogs; Drug Interactions; Enzyme Inhibitors; Humans; Irinotecan; Membrane Transport Proteins; Methotrexate; Mice; Mice, Knockout; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Omeprazole; Pantoprazole; Spodoptera; Sulfoxides; Topotecan; Transfection	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Antiprotozoal activity of proton-pump inhibitors. Bioorganic & medicinal chemistry letters, 2011, Dec-15, Volume: 21, Issue:24 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Drug Design; Entamoeba histolytica; Giardia lamblia; Humans; Lansoprazole; Omeprazole; Pantoprazole; Parasitic Diseases; Proton Pump Inhibitors; Rabeprazole; Trichomonas vaginalis	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Which metabolites circulate? Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5 Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations	2013
Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthase. Journal of medicinal chemistry, 2015, Jan-22, Volume: 58, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Repositioning; Fatty Acid Synthases; Humans; Hydrogen-Ion Concentration; Lansoprazole; Palmitic Acid; Palmitoyl-CoA Hydrolase; Protein Structure, Tertiary; Proton Pump Inhibitors	2015
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. European journal of medicinal chemistry, 2019, Oct-01, Volume: 179 Topics: Azoles; Biocatalysis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Insulysin; Isoindoles; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship	2019
Pantoprazole: a novel H+/K(+)-ATPase inhibitor with an improved pH stability. European journal of pharmacology, 1992, Aug-06, Volume: 218, Issue:2-3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Glutathione; Hydrogen-Ion Concentration; In Vitro Techniques; Omeprazole; Pantoprazole; Papain; Proton Pump Inhibitors; Sulfoxides; Swine	1992
Direct injection/h.p.l.c. methods for the analysis of drugs in biological samples. Xenobiotica; the fate of foreign compounds in biological systems, 1992, Volume: 22, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Pharmaceutical Preparations; Proton Pump Inhibitors; Purinones; Rats; Sulfones; Sulfoxides; Time Factors	1992
Ultrastructural investigations of the enterochromaffin-like (ECL) cells in three different rat strains (Sprague-Dawley, Fischer 344, Wistar) after treatment with the H+,K(+)-ATPase inhibitor pantoprazole. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 1992, Volume: 44, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Cell Count; Enterochromaffin Cells; Female; Gastric Mucosa; Microscopy, Electron; Omeprazole; Pantoprazole; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Rats, Wistar; Species Specificity; Sulfoxides	1992
Comparison of the ECL-cell frequency in the stomachs of 3 different rat strains. Pathology, research and practice, 1992, Volume: 188, Issue:4-5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Administration, Oral; Animals; Benzimidazoles; Cell Count; Enterochromaffin Cells; Female; Gastric Mucosa; Gastrins; Image Processing, Computer-Assisted; Omeprazole; Pantoprazole; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Rats, Wistar; Species Specificity; Stomach; Sulfoxides	1992
Helicobacter pylori and hypergastrinaemia during proton pump inhibitor therapy. Scandinavian journal of gastroenterology, 1992, Volume: 27, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Benzimidazoles; Duodenal Ulcer; Gastric Acidity Determination; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Pepsinogen A; Pepsinogens; Peptide Fragments; Sulfoxides	1992
The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole. Biochemical pharmacology, 1991, Jul-05, Volume: 42, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; 7-Alkoxycoumarin O-Dealkylase; Adenosine Triphosphatases; Animals; Benzimidazoles; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Ethylmorphine-N-Demethylase; Female; H(+)-K(+)-Exchanging ATPase; Kinetics; Lansoprazole; Liver; Omeprazole; Pantoprazole; Pyrazoles; Rats; Rats, Inbred Strains; Sulfoxides	1991
The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog. Life sciences, 1991, Volume: 49, Issue:14 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Dogs; Famotidine; Gastric Acid; Gastric Fistula; Gastric Mucosa; Male; Omeprazole; Pantoprazole; Pentagastrin; Stomach; Sulfoxides	1991
Lack of pharmacokinetic interaction as an equivalence problem. International journal of clinical pharmacology, therapy, and toxicology, 1991, Volume: 29, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Adenosine Triphosphatases; Administration, Oral; Adult; Benzimidazoles; Caffeine; Drug Interactions; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Models, Biological; Omeprazole; Pantoprazole; Pharmacokinetics; Sulfoxides; Theophylline; Therapeutic Equivalency	1991
Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Helicobacter pylori; Omeprazole; Pantoprazole; Sulfoxides	1991
Single intravenous administration of the H+, K(+)-ATPase inhibitor BY 1023/SK&F 96022--inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man. Alimentary pharmacology & therapeutics, 1990, Volume: 4, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Benzimidazoles; Dose-Response Relationship, Drug; Electrocardiography; Gastric Acid; Gastric Juice; H(+)-K(+)-Exchanging ATPase; Half-Life; Humans; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Pentagastrin; Single-Blind Method; Sulfoxides	1990
Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat. Pharmacology, 1990, Volume: 41, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Duodenal Ulcer; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Male; Muscarinic Antagonists; Omeprazole; Pantoprazole; Parasympatholytics; Pirenzepine; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulfoxides	1990
By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor. Biochemical pharmacology, 1990, Jun-01, Volume: 39, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Aminopyrine; Animals; Benzimidazoles; Gastric Mucosa; Glutathione; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Lysosomes; Magnesium; Omeprazole; Pantoprazole; Pyridines; Rabbits; Sulfoxides	1990
Two systems for the automated analysis of drugs in biological fluids using high-performance liquid chromatography. Journal of chromatography, 1990, Apr-27, Volume: 527, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine Triphosphatases; Animals; Benzimidazoles; Chromatography, High Pressure Liquid; H(+)-K(+)-Exchanging ATPase; Humans; Omeprazole; Pantoprazole; Purinones; Pyridines; Sulfoxides	1990
BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Diazepam; Female; Gastric Acid; H(+)-K(+)-Exchanging ATPase; In Vitro Techniques; Motor Activity; Omeprazole; Pantoprazole; Rabbits; Rats; Rats, Inbred Strains; Sulfoxides	1990
High-performance liquid chromatographic determination of the H+/K+ ATPase inhibitor (BY 1023/SK&F 96,022) and its sulphone metabolite in serum or plasma by direct injection and fully automated pre-column sample clean-up. Journal of chromatography, 1990, Aug-03, Volume: 529, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetonitriles; Adenosine Triphosphatases; Animals; Autoanalysis; Benzimidazoles; Chromatography, High Pressure Liquid; Dogs; H(+)-K(+)-Exchanging ATPase; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Sulfoxides; Temperature	1990
Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers. Zeitschrift fur Gastroenterologie, 1990, Volume: 28, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Pentagastrin; Single-Blind Method; Sodium-Potassium-Exchanging ATPase; Sulfoxides	1990
Management of Acid-Related Diseases: Focus on Pantoprazole. Proceedings of the 1st International Symposium on Pantoprazole. Berlin, Germany, 1 May 1993. Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides	1994
The site of action of pantoprazole in the gastric H+/K(+)-ATPase. Biochimica et biophysica acta, 1993, Jun-05, Volume: 1148, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amino Acid Sequence; Animals; Benzimidazoles; Binding Sites; Dithiothreitol; Gastric Mucosa; Molecular Sequence Data; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Swine; Trypsin	1993
[Pantoprazole. A new acid pump inhibitor against peptic ulcer and reflux esophagitis]. Ugeskrift for laeger, 1996, Mar-18, Volume: 158, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides	1996
Lack of pharmacokinetic interaction as an equivalence problem. International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Bronchodilator Agents; Drug Interactions; Enzyme Inhibitors; Humans; Omeprazole; Pantoprazole; Pharmaceutical Preparations; Pharmacokinetics; Proton Pump Inhibitors; Research Design; Statistics as Topic; Sulfoxides; Theophylline; Therapeutic Equivalency	1996
Direct determination of pantoprazole enantiomers in human serum by reversed-phase high-performance liquid chromatography using a cellulose-based chiral stationary phase and column-switching system as a sample cleanup procedure. Analytical chemistry, 1996, May-01, Volume: 68, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Calibration; Chromatography, High Pressure Liquid; Humans; Molecular Structure; Omeprazole; Pantoprazole; Reproducibility of Results; Sulfoxides	1996
Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs. European journal of gastroenterology & hepatology, 1996, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Structure-Activity Relationship; Sulfoxides	1996
[Do other proton pump blockers have advantages over Antra (omeprazole)?]. Der Internist, 1996, Volume: 37, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Structure-Activity Relationship; Sulfoxides	1996
[2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole]. Der Internist, 1996, Volume: 37, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Structure-Activity Relationship; Sulfoxides; Treatment Outcome	1996
Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man. European journal of clinical pharmacology, 1996, Volume: 51, Issue:3-4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anticoagulants; Benzimidazoles; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Male; Omeprazole; Pantoprazole; Phenprocoumon; Proton Pump Inhibitors; Stereoisomerism; Sulfoxides	1996
Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line. Xenobiotica; the fate of foreign compounds in biological systems, 1997, Volume: 27, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; beta-Naphthoflavone; Cell Line; Cytochrome P-450 CYP1A1; Enzyme Activation; Humans; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; RNA, Messenger; Sulfoxides	1997
Chiral resolution of pantoprazole sodium and related sulfoxides by complex formation with bovine serum albumin in capillary electrophoresis. Journal of chromatography. A, 1997, Jan-24, Volume: 759, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Serum Albumin, Bovine; Spectrophotometry, Ultraviolet; Stereoisomerism; Sulfoxides	1997
Differential stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor in extensive and poor metabolizers of pantoprazole--a preliminary study. Chirality, 1997, Volume: 9, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Benzimidazoles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Male; Omeprazole; Pantoprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Stereoisomerism; Sulfoxides; Tablets, Enteric-Coated	1997
Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 1997, Volume: 25, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Blotting, Western; Cytochrome P-450 Enzyme System; Cytochromes b5; Enzyme Induction; Enzyme Inhibitors; Female; Lansoprazole; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Omeprazole; Organ Size; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sulfoxides	1997
Proton-pump inhibitors: three of a kind? Lancet (London, England), 1997, Jun-07, Volume: 349, Issue:9066 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides	1997
Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. The Journal of biological chemistry, 1997, Sep-05, Volume: 272, Issue:36 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amino Acid Sequence; Animals; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Gastric Acid; H(+)-K(+)-Exchanging ATPase; Indicators and Reagents; Lansoprazole; Molecular Sequence Data; Omeprazole; Oxidoreductases; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sequence Homology, Amino Acid; Sphingosine; Stomach; Sulfhydryl Compounds; Sulfoxides; Swine	1997
An evaluation of the CYP1A induction potential of pantoprazole in primary rat hepatocytes: a comparison with other proton pump inhibitors. Chemico-biological interactions, 1997, Nov-06, Volume: 107, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP1A1; Enzyme Induction; Enzyme Inhibitors; Female; Lansoprazole; Liver; Microsomes, Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sulfoxides	1997
Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds. Annals of the New York Academy of Sciences, 1997, Nov-03, Volume: 834 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Binding Sites; Enzyme Inhibitors; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Humans; Kinetics; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Structure-Activity Relationship; Sulfoxides; Valinomycin	1997
Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction. Biochemical pharmacology, 1997, Dec-01, Volume: 54, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Bile; Enzyme Inhibitors; Female; Glucuronosyltransferase; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sulfoxides; Thyroid Hormones	1997
Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype. Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Half-Life; Humans; Japan; Male; Mephenytoin; Metabolic Clearance Rate; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1997
[Short-term (6 days) eradication of Helicobacter pylori infection in the practice of a health insurance physician]. Deutsche medizinische Wochenschrift (1946), 1998, Jan-30, Volume: 123, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Azithromycin; Benzimidazoles; Female; Helicobacter Infections; Helicobacter pylori; Humans; Insurance, Physician Services; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Practice Patterns, Physicians'; Sulfoxides; Time Factors; Tinidazole	1998
Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates. Pharmacology, 1998, Volume: 56, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Animals; Benzimidazoles; Biological Availability; Dogs; Drug Stability; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Half-Life; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Protein Binding; Proton Pump Inhibitors; Rabbits; Sulfoxides	1998
[Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection]. Medizinische Klinik (Munich, Germany : 1983), 1998, Feb-15, Volume: 93, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Stomach Ulcer; Sulfoxides; Treatment Outcome	1998
Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori. Helicobacter, 1998, Volume: 3, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Growth Inhibitors; Helicobacter pylori; Humans; Lansoprazole; Microscopy, Electron, Scanning; Omeprazole; Pantoprazole; Sulfoxides; Urease	1998
Pharmacokinetics of pantoprazole in patients with end-stage renal failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Blood Proteins; Dialysis Solutions; Enzyme Inhibitors; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Pantoprazole; Renal Dialysis; Sulfoxides	1998
Treatment of antibiotic-resistant Helicobacter pylori. The New England journal of medicine, 1998, Jul-02, Volume: 339, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rifabutin; Sulfoxides	1998
Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Stomach Ulcer; Sulfoxides; Tinidazole; Treatment Outcome	1998
[Is dental plaque a normal Helicobacter pylori reservoir?]. Acta gastroenterologica Latinoamericana, 1998, Volume: 28, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Dental Plaque; Disease Reservoirs; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prevalence; Recurrence; Sulfoxides	1998
An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes. Chemico-biological interactions, 1998, Jul-03, Volume: 114, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzimidazoles; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Humans; Lansoprazole; Liver; Male; Methylcholanthrene; Middle Aged; Omeprazole; Pantoprazole; Rifampin; Steroid Hydroxylases; Structure-Activity Relationship; Sulfoxides	1998
[Drug interactions. Proton pump inhibitors. 1]. Der Internist, 1998, Volume: 39, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1998
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male. Zeitschrift fur Gastroenterologie, 1998, Volume: 36, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome	1998
[Drug interactions. Proton pump inhibitors II]. Der Internist, 1998, Volume: 39, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	1998
Stereoselective chiral inversion of pantoprazole enantiomers after separate doses to rats. Chirality, 1998, Volume: 10, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Area Under Curve; Benzimidazoles; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Half-Life; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet; Stereoisomerism; Sulfoxides	1998
Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole. Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetic Acid; Animals; Anti-Ulcer Agents; Benzimidazoles; Bicarbonates; Dose-Response Relationship, Drug; Duodenal Ulcer; Enzyme Inhibitors; Epirizole; Gastric Acid; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sulfoxides; Wound Healing	1999
The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture. American journal of surgery, 1999, Volume: 177, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Deglutition Disorders; Drug Therapy, Combination; Enzyme Inhibitors; Esophageal Stenosis; Female; Follow-Up Studies; Fundoplication; Gastroesophageal Reflux; Heartburn; Humans; Hydrogen-Ion Concentration; Laparoscopy; Male; Manometry; Middle Aged; Omeprazole; Pantoprazole; Pressure; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Surveys and Questionnaires; Treatment Outcome	1999
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides	1999
Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole. Biochemical pharmacology, 1999, Oct-15, Volume: 58, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; 4-Nitrophenylphosphatase; Acids; Animals; Benzimidazoles; Enzyme Inhibitors; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Microsomes; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabbits; Stomach; Sulfoxides	1999
Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography. Drug development and industrial pharmacy, 1999, Volume: 25, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chromatography, High Pressure Liquid; Drug Stability; Enzyme Inhibitors; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Reproducibility of Results; Salts; Sulfoxides; Time Factors	1999
Lichenoid drug eruption with proton pump inhibitors. BMJ (Clinical research ed.), 2000, Jan-29, Volume: 320, Issue:7230 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Drug Eruptions; Enzyme Inhibitors; Humans; Lansoprazole; Lichenoid Eruptions; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2000
Multiple organ failure related to pantoprazole. Australian and New Zealand journal of medicine, 1999, Volume: 29, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acidosis, Lactic; Acute Kidney Injury; Aged; Anti-Ulcer Agents; Benzimidazoles; Humans; Liver Failure, Acute; Male; Multiple Organ Failure; Omeprazole; Pantoprazole; Rhabdomyolysis; Sulfoxides	1999
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers. Thrombosis research, 2000, Mar-15, Volume: 97, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute-Phase Reaction; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biomarkers; Breath Tests; Cholesterol, HDL; Cholesterol, LDL; Clarithromycin; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome; Triglycerides; Urea	2000
Spectrophotometric methods for the determination of lansoprazole and pantoprazole sodium sesquihydrate. Journal of pharmaceutical and biomedical analysis, 2000, Volume: 22, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Calibration; Capsules; Hydrogen-Ion Concentration; Indicators and Reagents; Lansoprazole; Omeprazole; Pantoprazole; Pharmaceutical Solutions; Spectrophotometry, Ultraviolet; Sulfoxides; Tablets	2000
Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy. The Journal of laryngology and otology, 1999, Volume: 113, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; Female; Gastroesophageal Reflux; Humans; Laryngitis; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Sulfoxides; Surveys and Questionnaires; Treatment Outcome; Voice Disorders	1999
Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation. Acta physiologica Scandinavica, 2000, Volume: 169, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cell Division; Cell Fractionation; Centrifugation; Cytoplasmic Granules; Enterochromaffin Cells; Enzyme Inhibitors; Female; Gastric Mucosa; Gastrins; Histamine; Hyperplasia; Microscopy, Electron; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Rats; Rats, Sprague-Dawley; Sulfoxides	2000
[Erectile dysfunction and proton pump inhibitors]. Medicina clinica, 2000, Apr-01, Volume: 114, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2000
Pantoprazole (Protonix). The Medical letter on drugs and therapeutics, 2000, Jul-24, Volume: 42, Issue:1083 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Erythema Multiforme; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Stevens-Johnson Syndrome; Stomach Ulcer; Sulfoxides	2000
Treatment of Helicobacter pylori infection: is less more? Journal of clinical gastroenterology, 2000, Volume: 31, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides; Time Factors	2000
The effect of pantoprazole on tacrolimus and cyclosporin A blood concentration in transplant recipients. European journal of clinical pharmacology, 2000, Volume: 56, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Cyclosporine; Enzyme Inhibitors; Enzyme Multiplied Immunoassay Technique; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Omeprazole; Organ Transplantation; Pantoprazole; Sulfoxides; Tacrolimus	2000
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. British journal of clinical pharmacology, 2000, Volume: 50, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Adverse Drug Reaction Reporting Systems; Age Distribution; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Cohort Studies; Diarrhea; Drug Prescriptions; England; Family Practice; Female; Headache; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2000
Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients. Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Sulfoxides; Treatment Outcome	2000
Helicobacter pylori, a frequent and potentially dangerous guest in the gastroduodenal mucosa of anticoagulated patients. The American journal of medicine, 2000, Volume: 108, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Amoxicillin; Anti-Ulcer Agents; Anticoagulants; Benzimidazoles; Cardiovascular Diseases; Duodenum; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; International Normalized Ratio; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Sulfoxides	2000
Does pantoprazole alleviate mouth dryness in patients with Sjögren's syndrome? Rheumatology (Oxford, England), 2001, Volume: 40, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Female; Humans; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sjogren's Syndrome; Sulfoxides; Treatment Outcome; Xerostomia	2001
Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study. Croatian medical journal, 2001, Volume: 42, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Cohort Studies; Croatia; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Risk Factors; Sulfoxides	2001
Treatment strategies for gastroesophageal reflux disease. Clinical therapeutics, 2000, Volume: 22, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cytochrome P-450 Enzyme System; Drug Interactions; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2000
Multiple organ failure and pantoprazole. Australian and New Zealand journal of medicine, 2000, Volume: 30, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Humans; Multiple Organ Failure; Omeprazole; Pantoprazole; Rhabdomyolysis; Sulfoxides	2000
Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. The American journal of gastroenterology, 2001, Volume: 96, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Benzimidazoles; Bile Reflux; Case-Control Studies; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides	2001
Pantoprazole and cyclosporine or tacrolimus. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Immunosuppressive Agents; Liver; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Tacrolimus	2001
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. Life sciences, 2001, Mar-09, Volume: 68, Issue:16 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bromocriptine; Cimetidine; Disease Models, Animal; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indomethacin; Lansoprazole; Male; Mice; Mice, Inbred Strains; Misoprostol; Omeprazole; Pantoprazole; Peptide Fragments; Proteins; Ranitidine; Stomach Diseases; Sulfoxides	2001
Functionally impaired, hypertrophic ECL cells accumulate vacuoles and lipofuscin bodies. An ultrastructural study of ECL cells isolated from hypergastrinemic rats. Cell and tissue research, 2001, Volume: 303, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cell Division; Cell Size; Enterochromaffin-like Cells; Enzyme Inhibitors; Female; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Histamine Release; Histidine Decarboxylase; Hypertrophy; Lipofuscin; Microscopy, Electron; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Secretory Vesicles; Stomach; Sulfoxides; Time Factors; Vacuoles	2001
Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases. Digestive diseases and sciences, 2001, Volume: 46, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Edema; Female; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides	2001
Proton pump inhibitors: a study of GPs' prescribing. Family practice, 2001, Volume: 18, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Costs; Drug Prescriptions; Drug Utilization; England; Family Practice; Female; Health Services Research; Hospitals, Teaching; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Practice Patterns, Physicians'; Proton Pump Inhibitors; Sulfoxides	2001
Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration. Clinical and experimental dermatology, 2001, Volume: 26, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Benzimidazoles; Dermatitis, Phototoxic; Female; Humans; Lupus Erythematosus, Discoid; Omeprazole; Pantoprazole; Sulfoxides	2001
Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction. Clinical therapeutics, 2001, Volume: 23, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Benzimidazoles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Liver Diseases; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides	2001
Resolution of Menetrier's disease after Helicobacter pylori eradication therapy. The New Zealand medical journal, 2001, Aug-24, Volume: 114, Issue:1138 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Dietary Proteins; Gastritis, Hypertrophic; Gastroscopy; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome	2001
Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease. Annals of surgery, 2001, Volume: 234, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles; Esophagitis, Peptic; Esophagogastric Junction; Esophagus; Female; Fundoplication; Gastroesophageal Reflux; Humans; Male; Manometry; Metaplasia; Middle Aged; Mucous Membrane; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides	2001
Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole. European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pantoprazole; Rosacea; Sulfoxides	2001
Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux. Acta oto-laryngologica, 2001, Volume: 121, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Gastroesophageal Reflux; Humans; Laryngitis; Laryngoscopy; Omeprazole; Pantoprazole; Prevalence; Prospective Studies; Sulfoxides; Surveys and Questionnaires; Voice Disorders; Voice Quality	2001
The novel use of an intravenous proton pump inhibitor in a patient with short bowel syndrome. Journal of clinical gastroenterology, 2002, Volume: 34, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Male; Omeprazole; Pantoprazole; Recurrence; Short Bowel Syndrome; Sulfoxides	2002
Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality. Scandinavian journal of gastroenterology. Supplement, 2001, Issue:234 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Esomeprazole; Half-Life; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Prodrugs; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2001
Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2001, Volume: 15, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Zollinger-Ellison Syndrome	2001
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. The American journal of gastroenterology, 2001, Volume: 96, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gastric Acid; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Retreatment; Sulfoxides; Zollinger-Ellison Syndrome	2001
Proton pump inhibitors and gastric acid secretion. The American journal of gastroenterology, 2001, Volume: 96, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Gastric Acid; Gastrointestinal Hemorrhage; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Secondary Prevention; Sulfoxides	2001
Enantiomeric determination of pantoprazole in human plasma by multidimensional high-performance liquid chromatography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002, Jan-05, Volume: 766, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Calibration; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Humans; Omeprazole; Pantoprazole; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Sulfoxides	2002
Cluster headache without autonomic symptoms? Cephalalgia : an international journal of headache, 2001, Volume: 21, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Inflammatory Agents; Anti-Ulcer Agents; Benzimidazoles; Cluster Headache; Diagnosis, Differential; Glucocorticoids; Humans; Male; Omeprazole; Pantoprazole; Prednisolone; Serotonin Receptor Agonists; Sulfoxides; Triazoles; Tryptamines	2001
Protonix. First i.v. proton pump inhibitor approved. Nursing, 2002, Volume: 32, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Drug Approval; Humans; Infusions, Intravenous; Multicenter Studies as Topic; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; United States; Zollinger-Ellison Syndrome	2002
Conformational analysis: a new approach by means of chemometrics. Journal of computational chemistry, 2002, Jan-30, Volume: 23, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Lansoprazole; Models, Molecular; Molecular Conformation; Omeprazole; Pantoprazole; Pharmaceutical Preparations; Sulfoxides; Thermodynamics	2002
Nonallergic anaphylaxis to pantoprazole. Allergy, 2002, Volume: 57, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anaphylaxis; Benzimidazoles; Diagnosis, Differential; Drug Hypersensitivity; Enzyme Inhibitors; Female; Food Hypersensitivity; Humans; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Skin Tests; Sulfoxides	2002
Selective colonization by Helicobacter pylori of the deep gastric glands and intracellular canaliculi of parietal cells in the setting of chronic proton pump inhibitor use. European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Gastric Mucins; Gastric Mucosa; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Proton Pump Inhibitors; Sulfoxides	2002
Pantoprazole IV (Protonix IV). The Medical letter on drugs and therapeutics, 2002, Apr-29, Volume: 44, Issue:1129 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clinical Trials as Topic; Drug Approval; Fees, Pharmaceutical; Gastroesophageal Reflux; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Omeprazole; Pantoprazole; Randomized Controlled Trials as Topic; Sulfoxides; Zollinger-Ellison Syndrome	2002
Stability of pantoprazole in an extemporaneously compounded oral liquid. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, May-15, Volume: 59, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Ulcer Agents; Benzimidazoles; Chromatography, High Pressure Liquid; Drug Compounding; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Sodium Bicarbonate; Sulfoxides; Suspensions; Tablets; Water	2002
Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate. BMJ (Clinical research ed.), 2002, Jun-22, Volume: 324, Issue:7352 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Benzimidazoles; Dermatologic Agents; Drug Interactions; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Muscular Diseases; Omeprazole; Pain; Pantoprazole; Sulfoxides	2002
Pantoprazole-induced recurrent anaphylactic shock. The American journal of gastroenterology, 2002, Volume: 97, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anaphylaxis; Benzimidazoles; Esophagitis, Peptic; Humans; Male; Omeprazole; Pantoprazole; Recurrence; Sulfoxides	2002
Proton pump inhibitors: an update. American family physician, 2002, Jul-15, Volume: 66, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Interactions; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2002
Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2002, Volume: 16, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Canada; Dyspepsia; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prevalence; Proton Pump Inhibitors; Sulfoxides; Surveys and Questionnaires; Time Factors	2002
[Effect of pantoprazole on non-variceal bleeding]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2000, Aug-28, Volume: 25, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Stomach Ulcer; Sulfoxides	2000
Factors associated with treatment failure of Helicobacter pylori infection in a developing country. Journal of clinical gastroenterology, 2002, Volume: 35, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Developing Countries; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Risk Factors; Sex Factors; Sulfoxides; Treatment Failure	2002
[Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2002, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Proton Pump Inhibitors; Sulfoxides	2002
Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations. Journal of pharmaceutical and biomedical analysis, 2002, Nov-07, Volume: 30, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chemistry, Pharmaceutical; Lansoprazole; Omeprazole; Pantoprazole; Spectrophotometry, Ultraviolet; Sulfoxides	2002
[Proton pump inhibitor in reflux disease. Administer for maximum effect from the beginning]. MMW Fortschritte der Medizin, 2002, Sep-26, Volume: 144, Issue:39 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clinical Trials as Topic; Dose-Response Relationship, Drug; Esophagitis, Peptic; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome	2002
Pantoprazole-induced recurrent anaphylactic shock. The American journal of gastroenterology, 2002, Volume: 97, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anaphylaxis; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Sulfoxides	2002
[In small steps to far ahead. Diminished risk of interactions as definite advantage]. MMW Fortschritte der Medizin, 2002, Oct-10, Volume: 144, Issue:41 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2002
Severe esophagitis healed in less than a week with intravenous pantoprazole. Journal of clinical gastroenterology, 2003, Volume: 36, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Enzyme Inhibitors; Esophagitis; Female; Gastroesophageal Reflux; Humans; Infusions, Intravenous; Injections, Intravenous; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2003
[Visual documentation of the stability of intravenous solutions of omeprazole (Losec) and pantoprazole (Pantoloc)]. Wiener medizinische Wochenschrift (1946), 2002, Volume: 152, Issue:21-22 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Stability; Drug Storage; Esophagitis, Peptic; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Structure-Activity Relationship; Sulfoxides; Zollinger-Ellison Syndrome	2002
The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England. Drug safety, 2003, Volume: 26, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Child; Cohort Studies; England; Enzyme Inhibitors; Female; Gastroenteritis; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Physicians, Family; Product Surveillance, Postmarketing; Sulfoxides	2003
[Patient with increased stomach cancer risk. Helicobacter can cause damage here]. MMW Fortschritte der Medizin, 2002, Oct-24, Volume: 144, Issue:43 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Precancerous Conditions; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Sulfoxides	2002
Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. The American journal of gastroenterology, 2003, Volume: 98, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Benzimidazoles; Dose-Response Relationship, Drug; Female; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Safety; Sulfoxides; Time Factors; Zollinger-Ellison Syndrome	2003
[Pantoprazole-induced hepatitis]. Deutsche medizinische Wochenschrift (1946), 2003, Mar-21, Volume: 128, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdomen; Abdominal Pain; Anti-Ulcer Agents; Benzimidazoles; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Enzyme Inhibitors; Female; Gastroesophageal Reflux; Humans; Liver; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Ultrasonography, Doppler, Duplex	2003
Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study. Medical electron microscopy : official journal of the Clinical Electron Microscopy Society of Japan, 2003, Volume: 36, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Clofibric Acid; Fibric Acids; Gastrin-Secreting Cells; Gastrins; Immunohistochemistry; Male; Microscopy, Immunoelectron; Omeprazole; Pantoprazole; Peroxisome Proliferators; Peroxisomes; Proton Pump Inhibitors; Pyloric Antrum; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Sulfoxides; Transcription Factors	2003
Update on prescribing information for pantoprazole. American family physician, 2003, Mar-15, Volume: 67, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Digoxin; Drug Interactions; Esophagitis; Humans; Nifedipine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2003
Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. European journal of pharmacology, 2003, Apr-11, Volume: 466, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hypericum; Lansoprazole; Omeprazole; Pantoprazole; Plant Preparations; Rabeprazole; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfoxides	2003
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole. Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adverse Drug Reaction Reporting Systems; Anti-Ulcer Agents; Anticoagulants; Benzimidazoles; Drug Interactions; Gastrointestinal Diseases; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; United States; United States Food and Drug Administration	2003
Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success. Revista espanola de enfermedades digestivas, 2003, Volume: 95, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides	2003
Determination of pantoprazole by adsorptive stripping voltammetry at carbon paste electrode. Farmaco (Societa chimica italiana : 1989), 2003, Volume: 58, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Calibration; Chemistry, Pharmaceutical; Electrochemistry; Electrodes; In Vitro Techniques; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Sulfoxides	2003
[Pantoprazole-induced hepatitis]. Deutsche medizinische Wochenschrift (1946), 2003, Jul-04, Volume: 128, Issue:27 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Benzimidazoles; Chemical and Drug Induced Liver Injury; Cholangitis; Diagnosis, Differential; Female; Gallstones; Humans; Omeprazole; Pantoprazole; Sulfoxides	2003
Adverse reactions to pantoprazole. Scandinavian journal of gastroenterology, 2003, Volume: 38, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anaphylaxis; Benzimidazoles; Enzyme Inhibitors; Female; Gastroesophageal Reflux; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides	2003
First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities. Journal of pharmaceutical and biomedical analysis, 2003, Aug-08, Volume: 32, Issue:4-5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Contamination; Omeprazole; Pantoprazole; Spectrophotometry, Ultraviolet; Sulfoxides; Technology, Pharmaceutical	2003
[References for reflux therapy. Preventing nocturnal acid recurrence]. MMW Fortschritte der Medizin, 2003, Jul-24, Volume: 145, Issue:29-30 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Chronotherapy; Delayed-Action Preparations; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2003
["Visual assessment" does not replace quality control with instrumental methods]. Wiener medizinische Wochenschrift (1946), 2003, Volume: 153, Issue:15-16 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Documentation; Drug Stability; Humans; Omeprazole; Pantoprazole; Quality Control; Reproducibility of Results; Sulfoxides	2003
Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates. Journal of pharmaceutical and biomedical analysis, 2003, Oct-15, Volume: 33, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chelating Agents; Omeprazole; Pantoprazole; Spectrophotometry, Ultraviolet; Sulfoxides; Technology, Pharmaceutical	2003
Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary. The American journal of managed care, 2003, Volume: 9, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Utilization; Enzyme Inhibitors; Formularies as Topic; Gastroesophageal Reflux; Health Care Sector; Health Maintenance Organizations; Humans; Insurance, Pharmaceutical Services; Maine; Medicaid; Omeprazole; Pantoprazole; Practice Patterns, Physicians'; Proton Pump Inhibitors; Proton Pumps; State Health Plans; Sulfoxides; United States	2003
Study of Mimusops elengi bark in experimental gastric ulcers. Journal of ethnopharmacology, 2003, Volume: 89, Issue:2-3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimidazoles; Ethanol; Female; Gastric Acid; Injections, Intraperitoneal; Male; Mimusops; Omeprazole; Pantoprazole; Plant Bark; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer; Sulfoxides	2003
[Mastopathy after estradiol and pantoprazol treatment]. Atencion primaria, 2003, Oct-31, Volume: 32, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Drug Therapy, Combination; Estradiol; Female; Fibrocystic Breast Disease; Humans; Omeprazole; Pantoprazole; Sulfoxides	2003
Differential pulse anodic voltammetric determination of pantoprazole in pharmaceutical dosage forms and human plasma using glassy carbon electrode. Analytical biochemistry, 2003, Dec-01, Volume: 323, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Carbon; Drug Monitoring; Electrochemistry; Electrodes; Humans; Omeprazole; Pantoprazole; Pharmaceutical Preparations; Sulfoxides; Tablets	2003
Square-wave adsorptive cathodic stripping voltammetry of pantoprazole. Journal of pharmaceutical and biomedical analysis, 2003, Nov-24, Volume: 33, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Electrochemistry; Omeprazole; Pantoprazole; Sulfoxides	2003
Asthma-like syndrome in a teenager. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2003, Volume: 14, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Albuterol; Amoxicillin; Androstadienes; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Asthma; Benzimidazoles; Bronchi; Bronchodilator Agents; Bronchoscopy; Carcinoid Tumor; Diagnosis, Differential; Drug Therapy, Combination; Fluticasone; Forced Expiratory Flow Rates; Forced Expiratory Volume; Gastroesophageal Reflux; Humans; Immunoglobulin E; Lung Neoplasms; Male; Metronidazole; Omeprazole; Pantoprazole; Radioallergosorbent Test; Respiratory Sounds; Sulfoxides; Syndrome; Tomography, X-Ray Computed; Tuberculin Test; Vital Capacity	2003
["Mirror, mirror on the wall which is the best proton pump inhibitor of all?"]. Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antifibrinolytic Agents; Benzimidazoles; Drug Interactions; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Vitamin K	2003
Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. The American journal of gastroenterology, 2003, Volume: 98, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Female; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Pilot Projects; Prospective Studies; Recurrence; Sulfoxides; Treatment Outcome	2003
Dosage of intravenous pantoprazole. The American journal of gastroenterology, 2003, Volume: 98, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides	2003
Acute interstitial nephritis due to pantoprazole. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Benzimidazoles; Biopsy; Ciprofloxacin; Creatinine; Female; Gastroesophageal Reflux; Humans; Kidney; Nephritis, Interstitial; Oliguria; Omeprazole; Pantoprazole; Prednisone; Proton Pump Inhibitors; Proton Pumps; Sulfoxides; Time Factors	2004
The acidity index: a simple approach to the measurement of gastric acidity. Alimentary pharmacology & therapeutics, 2004, Feb-15, Volume: 19, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2004
[Efficacy of controloc in the treatment of acid-dependent diseases]. Likars'ka sprava, 2003, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome	2003
[The proton pump especially steady in grip. Fast help for nightly reflux complaints]. MMW Fortschritte der Medizin, 2003, Dec-18, Volume: 145, Issue:51-52 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Heartburn; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Time Factors	2003
pH probe positioning for 24-hour pH-metry by manometry or pH step-up. European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Benzimidazoles; Enzyme Inhibitors; Female; Gastric Acidity Determination; Gastroesophageal Reflux; Hernia, Hiatal; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Monitoring, Ambulatory; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2004
Effectiveness of peripheral hepatogastrostomy versus hepatojejunostomy in the treatment of obstructive cholestasis: results of an experimental model. Surgery today, 2004, Volume: 34, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cholestasis; Common Bile Duct; Feasibility Studies; Gastrostomy; H(+)-K(+)-Exchanging ATPase; Jejunostomy; Liver; Omeprazole; Pantoprazole; Sulfoxides; Swine; Treatment Outcome	2004
An audit of argon plasma coagulation, epinephrine injection, and proton-pump infusion therapy in the management of bleeding peptic ulcer disease. Endoscopy, 2004, Volume: 36, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cohort Studies; Epinephrine; Gastroscopy; Hemostasis, Endoscopic; Humans; Infusions, Intravenous; Injections, Intralesional; Laser Coagulation; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Proton Pumps; Retrospective Studies; Sulfoxides; Treatment Outcome; Vasoconstrictor Agents	2004
[Electrochemical behaviour of pantoprazole]. Die Pharmazie, 2004, Volume: 59, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Electrochemistry; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Sulfoxides	2004
[When sour does not make merry at all . Fast relief for patients with reflux]. MMW Fortschritte der Medizin, 2003, Apr-10, Volume: 145, Issue:15 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Gastroesophageal Reflux; Heartburn; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Time Factors	2003
[Stubborn reflux pain, inconspicuous esophagus. Which therapy brings the fastest relief?]. MMW Fortschritte der Medizin, 2004, Mar-11, Volume: 146, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagoscopy; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Sulfoxides; Time Factors	2004
[Graded therapy in reflux disease. "In severe cases 40 mg., in milder 20 mg."]. MMW Fortschritte der Medizin, 2004, Mar-11, Volume: 146, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Meta-Analysis as Topic; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Time Factors	2004
GERD 2003: issues from the past and a consensus for the future. Drugs of today (Barcelona, Spain : 1998), 2004, Volume: 40 Suppl A Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Gastroesophageal Reflux; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Omeprazole; Pantoprazole; Postoperative Complications; Proton Pump Inhibitors; Sulfoxides	2004
Pantoprazole treatment does not invoke anti-inflammatory properties in vivo. International immunopharmacology, 2004, Volume: 4, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Benzimidazoles; Carrageenan; Helicobacter pylori; Inflammation; Lansoprazole; Male; Neutrophils; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar; Sulfoxides	2004
Retrospective evaluation of the effect of omeprazole on clozapine metabolism. Pharmacy world & science : PWS, 2004, Volume: 26, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Antipsychotic Agents; Benzimidazoles; Clozapine; Drug Interactions; Female; Humans; Long-Term Care; Male; Middle Aged; Omeprazole; Pantoprazole; Psychiatric Department, Hospital; Psychotic Disorders; Retrospective Studies; Smoking; Sulfoxides	2004
Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage? The American journal of gastroenterology, 2004, Volume: 99, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Costs and Cost Analysis; Drug Prescriptions; Drug Utilization Review; Female; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; United States	2004
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Esomeprazole; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Sulfoxides	2004
Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard. Arzneimittel-Forschung, 2004, Volume: 54, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Calibration; Chemistry, Pharmaceutical; Chromatography, Liquid; Humans; Indicators and Reagents; Lansoprazole; Mass Spectrometry; Omeprazole; Pantoprazole; Quality Control; Reference Standards; Reproducibility of Results; Sulfoxides; Therapeutic Equivalency	2004
Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers. Saudi medical journal, 2004, Volume: 25, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Benzimidazoles; Clarithromycin; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Jordan; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Risk Assessment; Severity of Illness Index; Sulfoxides; Treatment Outcome	2004
[Studies on chiral inversion of dextropantoprazole in human]. Yao xue xue bao = Acta pharmaceutica Sinica, 2004, Volume: 39, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Chromatography, High Pressure Liquid; Humans; Male; Omeprazole; Pantoprazole; Stereoisomerism; Sulfoxides	2004
[Treatment of reflux esophagitis by Xuanfu Daizhe Decoction combined with pantoprazole or omeprazole: a comparative study]. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2003, Volume: 1, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Benzimidazoles; Drug Therapy, Combination; Esophagitis, Peptic; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides	2003
Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzimidazoles; Chronic Disease; Dibenzothiazepines; Dose-Response Relationship, Drug; Doxepin; Drug Interactions; Drug Therapy, Combination; Esophagitis, Peptic; Humans; Lorazepam; Male; Metabolic Clearance Rate; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Quetiapine Fumarate; Schizophrenia; Sulfoxides	2004
Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography. Journal of separation science, 2004, Volume: 27, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohols; Amylose; Benzimidazoles; Chromatography; Lansoprazole; Models, Chemical; Omeprazole; Pantoprazole; Pressure; Rabeprazole; Stereoisomerism; Sulfoxides; Temperature; Time Factors	2004
Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage. Connecticut medicine, 2004, Volume: 68, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Connecticut; Cost-Benefit Analysis; Enzyme Inhibitors; Formularies, Hospital as Topic; Gastric Acid; Gastroscopy; Histamine H2 Antagonists; Humans; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Pharmacy and Therapeutics Committee; Proton Pump Inhibitors; Sulfoxides	2004
Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2004, Volume: 18, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Practice Patterns, Physicians'; Retrospective Studies; Sulfoxides	2004
Pantoprazole for sleepiness associated with acid reflux and obstructive sleep disordered breathing. The Laryngoscope, 2004, Volume: 114, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Arousal; Benzimidazoles; Circadian Rhythm; Cohort Studies; Disorders of Excessive Somnolence; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sleep Apnea, Obstructive; Sulfoxides; Treatment Outcome; Wakefulness	2004
Pachydermia is not diagnostic of active laryngopharyngeal reflux disease. The Laryngoscope, 2004, Volume: 114, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Hypertrophy; Lansoprazole; Laryngeal Diseases; Laryngeal Mucosa; Laryngoscopy; Long-Term Care; Male; Middle Aged; Omeprazole; Pantoprazole; Pharyngeal Diseases; Proton Pump Inhibitors; Retrospective Studies; Sulfoxides; Treatment Outcome; Voice Disorders	2004
Recurrent anaphylaxis linked to pantoprazole. The Journal of allergy and clinical immunology, 2004, Volume: 114, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anaphylaxis; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Gastroesophageal Reflux; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Recurrence; Sulfoxides	2004
Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo. Biochemical pharmacology, 2004, Dec-01, Volume: 68, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stomach; Sulfoxides	2004
[Choice of proton pump inhibitors--does it play any role?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2004, Oct-21, Volume: 124, Issue:20 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drugs, Generic; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2004
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. Journal of the National Cancer Institute, 2004, Nov-17, Volume: 96, Issue:22 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Antineoplastic Agents; Benzimidazoles; Blotting, Western; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Electrophoresis, Polyacrylamide Gel; Esomeprazole; Fluorouracil; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Inhibitory Concentration 50; Lymphoma; Melanoma; Mice; Mice, SCID; Microscopy, Confocal; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Transplantation, Heterologous; Vinblastine	2004
Results of triple eradication therapy in Japanese children: a retrospective multicenter study. Journal of gastroenterology, 2004, Volume: 39, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Humans; Infant; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sulfoxides	2004
[The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia]. Orvosi hetilap, 2004, Oct-17, Volume: 145, Issue:42 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Cisapride; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Quality of Life; Ranitidine; Reproducibility of Results; Sulfoxides; Surveys and Questionnaires; Time Factors; Treatment Outcome	2004
Excretion of pantoprazole in human breast. The Journal of reproductive medicine, 2004, Volume: 49, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Biological Transport, Active; Breast Feeding; Chromatography, High Pressure Liquid; Female; Humans; Milk, Human; Omeprazole; Pantoprazole; Risk Assessment; Sensitivity and Specificity; Sulfoxides	2004
[Paradigm change in reflux disease. In reflux patients listening to is often more important than endoscopy]. MMW Fortschritte der Medizin, 2004, Nov-04, Volume: 146, Issue:45 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Diagnosis, Differential; Endoscopy; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Surveys and Questionnaires; Time Factors	2004
[Attention! Cough, asthma and Co. are often caused by reflux]. MMW Fortschritte der Medizin, 2004, Nov-04, Volume: 146, Issue:45 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Asthma; Benzimidazoles; Clinical Trials as Topic; Cough; Gastroesophageal Reflux; Humans; Laryngoscopy; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Time Factors	2004
Less acid + less bleeding = better outcomes and more money! Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2004, Volume: 18, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Cost-Benefit Analysis; Enzyme Inhibitors; Gastric Acid; Gastroscopy; Health Care Costs; Humans; Infusions, Intravenous; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides; Treatment Outcome	2004
Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Dec-15, Volume: 10, Issue:24 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Annexin A5; Anti-Ulcer Agents; Apoptosis; Benzimidazoles; Biological Transport; Enzyme Activation; Fibroblasts; H(+)-K(+)-Exchanging ATPase; Heat-Shock Proteins; Humans; In Situ Nick-End Labeling; Intestinal Mucosa; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Rats; Stomach Neoplasms; Sulfoxides; Transplantation, Heterologous; Tumor Cells, Cultured	2004
Quality of life after peptic perforation. The Journal of the Association of Physicians of India, 2004, Volume: 52 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Digestive System Surgical Procedures; Female; Humans; Male; Middle Aged; Omeprazole; Outcome Assessment, Health Care; Pantoprazole; Peptic Ulcer Perforation; Prospective Studies; Quality of Life; Sickness Impact Profile; Sulfoxides; Surveys and Questionnaires	2004
Spillover effects of restrictive drug formularies: a case study of PacifiCare in California. The American journal of managed care, 2005, Volume: 11, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; California; Formularies as Topic; Gatekeeping; Managed Care Programs; Omeprazole; Organizational Case Studies; Pantoprazole; Physician-Patient Relations; Rabeprazole; Sulfoxides	2005
Probiotics: wanted dead or alive. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Feces; Humans; Hydrogen-Ion Concentration; Lactobacillus plantarum; Omeprazole; Pantoprazole; Probiotics; Proton Pump Inhibitors; Stomach; Sulfoxides	2005
Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cell Count; Enteroendocrine Cells; Female; Gastric Mucosa; Gastrin-Secreting Cells; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides	2005
Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Double-Blind Method; Fatty Acids; Feces; Female; Humans; Hydrogen-Ion Concentration; Lactobacillus plantarum; Male; Middle Aged; Omeprazole; Pantoprazole; Probiotics; Proton Pump Inhibitors; Stomach; Sulfoxides	2005
Physical characterization of pantoprazole sodium hydrates. International journal of pharmaceutics, 2005, Mar-03, Volume: 291, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Omeprazole; Pantoprazole; Solubility; Sulfoxides; Technology, Pharmaceutical	2005
Initial-rate method for the determination of pantoprazole in pharmaceutical formulations using 1-fluoro 2,4-dinitrobenzene. Die Pharmazie, 2005, Volume: 60, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Algorithms; Anti-Ulcer Agents; Benzimidazoles; Chemistry, Pharmaceutical; Chromatography, Thin Layer; Dimethyl Sulfoxide; Dinitrofluorobenzene; Dosage Forms; Indicators and Reagents; Kinetics; Omeprazole; Pantoprazole; Reference Standards; Solvents; Spectrophotometry, Ultraviolet; Sulfoxides	2005
The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in pat Cancer research, 2005, Apr-01, Volume: 65, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Benzimidazoles; Biological Transport; Brain; Dogs; Drug Synergism; Humans; Imatinib Mesylate; Male; Membranes; Methotrexate; Mice; Mice, Knockout; Neoplasm Proteins; Omeprazole; Pantoprazole; Piperazines; Pyrimidines; Spodoptera; Sulfoxides; Tetrahydroisoquinolines	2005
Metabolism of pantoprazole involving conjugation with glutathione in rats. The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimidazoles; Chromatography, High Pressure Liquid; Glutathione; Magnetic Resonance Spectroscopy; Male; Omeprazole; Pantoprazole; Pyridines; Rats; Rats, Wistar; Spectrometry, Mass, Electrospray Ionization; Sulfoxides	2005
Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. Digestive diseases and sciences, 2005, Volume: 50, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Benzimidazoles; Case-Control Studies; Chi-Square Distribution; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophagitis, Peptic; Esophagoscopy; Female; Follow-Up Studies; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Sulfoxides; Time Factors; Treatment Outcome	2005
Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs. American journal of veterinary research, 2005, Volume: 66, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Animals; Benzimidazoles; Dogs; Dose-Response Relationship, Drug; Famotidine; Food Deprivation; Gastric Acidity Determination; Gastric Juice; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Reference Values; Sulfoxides	2005
Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme. Irish medical journal, 2005, Volume: 98, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Community Pharmacy Services; Cost-Benefit Analysis; Drug Costs; Enzyme Inhibitors; Health Care Surveys; Humans; Ireland; Lansoprazole; National Health Programs; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2005
[Basic principles of successful GERD (gastroesophageal reflux disease) therapy]. Krankenpflege Journal, 2005, Volume: 43, Issue:1-3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Fundoplication; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Risk Factors; Sulfoxides	2005
Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs. The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Gastric Acid; Gastric Fistula; Guinea Pigs; Isomerism; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sulfoxides	2005
Apparent anaphylaxis associated with pantoprazole. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Jul-01, Volume: 62, Issue:13 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anaphylaxis; Anti-Ulcer Agents; Benzimidazoles; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2005
Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection. European journal of clinical pharmacology, 2005, Volume: 61, Issue:5-6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastroesophageal Reflux; Gene Frequency; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Retrospective Studies; Stomach Ulcer; Sulfoxides	2005
The healing course of thermal esophageal injury: a case report. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Burns; Esophagoscopy; Esophagus; Female; Follow-Up Studies; Granulation Tissue; Hot Temperature; Humans; Intestinal Mucosa; Omeprazole; Pantoprazole; Sulfoxides; Wound Healing	2005
High-performance liquid chromatography method for the quantification of pantoprazole in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005, Aug-05, Volume: 822, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chromatography, High Pressure Liquid; Humans; Omeprazole; Pantoprazole; Reproducibility of Results; Sensitivity and Specificity; Sulfoxides; Ultraviolet Rays	2005
Biotransformation of pantoprazole by the fungus Cunninghamella blakesleeana. Xenobiotica; the fate of foreign compounds in biological systems, 2005, Volume: 35, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Biotransformation; Cunninghamella; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Molecular Structure; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2005
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage. Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 372, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Diclofenac; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Glutathione; Indomethacin; Ligation; Lipoproteins, LDL; Male; Malondialdehyde; Omeprazole; Oxidation-Reduction; Pantoprazole; Peroxidase; Piroxicam; Proton Pump Inhibitors; Pylorus; Rats; Rats, Wistar; Sulfoxides	2005
Proton-pump-inhibitor-induced hepatitis. Southern medical journal, 2005, Volume: 98, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chemical and Drug Induced Liver Injury; Female; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2005
Pharmacokinetic differences between pantoprazole enantiomers in rats. Pharmaceutical research, 2005, Volume: 22, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme System; Intestine, Small; Male; Microsomes, Liver; Omeprazole; Pantoprazole; Protein Binding; Rats; Rats, Wistar; Stereoisomerism; Sulfoxides	2005
Balanced perspective essential in erosive oesophagitis treatment. Alimentary pharmacology & therapeutics, 2005, Nov-01, Volume: 22, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome	2005
Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK. Current medical research and opinion, 2005, Volume: 21, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; United Kingdom	2005
Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings. Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gene Rearrangement, B-Lymphocyte, Light Chain; Humans; Immunophenotyping; Immunoproliferative Small Intestinal Disease; Intestine, Small; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Mesentery; Metronidazole; Omeprazole; Pantoprazole; Retroperitoneal Space; Sulfoxides	2005
Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy. Scandinavian journal of gastroenterology, 2005, Volume: 40, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Mitoxantrone; Neoplasm Staging; Omeprazole; Pantoprazole; Patient Compliance; Prednisone; Proton Pump Inhibitors; Rituximab; Stomach Neoplasms; Sulfoxides; Treatment Outcome; Vincristine	2005
Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Nov-15, Volume: 62, Issue:22 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Stability; Omeprazole; Pantoprazole; Polypropylenes; Proton Pump Inhibitors; Sodium Chloride; Sulfoxides; Syringes; Temperature; Time Factors	2005
Helicobacter pylori: factors affecting eradication and recurrence. The American journal of gastroenterology, 2005, Volume: 100, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biological Availability; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Sulfoxides	2005
Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2005, Volume: 19, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Benzimidazoles; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Preoperative Care; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Sulfoxides; Time Factors; Treatment Outcome	2005
[Gastroesophageal reflux and obstructive sleep apnea syndrome]. Acta otorrinolaringologica espanola, 2005, Volume: 56, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sleep Apnea, Obstructive; Sulfoxides	2005
Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Benzimidazoles; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Medication Errors; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Sulfoxides	2005
Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis. Digestive diseases and sciences, 2006, Volume: 51, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Edema; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Pyloric Stenosis; Remission, Spontaneous; Sulfoxides	2006
Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. World journal of gastroenterology, 2005, Dec-28, Volume: 11, Issue:48 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Asthma; Benzimidazoles; Female; Forced Expiratory Volume; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides	2005
Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2006, Feb-15, Volume: 23, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Rifabutin; Sulfoxides; Treatment Outcome	2006
Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis. The Journal of rheumatology, 2006, Volume: 33, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Aged; Anti-Ulcer Agents; Antibodies, Antineutrophil Cytoplasmic; Benzimidazoles; Cell Nucleus; Chronic Disease; Exanthema; Female; Humans; Methylprednisolone; Nephritis, Interstitial; Omeprazole; Pantoprazole; Peroxidase; Renal Dialysis; Sulfoxides; Treatment Outcome; Vasculitis, Leukocytoclastic, Cutaneous	2006
Hydroxyl radical scavenging reactivity of proton pump inhibitors. Biochemical pharmacology, 2006, Apr-28, Volume: 71, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cattle; Copper Sulfate; Deoxyribose; Enzyme Inhibitors; Erythrocytes; Free Radical Scavengers; Heme; Hyaluronic Acid; Hydroxyl Radical; Iron Compounds; Lansoprazole; Omeprazole; Pantoprazole; Proton Pumps; Sulfides; Sulfoxides	2006
[Reflux therapy in the elderly]. Krankenpflege Journal, 2005, Volume: 43, Issue:7-10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Benzimidazoles; Gastroesophageal Reflux; Humans; Long-Term Care; Nursing Diagnosis; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides	2005
Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2006, Volume: 63, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Male; Microscopy, Electron, Scanning; Omeprazole; Pantoprazole; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Solubility; Sulfoxides	2006
Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2005, Volume: 16, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome	2005
Pantoprazole-induced thrombocytopenia. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Count; Sulfoxides; Thrombocytopenia	2006
A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; British Columbia; Cost Savings; Databases, Factual; Drug Utilization Review; Female; Health Services for the Aged; Hospitalization; Humans; Insurance, Pharmaceutical Services; Lansoprazole; Male; Omeprazole; Pantoprazole; Practice Patterns, Physicians'; Rabeprazole; Sulfoxides	2006
Proton pump inhibitors and acute interstitial nephritis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2006, Volume: 4, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Adult; Age Distribution; Aged; Aged, 80 and over; Australia; Benzimidazoles; Dyspepsia; Education, Medical, Continuing; Enzyme Inhibitors; Female; Gastroesophageal Reflux; Hospitals, Teaching; Humans; Male; Middle Aged; Nephritis, Interstitial; Omeprazole; Pantoprazole; Prevalence; Prognosis; Proton Pump Inhibitors; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution; Sulfoxides	2006
Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics, 2006, May-15, Volume: 23, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Administration Schedule; Enzyme Inhibitors; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Time Factors	2006
Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products. Chemical & pharmaceutical bulletin, 2006, Volume: 54, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acids; Anti-Ulcer Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2006
Effect of proton pump inhibitors on hepatic regeneration. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 2006, Volume: 38, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Female; Hepatectomy; Ki-67 Antigen; Lansoprazole; Liver; Liver Regeneration; Male; Omeprazole; Organ Size; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar; Sulfoxides	2006
An in vitro investigation on acid catalyzed reactions of proton pump inhibitors in the absence of an electrophile. International journal of pharmaceutics, 2006, Oct-12, Volume: 323, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acids; Anti-Ulcer Agents; Catalysis; Dimerization; Drug Stability; Electrochemistry; Enzyme Inhibitors; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Polarography; Proton Pump Inhibitors	2006
Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography. Die Pharmazie, 2006, Volume: 61, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antihypertensive Agents; Benzimidazoles; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Ketoprofen; Omeprazole; Pantoprazole; Reference Standards; Reproducibility of Results; Sulfoxides; Tetrazoles; Valine; Valsartan	2006
Severe laryngeal hyperkeratosis secondaryto laryngopharyngeal reflux. Ear, nose, & throat journal, 2006, Volume: 85, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Therapy, Combination; Gastroesophageal Reflux; Hoarseness; Humans; Keratosis; Laryngeal Diseases; Laryngeal Mucosa; Laryngoscopy; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Ranitidine; Respiratory Tract Infections; Sulfoxides	2006
Treatment of laryngopharyngeal reflux improves asthma symptoms in asthmatics. The Journal of asthma : official journal of the Association for the Care of Asthma, 2006, Volume: 43, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Asthma; Benzimidazoles; Combined Modality Therapy; Cross-Sectional Studies; Feeding Behavior; Female; Gastroesophageal Reflux; Humans; Laryngoscopy; Life Style; Male; Middle Aged; Omeprazole; Pantoprazole; Statistics as Topic; Sulfoxides; Treatment Outcome	2006
Thyroxine in goiter, H. pylori infection, and gastritis. The New England journal of medicine, 2006, Sep-14, Volume: 355, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adsorption; Anti-Ulcer Agents; Benzimidazoles; Biological Availability; Gastric Acid; Gastritis; Goiter; Helicobacter Infections; Humans; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Thyroxine	2006
Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Nephrology (Carlton, Vic.), 2006, Volume: 11, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Ulcer Agents; Biopsy; Blood Sedimentation; C-Reactive Protein; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nephritis, Interstitial; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Risk Factors	2006
Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding. Alimentary pharmacology & therapeutics, 2006, Oct-15, Volume: 24, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Treatment Outcome	2006
Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding. Alimentary pharmacology & therapeutics, 2007, Feb-01, Volume: 25, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Treatment Outcome	2007
Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles. Chirality, 2007, Volume: 19, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chromatography; Chromatography, Supercritical Fluid; Circular Dichroism; Enzyme Inhibitors; Lansoprazole; Models, Chemical; Molecular Conformation; Molecular Structure; Omeprazole; Pantoprazole; Rabeprazole; Stereoisomerism	2007
Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004. Journal of toxicology and environmental health. Part A, 2007, Apr-15, Volume: 70, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Animals; Child; Child, Preschool; Enzyme Inhibitors; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Poison Control Centers; Poisoning; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Texas	2007
The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2007, Volume: 56, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Apoptosis; Calcium; Cell Movement; Cells, Cultured; Gastric Acid; H(+)-K(+)-Exchanging ATPase; Humans; Interleukin-8; Ionophores; Macrolides; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nigericin; Omeprazole; p38 Mitogen-Activated Protein Kinases; Pantoprazole; Potassium; Protein Kinase Inhibitors; Proton Pump Inhibitors	2007
Long-term proton pump inhibitor use in children: a retrospective review of safety. Digestive diseases and sciences, 2008, Volume: 53, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Child; Child, Preschool; Esophagitis; Female; Gastrins; Humans; Lansoprazole; Liver Function Tests; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Vitamin B 12	2008
Laparoscopic partial posterior (Toupet) fundoplication improves esophageal bolus propagation on scintigraphy. Surgical endoscopy, 2008, Volume: 22, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Cross-Over Studies; Esophageal Sphincter, Lower; Esophagus; Fundoplication; Gastroesophageal Reflux; Humans; Laparoscopy; Manometry; Middle Aged; Omeprazole; Pantoprazole; Peristalsis; Prospective Studies; Proton Pump Inhibitors; Radionuclide Imaging; Treatment Outcome	2008
Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. Acta dermato-venereologica, 2008, Volume: 88, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Autoantibodies; Duodenal Ulcer; Esophagitis; Female; Humans; Lansoprazole; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Skin	2008
EMANCIPATE study: drawing conclusions may be difficult in the absence of fundamental information. European journal of gastroenterology & hepatology, 2008, Volume: 20, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Research Design; Secondary Prevention	2008
EMANCIPATE versus EXPO: different results can be explained by differing study designs. European journal of gastroenterology & hepatology, 2008, Volume: 20, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Research Design; Secondary Prevention	2008
Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer. Cancer science, 2008, Volume: 99, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Apoptosis; Caspases; Cell Line, Tumor; Culture Media; Enzyme Activation; Humans; Hydrogen-Ion Concentration; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Omeprazole; Pantoprazole; Phosphorylation; Proton Pump Inhibitors; Stomach Neoplasms	2008
[Drug treatment and surgical indications in gastroesophageal reflux]. Revista de gastroenterologia de Mexico, 2007, Volume: 72 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clinical Trials as Topic; Fundoplication; Gastroesophageal Reflux; Histamine Antagonists; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Time Factors	2007
[General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study]. Presse medicale (Paris, France : 1983), 2008, Volume: 37, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Costs and Cost Analysis; Esomeprazole; Family Practice; Female; France; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pumps; Rabeprazole	2008
Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat. Pharmacological research, 2008, Volume: 58, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anesthesia; Animals; Blood Pressure; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Female; Heart Atria; Heart Rate; Humans; In Vitro Techniques; Injections, Intravenous; Lansoprazole; Male; Myocardial Contraction; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar	2008
IgE-mediated anaphylaxis to proton pump inhibitors - cross-reacting study. Allergy, 2008, Volume: 63, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anaphylaxis; Female; Humans; Immunoglobulin E; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Skin Tests	2008
[Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts]. MMW Fortschritte der Medizin, 2008, Oct-02, Volume: 150, Issue:40 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Costs and Cost Analysis; Drugs, Generic; Family Practice; Female; Gastroesophageal Reflux; Germany; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Tablets; Time Factors	2008
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 52, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole	2008
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. American heart journal, 2009, Volume: 157, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Blood Platelets; Clopidogrel; Drug Interactions; Esomeprazole; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2009
Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. Journal of clinical pharmacy and therapeutics, 2009, Volume: 34, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analgesics, Non-Narcotic; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Color; Drug Incompatibility; Drug Stability; Drug Storage; Esomeprazole; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Nefopam; Omeprazole; Pantoprazole; Pharmaceutical Solutions; Proton Pump Inhibitors; Temperature; Time Factors	2009
Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit? Thrombosis and haemostasis, 2009, Volume: 101, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Humans; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Stents; Ticlopidine	2009
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thrombosis and haemostasis, 2009, Volume: 101, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Stents; Ticlopidine	2009
Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. Biomedical chromatography : BMC, 2009, Volume: 23, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, High Pressure Liquid; Drug Stability; Humans; Isoxazoles; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Zonisamide	2009
[Therapy of gastric acid-induced illnesses in general practice. The first pantoprazole generic drug has arrived]. MMW Fortschritte der Medizin, 2009, Jan-29, Volume: 151, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biological Availability; Cost-Benefit Analysis; Drug Costs; Drug Interactions; Drugs, Generic; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole	2009
Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo. Current drug delivery, 2009, Volume: 6, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acid Phosphatase; Animals; Bone Cements; Bone Resorption; Calcium Phosphates; Femur; Isoenzymes; Male; Omeprazole; Osteoblasts; Osteoclasts; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar; Tartrate-Resistant Acid Phosphatase	2009
Proton pump inhibitors and clopidogrel: a difficult dilemma. American heart journal, 2009, Volume: 157, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Thrombosis; Ticlopidine	2009
Do the association of cytochrome P450 interacting drugs, influence clopidogrel efficacity? American heart journal, 2009, Volume: 158, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Blood Platelets; Clopidogrel; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2009
Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma. The Journal of allergy and clinical immunology, 2009, Volume: 124, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Asthma; Cell Line, Tumor; Disease Models, Animal; Interleukin-13; Interleukin-4; Mice; Omeprazole; Pantoprazole; Phosphorylation; Pneumonia; Proton Pump Inhibitors; Signal Transduction; STAT6 Transcription Factor	2009
Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Asian People; Drug Administration Schedule; Duodenal Ulcer; Duodenoscopy; Gastroscopy; Hemostatic Techniques; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Rabeprazole; Recurrence; Stomach Ulcer; Time Factors; Treatment Outcome	2009
[Why some proton pump inhibitors are more equal than others]. Nederlands tijdschrift voor geneeskunde, 2009, Volume: 153 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Deglutition Disorders; Drugs, Generic; Female; Gastroesophageal Reflux; Humans; Intestinal Absorption; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2009
Immediate-release oral proton pump inhibitors: Panacea or a flash in the pan? Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Buffers; Chemistry, Pharmaceutical; Down-Regulation; Gastric Acid; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Injections, Intravenous; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Sodium Bicarbonate; Time Factors	2010
[Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors]. Medicina clinica, 2010, May-08, Volume: 134, Issue:13 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Drug Costs; Female; Health Resources; Hospital Costs; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Salaries and Fringe Benefits; Severity of Illness Index; Treatment Outcome	2010
Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. Clinical drug investigation, 2010, Volume: 30, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cross Reactions; Humans; Male; Middle Aged; Neutropenia; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2010
Editorial: just how "difficult" is it to withdraw PPI treatment? The American journal of gastroenterology, 2010, Volume: 105, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dyspepsia; Esophagitis; Gastric Acid; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Placebos; Proton Pump Inhibitors	2010
Spectrophotometric determination of peptic ulcer sulfur-containing drugs in bulk form and in tablets. Drug testing and analysis, 2010, Volume: 2, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Iodates; Limit of Detection; Omeprazole; Pantoprazole; Potassium Compounds; Powders; Proton Pump Inhibitors; Rabeprazole; Spectrophotometry; Sulfur Compounds; Tablets	2010
Novel approaches to inhibition of gastric acid secretion. Current gastroenterology reports, 2010, Volume: 12, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Histamine Antagonists; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine	2010
Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole. The Netherlands journal of medicine, 2010, Volume: 68, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonists; Humans; Magnesium Deficiency; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome	2010
It is difficult to discontinue PPI treatment in patients with GERD. The American journal of gastroenterology, 2011, Volume: 106, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clinical Trials as Topic; Dyspepsia; Esophagitis; Gastric Acid; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Placebos; Proton Pump Inhibitors	2011
Clopidogrel with or without omeprazole in coronary disease. The New England journal of medicine, 2011, 02-17, Volume: 364, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cardiovascular Diseases; Chemistry, Pharmaceutical; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2011
False elevation of chromogranin A due to proton pump inhibitors. The Netherlands journal of medicine, 2011, Volume: 69, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Biomarkers; Chromogranin A; Female; Humans; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2011
Effects of different proton pump inhibitors on cardiac contractility in isolated human failing myocardium. The Journal of cardiovascular surgery, 2011, Volume: 52, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dose-Response Relationship, Drug; Esomeprazole; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Kinetics; Myocardial Contraction; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ventricular Function, Right	2011
The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Hepatocytes; Humans; Inhibitory Concentration 50; Lansoprazole; Microsomes; Microsomes, Liver; Omeprazole; Pantoprazole; Protein Binding; Proton Pump Inhibitors; Recombinant Proteins; Ticlopidine	2011
Differential effects of Cu(II) and Fe(III) on the binding of omeprazole and pantoprazole to bovine serum albumin: toxic effect of metal ions on drugs. Journal of pharmaceutical and biomedical analysis, 2011, Dec-15, Volume: 56, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Copper; Fluorescence; Iron; Omeprazole; Pantoprazole; Protein Binding; Serum Albumin, Bovine	2011
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 58, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms	2011
Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter. The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Angiotensins; Animals; Carbachol; Electric Stimulation; Esophageal Sphincter, Lower; Gastroesophageal Reflux; Lansoprazole; Muscle Relaxation; Muscle, Smooth; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar	2011
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins. Acta dermato-venereologica, 2012, Volume: 92, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays	2012
Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability. European journal of clinical investigation, 2012, Volume: 42, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Animals; Bacteria; Bacterial Infections; Cohort Studies; Female; Humans; Jejunum; Liver Cirrhosis; Male; Middle Aged; Models, Animal; Netherlands; Omeprazole; Pantoprazole; Peritonitis; Permeability; Polyethylene Glycols; Proton Pump Inhibitors; Ranitidine; Rats; Rats, Wistar; Risk Factors	2012
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cells, Cultured; Computer Simulation; Cytochrome P-450 CYP2C19; Dealkylation; Dexlansoprazole; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Hepatocytes; Humans; Kinetics; Lansoprazole; Liver; Microsomes, Liver; Models, Biological; NADP; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Recombinant Proteins; Substrate Specificity	2012
Nine cases of allergy to omeprazole. Journal of investigational allergology & clinical immunology, 2012, Volume: 22, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Cross Reactions; Drug Hypersensitivity; Enzyme Inhibitors; Female; Humans; Immunoglobulin E; Male; Middle Aged; Omeprazole; Pantoprazole; Young Adult	2012
[Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors]. Terapevticheskii arkhiv, 2012, Volume: 84, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome	2012
Tetany, hypomagnesemia, and proton-pump inhibitors. The American journal of medicine, 2012, Volume: 125, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biomarkers; Female; Humans; Hypoparathyroidism; Magnesium; Magnesium Deficiency; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Tetany	2012
Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats. Pharmacological reports : PR, 2012, Volume: 64, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alendronate; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Drug Interactions; Estrogens; Female; Femur; Omeprazole; Ovariectomy; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Wistar; Tibia	2012
Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients. Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Esomeprazole; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Time Factors; Treatment Outcome	2012
Cutaneous reactions to proton pump inhibitors: a case-control study. Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Case-Control Studies; Chi-Square Distribution; Drug Eruptions; Esomeprazole; Exanthema; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Prevalence; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Statistics, Nonparametric; Stevens-Johnson Syndrome; Thailand; Urticaria; Young Adult	2012
Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients. Current medical research and opinion, 2013, Volume: 29, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Case-Control Studies; Clopidogrel; Cohort Studies; Coronary Artery Bypass; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Myocardial Infarction; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Rabeprazole; Risk; Stroke; Ticlopidine	2013
Inhibition of lysosomal enzyme activities by proton pump inhibitors. Journal of gastroenterology, 2013, Volume: 48, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzymes; Humans; Hydrogen-Ion Concentration; Immune System; Immunotherapy; Lansoprazole; Lysosomes; Male; Mass Spectrometry; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Omeprazole; Pantoprazole; Prodrugs; Proton Pump Inhibitors; Spleen	2013
Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors. Dermatology (Basel, Switzerland), 2013, Volume: 226, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Esomeprazole; Female; Humans; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2013
Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole. Biomedical chromatography : BMC, 2014, Volume: 28, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Stereoisomerism	2014
Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study. Scandinavian journal of gastroenterology, 2013, Volume: 48, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Drug Substitution; Esomeprazole; Gastroesophageal Reflux; Health Policy; Humans; Insurance, Health, Reimbursement; Lansoprazole; Norway; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2013
Reaction of proton pump inhibitors with model peptides results in novel products. Journal of pharmacological sciences, 2013, Volume: 122, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Catalytic Domain; Cysteine; Enzyme Inhibitors; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Lansoprazole; Mass Spectrometry; Molecular Structure; Omeprazole; Pantoprazole; Peptides; Proton Pump Inhibitors; Pyridones; Sulfamerazine	2013
Slow, spontaneous degradation of lansoprazole, omeprazole and pantoprazole tablets: isolation and structural characterization of the toxic antioxidants 3H-benzimidazole-2-thiones. Die Pharmazie, 2013, Volume: 68, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antioxidants; Benzimidazoles; Chromatography, High Pressure Liquid; Drug Stability; Indicators and Reagents; Lansoprazole; Magnetic Resonance Spectroscopy; Omeprazole; Pantoprazole; Spectrometry, Mass, Electrospray Ionization; Tablets; Temperature; Thiones	2013
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2014, Feb-14, Volume: 52 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Apamin; Calcium; Dinoprostone; Esomeprazole; Female; Humans; In Vitro Techniques; Indomethacin; Lansoprazole; Muscle Contraction; Myometrium; NG-Nitroarginine Methyl Ester; Omeprazole; Oxytocin; Pantoprazole; Peptides; Potassium Chloride; Pregnancy; Proton Pump Inhibitors; Rabeprazole; Tocolytic Agents	2014
The stereoselectivity of CYP2C19 on R- and S-isomers of proton pump inhibitors. Chemical biology & drug design, 2014, Volume: 83, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Binding Sites; Cytochrome P-450 CYP2C19; Lansoprazole; Molecular Conformation; Molecular Dynamics Simulation; Omeprazole; Pantoprazole; Protein Binding; Protein Structure, Tertiary; Proton Pump Inhibitors; Stereoisomerism; Thermodynamics	2014
Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase. Bioorganic & medicinal chemistry letters, 2014, Feb-15, Volume: 24, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dose-Response Relationship, Drug; Molecular Structure; N-Glycosyl Hydrolases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Structure-Activity Relationship; Trichomonas vaginalis	2014
Proton-pump inhibitor use and hip fractures in men: a population-based case-control study. Annals of epidemiology, 2014, Volume: 24, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; California; Case-Control Studies; Confidence Intervals; Hip Fractures; Humans; Male; Middle Aged; Odds Ratio; Omeprazole; Osteoporosis; Pantoprazole; Proton Pump Inhibitors	2014
Clopidogrel and proton pump inhibitors. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2014, Feb-18, Volume: 186, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Coronary Syndrome; Clinical Trials as Topic; Clopidogrel; Drug Combinations; Drug Interactions; Humans; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2014
Clopidogrel and proton pump inhibitors. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2014, Feb-18, Volume: 186, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clopidogrel; Humans; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2014
Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress. Wiener klinische Wochenschrift, 2015, Volume: 127, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Stomach Ulcer; Stress, Psychological; Treatment Outcome; Young Adult	2015
Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole. Pharmacogenomics, 2014, Volume: 15, Issue:15 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Cytochrome P-450 CYP2C19; Female; Genetic Association Studies; Genotype; Humans; Inactivation, Metabolic; Male; Omeprazole; Pantoprazole; Polymorphism, Genetic; Rabeprazole	2014
[Comparison of the effectiveness of omeprazole and pantoprazole treatment of gastroesophageal reflux disease in patients with asthma]. Likars'ka sprava, 2013, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Asthma; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lung; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Respiratory Function Tests; Treatment Outcome	2013
Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors. Stroke, 2015, Volume: 46, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Data Interpretation, Statistical; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proportional Hazards Models; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Risk; Stroke; Ticlopidine	2015
In vitro study of the variable effects of proton pump inhibitors on voriconazole. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antifungal Agents; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Esomeprazole; Humans; Lansoprazole; Microsomes, Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Voriconazole	2015
Increased liver enzyme levels during azathioprine treatment: beware of concomitant use of proton pump inhibitors. The British journal of dermatology, 2015, Volume: 173, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine Transaminase; Azathioprine; Dermatitis, Atopic; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Foot Dermatoses; gamma-Glutamyltransferase; Hand Dermatoses; Humans; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2015
Lansoprazole is an antituberculous prodrug targeting cytochrome bc1. Nature communications, 2015, Jul-09, Volume: 6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antitubercular Agents; Cell Line; Drug Discovery; Drug Resistance, Bacterial; Electron Transport Complex III; Fibroblasts; High-Throughput Screening Assays; Humans; Lansoprazole; Macrophages; Mice; Mycobacterium tuberculosis; Omeprazole; Pantoprazole; Prodrugs; Proton Pump Inhibitors; Sulfides; Tuberculosis, Multidrug-Resistant	2015
CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine. The Journal of pharmacology and experimental therapeutics, 2015, Volume: 354, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Cytochrome P-450 CYP2C19; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Precision Medicine; Proton Pump Inhibitors; Reproducibility of Results; Young Adult	2015
Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study. Helicobacter, 2016, Volume: 21, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Urease; Young Adult	2016
Possible drug-drug interaction between high-dose esomeprazole and phenprocoumon. European journal of clinical pharmacology, 2015, Volume: 71, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acenocoumarol; Aged; Aged, 80 and over; Anti-Ulcer Agents; Anticoagulants; Dose-Response Relationship, Drug; Drug Interactions; Esomeprazole; Female; Hospitalization; Hospitals, Teaching; Humans; International Normalized Ratio; Male; Omeprazole; Pantoprazole; Phenprocoumon	2015
Acute interstitial nephritis caused by two different proton pump inhibitors. British journal of hospital medicine (London, England : 2005), 2016, Volume: 77, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Female; Humans; Middle Aged; Nephritis, Interstitial; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2016
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Rabeprazole; Young Adult	2016
Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study. International journal of molecular sciences, 2016, Apr-15, Volume: 17, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Arginine; Coronary Artery Disease; Cross-Sectional Studies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome	2016
Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period. Alimentary pharmacology & therapeutics, 2016, Volume: 44, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Young Adult	2016
Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA, 2016, May-17, Volume: 315, Issue:19 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biopsy; Eosinophils; Esophagitis, Peptic; Esophagus; Female; Gastroesophageal Reflux; Humans; Lymphocytes; Male; Middle Aged; Neutrophils; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Withholding Treatment	2016
Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology, 2017, Volume: 152, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administrative Claims, Healthcare; Adult; Aged; Case-Control Studies; Esomeprazole; Female; Hepatic Encephalopathy; Humans; Incidence; Insurance, Health; Lansoprazole; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Taiwan	2017
The influence of changes in hospital drug formulary on the prescription of proton pump inhibitors. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2017, Jan-01, Volume: 41, Issue:n01 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Drug Prescriptions; Drug Utilization; Formularies, Hospital as Topic; Humans; Omeprazole; Outpatients; Pantoprazole; Proton Pump Inhibitors; Retrospective Studies	2017
BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS. Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2015, Dec-31, Volume: 22, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Critical Illness; Drug Costs; Humans; Infusions, Intravenous; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Suspensions	2015
Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine. Clinical pharmacokinetics, 2018, Volume: 57, Issue:6 Topics: Antidepressive Agents, Second-Generation; Cytochrome P-450 Enzyme System; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Venlafaxine Hydrochloride	2018
[Immediate type reactions to proton pump inhibitors using pantoprazole and omeprazole as examples]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2018, Volume: 69, Issue:2 Topics: Administration, Oral; Anaphylaxis; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Female; Heart Arrest; Humans; Intradermal Tests; Male; Middle Aged; Omeprazole; Pantoprazole; Patch Tests; Proton Pump Inhibitors	2018
Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study). Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Asian People; Esomeprazole; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Outpatients; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Time Factors; Treatment Outcome; Young Adult	2018
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. European journal of internal medicine, 2019, Volume: 59 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Esomeprazole; Female; Hospitalization; Humans; Hyponatremia; Lansoprazole; Logistic Models; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Population; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sweden; Young Adult	2019
Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference? European journal of clinical pharmacology, 2019, Volume: 75, Issue:6 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Interactions; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors	2019
A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors. The Journal of pharmacy and pharmacology, 2019, Volume: 71, Issue:10 Topics: Aryldialkylphosphatase; Enzyme Inhibitors; Esomeprazole; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Risk Factors	2019
Qualimetric analysis of proton pump inhibitors in Ukraine. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2019, Volume: 72, Issue:9 cz 2 Topics: Dexlansoprazole; Esomeprazole; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Quality Control; Rabeprazole; Ukraine	2019
The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study. Journal of cardiovascular pharmacology, 2020, Volume: 75, Issue:4 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Time Factors; Treatment Outcome	2020
A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations. British journal of clinical pharmacology, 2020, Volume: 86, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Humans; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Voriconazole	2020
Effect of proton pump inhibitors on voriconazole concentrations in Chinese patients with malignant hematological diseases. European journal of clinical pharmacology, 2020, Volume: 76, Issue:6 Topics: Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Lansoprazole; Male; Molecular Docking Simulation; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Retrospective Studies; Voriconazole	2020
Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole. Pharmacology, 2020, Volume: 105, Issue:11-12 Topics: Antioxidants; Ascorbic Acid; Biphenyl Compounds; Esomeprazole; Free Radicals; In Vitro Techniques; Inhibitory Concentration 50; Lansoprazole; Omeprazole; Pantoprazole; Picrates; Proton Pump Inhibitors; Rabeprazole; Spectrophotometry	2020
Simultaneous enantioselective determination of omeprazole, rabeprazole, lansoprazole, and pantoprazole enantiomers in human plasma by chiral liquid chromatography-tandem mass spectrometry. Journal of separation science, 2020, Volume: 43, Issue:16 Topics: Chromatography, High Pressure Liquid; Humans; Lansoprazole; Molecular Structure; Omeprazole; Pantoprazole; Rabeprazole; Stereoisomerism; Tandem Mass Spectrometry	2020
Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report. Journal of medical case reports, 2020, Jun-29, Volume: 14, Issue:1 Topics: Aged; Asymptomatic Diseases; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2020
Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro. Andrology, 2020, Volume: 8, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Fertilization; Humans; Lansoprazole; Male; Membrane Potentials; Middle Aged; Omeprazole; Pantoprazole; Phosphorylation; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Semen Analysis; Sperm Capacitation; Sperm Maturation; Sperm Motility; Spermatozoa; Young Adult	2020
Spectroscopic study of in situ-formed metallocomplexes of proton pump inhibitors in water. Chemical biology & drug design, 2021, Volume: 97, Issue:2 Topics: Coordination Complexes; Ferric Compounds; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Spectrophotometry; Transition Elements; Water	2021
Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis. Medicine, 2020, Dec-11, Volume: 99, Issue:50 Topics: Bacterial Infections; Case-Control Studies; Databases, Factual; Female; Germany; Humans; Liver Cirrhosis; Male; Middle Aged; Omeprazole; Pantoprazole; Propensity Score; Proton Pump Inhibitors; Regression Analysis; Risk Factors	2020
Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use. Drug design, development and therapy, 2020, Volume: 14 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, High Pressure Liquid; Drugs, Investigational; Esomeprazole; Humans; Lansoprazole; Molecular Structure; Omeprazole; Pantoprazole; Polypropylenes; Proton Pump Inhibitors; Rabeprazole	2020
Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis. Medicine, 2021, Feb-26, Volume: 100, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Humans; Meta-Analysis as Topic; Omeprazole; Pancreatitis; Pantoprazole; Proton Pump Inhibitors; Research Design; Systematic Review as Topic	2021
Anaphylaxis to Pantoprazole: A Case Report and Prerequisite for Vigilant Prescribing Practises for Proton Pump Inhibitors. Current drug safety, 2022, Volume: 17, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anaphylaxis; Female; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2022
Proton pump inhibitor therapy and risk of knee replacement surgery: a general population-based cohort study. Osteoarthritis and cartilage, 2022, Volume: 30, Issue:4 Topics: Cohort Studies; Esomeprazole; Humans; Lansoprazole; Omeprazole; Osteoarthritis, Knee; Pantoprazole; Proton Pump Inhibitors; Rabeprazole	2022
Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies. Journal of clinical epidemiology, 2022, Volume: 151 Topics: COVID-19; Famotidine; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2022
Patient journey in erosive oesophagitis: real-world perspectives from US physicians and patients. BMJ open gastroenterology, 2022, Volume: 9, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Esophagitis; Gastroesophageal Reflux; Heartburn; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Physicians; Proton Pump Inhibitors	2022
Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults. Atherosclerosis, 2022, Volume: 358 Topics: Aged; Antihypertensive Agents; Atherosclerosis; Cardiovascular Diseases; Histamine; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Risk Assessment; Risk Factors	2022
Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation. Chemico-biological interactions, 2022, Dec-01, Volume: 368 Topics: Animals; Cytochrome P-450 CYP2E1; Indican; Lansoprazole; Mice; Omeprazole; Pantoprazole; Proteolysis; Proton Pump Inhibitors; Renal Insufficiency, Chronic; Uremic Toxins	2022
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany. Drugs & aging, 2023, Volume: 40, Issue:7 Topics: Cognitive Dysfunction; Dementia; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors	2023